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Abstract. 
Background: Multi-step cancerogenesis guides laryngeal cancer onset and it includes a wide 
variety of pre-cancerous lesions that are macroscopically challenging to identify and distinguish 
from initial cancerous foci. Since the treatment of laryngeal cancer and its precursor lesions has a 
great impact on important laryngeal basic functions, early detection and preoperative assessment are 
important for a curative and function-preserving therapy. Nowadays, despite the high number of 
more advanced diagnostic techniques and methods, unfortunately, it is not uncommon for different 
clinicians to use different nomenclature or to identify different stage for the same laryngeal lesion. 
From these observations, it is obvious that an instrument offering the possibility to detect pre-
cancerous lesions, early cancerous lesions, and satellite foci or second primaries would be the key 
to improving management and outcome in laryngeal patients.  
Object. Different modalities of diagnostic techniques of laryngeal lesions exist. Rather than 
difference between benign and obvious malignant diseases, more difficult is to detect the presence 
of precancerous epithelial alterations. Not all tests achieve the same diagnostic accuracy, hence this 
meta-analysis of literature aimed to synthesize the validity of each single diagnostic technique in 
identifying and staging laryngeal disease. 
Methods: A systematic review of literature was led searching for articles mentioning the following 
terms including their various combinations to maximize the yield: larynx, laryngeal precancerous 
lesions, laryngeal cancer, white light (WL) endoscopy, stroboscopy, contact endoscopy (CE), 
autofluorescence (AF), ultrasound (US), narrow band imaging (NBI), computed axial tomography 
(CAT), magnetic resonance imaging (MRI), positron emission tomography (PET), CAT/PET. Then, 
a quantitative analysis was carried on for paper published after 2005 onward, reporting a minumun 
series of 10 patients each study, declaring sensitivity and specificity of each diagnostic system.  
Results: The search identified 7215 publications, of which 3616 published after 2005, with a final 
results of a total of 214 articles stratified and included by our selection criteria. 42 out of 214 
articles were selected for quantitative synthesis. 25 out of 41 studies had a quality score of ≥ 6 
(good), 16 presented a score between 4 and 5 (fair). While objections can be raised about the 
pooling of different diagnostic procedures under the same group and the high level of heterogeneity 
in the meta-analyses, the inclusion of over 4400 laryngeal lesions makes the results fairly robust. 
Conclusions: A comprehensive overview of the most recent advances in laryngeal imaging 
technology combined with all of the information needed to interpret findings and successfully 
manage patients with voice disorders can be found herein. With these data, clinicians can risk-
stratify patients and select proper examination modalities in order to provide appropriate care. 
Moreover, study limitations, together with possible clinical and research implications have been 
counted, as well. !
Key words: laryngeal cancer; laryngeal lesions diagnosis; laryngeal precancerosis; diagnostic 
imaging; meta-analysis; systematic review !
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1. Introduction. 
Across medicine, there has been great effort to parse out the sensitivity and specificity of clinical 
metrics employed to diagnose disorders related to a given symptom. This principle rests upon the 
notion that not all tests achieve the same diagnostic accuracy and that all tests must be considered 
against a gold standard. With these data, clinicians can risk-stratify patients and select proper 
examination modalities in order to provide appropriate care.  
In otolaryngology, hoarseness is the most common laryngeal symptom for which patients seek 
treatment and may be caused by a diversity of potential disorders. In this setting, visualization of the 
structure and function of the vocal folds has become an essential component of the clinical voice 
assessment protocol (1,2), because the capacity of history and physical examination alone to yield 
adequate information to get the right diagnosis or even risk-stratify patients has not yet been 
reported. Attempts to examine the human larynx date back more than 150 years, in fact, in 1854 
Manuel Garcia, a vocal music teacher, examined his own larynx using a dental mirror and a hand 
mirror, and published his observations in 1855 (3). Imaging technologies applicable in laryngology 
developed enormously since then. 
Nowadays, the diagnostic procedure of laryngeal diseases in clinical practice is rather complex and 
is based on the evaluation of patient’s complaints, history, and data of instrumental as well as 
histological examinations. During the last two decades a variety of imaging techniques for the 
examination of the larynx and obtaining objective measurements of voice quality have been 
developed (4,5). The term “laryngeal imaging” typically refers to the endoscopic imaging of vocal 
fold tissue clinical aspect and vibration via videoendoscopy and videostroboscopy; in addition, 
evaluation of larynx has improved significantly with the establishment of computed axial 
tomography (CAT) and magnetic resonance imaging (MRI), as these technologies provide insights 
into the endoscopically blind areas and reveal the depth of tumor infiltration (6). These technologies 
may be beneficial in staging laryngeal carcinoma and planning the most appropriate surgical 
procedure (7,8). Recently, ultrasonography has become useful as well in cases of larger laryngeal 
lesions and may have some role in screening for unilateral vocal fold pathologies. At the same time, 
further fine-tuning of the technique may be necessary (9,10). 
Despite all of these efforts in achieving the perfect diagnostic tool, nowadays surgeons cannot trust 
one single imaging technique to plan laryngeal patients management and treatment. In this setting, 
recent reviews emphasized the need for further technological, methodological and clinical research 
on laryngeal imaging, including the development of clinical norms and objective image processing 
and measurement methods (11-13).  
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This paper provides a review of the latest advances in laryngeal imaging over the last decade in 
order to give a comprehensive overview of the most recent advances in laryngeal imaging 
technology combined with all of the information needed to interpret findings and successfully 
manage patients with voice disorders. !
2. How to write a systematic review and a meta-analysis. 
Systematic reviews and meta-analyses have become increasingly important in health care. 
Clinicians read them to keep up to date with their field (14,15), and they are often used as a starting 
point for developing clinical practice guidelines. As with all research, the value of a systematic 
review depends on what was done, what was found, and the clarity of reporting. 
Undertaking a systematic review allows for the acquisition of skills in electronic searching, research 
methodology, critical appraisal, and statistical analysis. Even when reviews have inconclusive 
findings, they may be of tremendous value in providing a firm foundation from which to embark on 
a new research project. Understanding the extent of the evidence base in our specialty and how it is 
synthesized, greatly empowers the surgeon. This allows the uncertainties of patients and the 
concerns of health resource managers to be addressed.	

High quality Cochrane systematic reviews are undertaken to provide answers to clinical research 
questions. However, they serve an equally important purpose as a primer for future work. The 
“empty” review, or one that does not come to a solid conclusion, is often interpreted with 
disappointment (16), but the review still retains tremendous value. An integral part of every 
Cochrane review is a section in which the authors comment on “Implications for research.” This is 
an invaluable part of the reviewing process that allows for the constructive synthesis of those 
failings and criticisms of trials that were not evident until the original trials concluded. It would 
appear prudent for those undertaking any new project to incorporate these findings before 
embarking on further study. Unfortunately, many of the methodologic shortcomings are often 
repeated despite the identification and acknowledgment of these by the authors of previous studies 
in their conclusions. Paradoxically therefore, a well-conducted and comprehensive systematic 
review potentially serves as great a purpose as a starting point as it does an endpoint to a clinical 
question (17). 
The literature review lies at the heart of any scientific thesis. Often much of the reviewing work will 
already have been done by a reviewer woking in collaboration with review groups such as Cochrane 
group. There are several easily accessed electronic resources in which to search for systematic 
reviews and meta-analyses: the NLH ENT and Audiology Specialist Library, http://
www.library.nhs.uk/ent/; The Cochrane Library, www.cochrane.org/; PubMed Clinical Queries, 
www.ncbi.nlm.nih.gov/entrez/query.  
As the explosion of scientific knowledge continues, it is difficult to remain up to date by merely 
reading a few journal publications; moreover, the reporting quality of systematic reviews varies 
depending on publication bias.  
In 1987, Sacks and colleagues (18) evaluated the adequacy of reporting of 83 meta-analyses on 23 
characteristics in six domains. Reporting was generally poor; between one and 14 characteristics 
were adequately reported (mean=7.7; standard deviation=2.7). 
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In 1987, Mulrow examined 50 review articles published in four leading medical journals in 1985 
and 1986 and found that none met all eight explicit scientific criteria, such as a quality assessment 
of included studies (19). 
In 1996, to address the suboptimal reporting of meta-analyses, an international group developed a 
guidance called the QUOROM Statement (QUality Of Reporting Of Meta-analyses), which focused 
on the reporting of meta-analyses of randomized controlled trials (20). !
 2.1 Guidelines. 
A systematic review is an overview of primary studies that used explicit and reproducible methods. 
Systematic reviews apply scientific strategies that limit bias by the systematic assembly, critical 
appraisal and synthesis of all relevant studies on a specific topic. 
It does attempt to collate all relevant evidence that fits pre-specified eligibility criteria to answer a 
specific research question. It uses explicit, systematic methods to minimize bias in the 
identification, selection, synthesis, and summary of studies. When done well, this provides reliable 
findings from which conclusions can be drawn and decisions made.179 180 The key characteristics 
of a systematic review are: (a) a clearly stated set of objectives with an explicit, reproducible 
methodology; (b) a systematic search that attempts to identify all studies that would meet the 
eligibility criteria; (c) an assessment of the validity of the findings of the included studies (such as 
assessment of risk of bias and confidence in cumulative estimates); and (d) systematic presentation, 
and synthesis, of the characteristics and findings of the included studies. 
A meta-analysis is a mathematical synthesis of the results of two or more primary studies that 
addressed the same hypothesis in the same way. 
Systematic reviews as well as meta-analyses of appropriate studies can be the best form of evidence 
available for health care practitioners. 
A Systematic review protocol is a document that presents an explicit scientific “road map” of a 
planned, uninitiated systematic review. The protocol details the rational and planned methodological 
and analytical approach of the review. !
SYSTEMATIC REVIEW STEPS: 
Research Question  
Research Protocol  
Literature Search  
Data Extraction  
Quality Appraisal  
Data Analysis and Results  
Interpretation of Results  !
1. Research Question 
The first step in performing a systematic review is to formulate a primary research question as part 
of the research protocol. Appropriate questions to be addressed include: (1) phenomena associated 
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with disease or interventions, (2) disease or condition frequency, (3) diagnostic accuracy, (4) disease 
etiology and/or risk factors, (5) prognosis, and (6) intervention effects. 
The aims of a systematic review can be varied and include: (1) clarifying the relative strengths and 
weaknesses of the literature on the question, (2) summarizing a large amount of literature, (3) 
resolving literature conflicts, (4) evaluating the need for a large clinical trial, (5) avoiding a 
redundant unnecessary trial, (6) increasing the statistical power of smaller studies, (7) improving the 
precision or identify a smaller treatment effect, and (8) improving the generalizability of treatment 
outcomes. !
2. Research Protocol 
A systematic review protocol is important for several reasons: (1) it allows systematic reviewers to 
plan carefully and thereby anticipate potential problems; (2) it allows reviewers to explicitly 
document what is planned before they start their review, enabling others to compare the protocol 
and the completed review (that is, to identify selective reporting), to replicate review methods if 
desired, and to judge the validity of planned methods; (3) it prevents arbitrary decision making with 
respect to inclusion criteria and extraction of data; and (4) it may reduce duplication of efforts and 
enhance collaboration, when available. 
Once the research question is formulated, the research protocol is developed. The goal of 
developing a research protocol is to develop formulation of the questions and methods of the review 
before retrieving the literature. The methods for literature searching, screening, data extraction, and 
analysis should be contained in a written document to minimize bias before starting the literature 
search. !
3. Literature Search 
Sources to search for studies for systematic reviews: 
 Cochrane Central Register of Controlled Trials (via Cochrane Library) 
 Cochrane Database of Systematic Reviews (via Cochrane Library) 
 Database of Abstracts of Reviews of Effects (DARE) database – ie: other reviews (via Cochrane 
Library) 
 Medline and Embase (Library does not subscribe to Embase) 
 Other databases, eg CINAHL, Scopus, PsycINFO 
 Journals 
 Conference proceedings 
 Bibliographies and references listed in primary sources 
 Unpublished and ongoing studies, including known experts in the field (seek by personal 
communication) 
 Raw data from published trials (seek by personal communication) 
 Foreign language literature (do not limit searches to English) 
 “Grey literature” (theses, internal reports, non peer-reviewed journals, pharmaceutical industry 
files) 
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 PubMed Clinical Queries (www.ncbi.nlm.nih.gov/entrez/query ) includes search filters offering 4 
categories of aetiology, prognosis, treatment, diagnosis, and choice of emphasizing sensitivity or 
specificity.  
Cochrane Handbook appendix contains a list of approximately 30 clinical trials registries for 
finding unpublished primary studies (See Reference List for Library call number) 
A minimum of two reviewers performs a first-stage screening of titles and abstracts based on the 
research question and its study design, population, intervention, and outcome to be studied. Based 
on the initial screening, selected full-text articles are obtained for the second-stage screening. Using 
the full text a second-stage screening is performed by at least two reviewers. The studies selected 
are then submitted for data extraction. !
4. Data Extraction 
A standardized form (paper or electronic) assists in the task of data extraction. For example: 
Sample Data Extraction Form Items: 
• Reference—including journal, title, author, volume in page numbers Objective—the study 
objective as stated by the authors 
• Study design—type of trial  
• Population—demographics of the participants in the study Intervention—description of the 
intervention 
• Control—description of the control group or alternative intervention Outcome—results of the 
intervention and how measured including statistics used Comments—details regarding the study 
quality !
5. Quality Appraisal 
A checklist to assess for biases is important: several quality scales and checklists have been 
developed for this.  
Each trial should be evaluated in terms of its: 
• Methodological quality—the extent to which the design and conduct are likely to have prevented 
systematic errors (bias) 
• Precision—a measure of the likelihood of random errors (usually depicted as the width of the 
confidence interval around the result) 
• External validity—the extent to which the results are generalizable or applicable to a particular 
target population !
6. Data Analysis and Results 
After including and excluding studies based on the quality appraisal, data analysis and results of the 
studies should be undertaken. The initial step for this process involves a simple descriptive 
evaluation of each study, commonly presented in tabular format. Tables should include the 
population under study, the interventions, and outcomes. !
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7. Interpretation of Results 
Most of this information can be presented in the data analysis and results table in the manuscript. 
The strengths and weaknesses of the included studies must be discussed. Conclusions should be 
based on the best available scientific evidence. Recommendations regarding future studies can also 
be made.  !
 2.2 Publication bias. 
As well as positive outcome studies being preferentially published or followed by full text 
publication (21) authors are more likely to publish positive results in English- language journals 
(22). This unequal distribution of trials leads to a selection bias in evidence l level studies, like 
systematic reviews, meta-analysis or health technology assessments followed by a systematic 
failure of interpretation and in clinical decisions. 
Even if a study is published in electronic journals not every journal is listed on the major databases 
like PUBMED.GOV or EMBASE which hinders its identification. 
Most of the published studies are not accessible openly; moreover, many large clinical centers do 
not have all the necessary licenses for all the relevant publications which limit the number of studies 
they can identify. 
Publication bias in a systematic review occurs mostly during the selection process and a transparent 
selection process is necessary to avoid such bias. 
For studies included in a systematic review, a thorough assessment of the risk of bias requires both a 
‘‘study-level’’ assessment (e.g., adequacy of allocation concealment) and, for some features, a 
newer approach called ‘‘outcome-level’’ assessment. An outcome-level assessment involves 
evaluating the reliability and validity of the data for each important outcome by determining the 
methods used to assess them in each individual study (23). The quality of evidence may differ 
across outcomes, even within a study, such as between a primary efficacy outcome, which is likely 
to be very carefully and systematically measured, and the assessment of serious harms (24), which 
may rely on spontaneous reports by investigators. This information should be reported to allow an 
explicit assessment of the extent to which an estimate of effect is correct (23). 
Different types of reporting biases may hamper the conduct and interpretation of systematic 
reviews. Selective reporting of complete studies (e.g., publication bias) (25) as well as the more 
recently empirically demonstrated ‘‘outcome reporting bias’’ within individual studies (26) should 
be considered by authors when conducting a systematic review and reporting its results. Though the 
implications of these biases on the conduct and reporting of systematic reviews themselves are 
unclear, some previous research has identified that selective outcome reporting may occur also in 
the context of systematic reviews (27). !
 2.2.1 Risk of bias individuals studies. 
An assessment of the risk of bias (or “quality”) of studies included in a review is an important 
component of any well planned or conducted systematic review. Such an assessment contributes to 
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the evaluation of the overall strength of evidence of the review. Established methods for assessing 
risk of bias in reviews have been documented (28,29). 
Descriptions of the planned approach to assessing risk of bias should include the constructs being 
assessed and a definition for each, reviewer judgment options (high, low, unclear), the number of 
assessors, experience of assessors (training, piloting, previous risk of bias assessment experience), 
as well as method(s) of assessment (independent or in duplicate) (30). Whether reviewers are going 
to be blinded to studies should also be reported, (31,32) as well as whether agreement between 
reviewers will be evaluated and, if so, how. 
Details of planned methods to summarize risk of bias assessments across studies or outcomes 
should be provided. Although authors may spend a large proportion of time assessing risk of bias in 
included studies, they are often silent on how the results might influence their review findings. 
Thus, authors are encouraged to think about this at the development stage and document their plans 
in the protocol. Authors should also describe how risk of bias assessments will be incorporated into 
data synthesis (that is, subgroup or sensitivity analyses) and their potential influence on findings of 
the review in the protocol. 
The likelihood that the treatment effect reported in a systematic review represents the true effect 
depends on the validity of the included studies, namely, the internal validity. Therefore, authors 
should not only describe risk of bias methods and constructs to be assessed for each included study, 
but also describe how results of the assessment contribute to the overall findings of the review (33). 
Additionally, authors should provide a rationale if they do not intend to assess risk of bias. 
Many methods exist to assess the overall risk of bias in included studies, including scales, 
checklists, and individual components (34,35). As summarized in the PRISMA elaboration 
document,17 scales that numerically summarize multiple components into a single number are 
misleading and unhelpful (36). Rather, authors should specify the methodological components that 
they plan to assess and how they plan to assess said components. 
Authors should give careful consideration to assessments for reviews that expect to include non-
parallel group randomised controlled trials and studies of non-randomised design, for which 
methodological standards are currently under development. The ultimate decision regarding which 
methodological features should be evaluated requires consideration of the strength of the empirical 
data, theoretical rationale, and the unique circumstances of the included studies within the context 
of the review question. !
 2.2.2 Meta-bias(es): 
Authors should pre-specify any methods used to explore the possibility that the data identified are 
biased due to non-study related processes (37). Such bias may result from non-publication of 
studies (publication or dissemination bias) and the reporting of a subset of measured outcomes and 
analyses within studies (outcome reporting bias) 
Systematic reviews aim to synthesize the results of all relevant studies. However, some studies may 
not be published, and a subset of outcomes and analyses may be incompletely, inadequately, or 
selectively reported in a published article, based on the results (such as statistical significance, 
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magnitude, or direction of effect). The validity of systematic reviews may be threatened if the 
outcome data available to reviewers comprise a biased selection of all data that actually exists (38). 
Such biases are termed meta-biases, meaning that they occur independent of procedural problems 
during the conduct of a primary study as do typical methodological biases (such as inappropriate 
method of random sequence generation in randomized trials) (37). !
In specific: 
• Publication or dissemination bias—Several systematic reviews of empirical studies have found 
that clinical trials with statistically significant (P<0.05) or positive results are more likely to be 
published than those with non-significant or negative results (39-41). Investigators’ decisions not to 
submit papers with negative results for publication, rather than editors’ rejection of such papers, 
tend to be the main source of publication bias (42). However, the decision to write up a study for 
publication may be influenced by pressure from study sponsors and journal editor (25). Studies with 
statistically significant results also tend to be published earlier than studies with non-significant 
results (40). If studies are missing from a systematic review for these reasons, exaggerated results 
may be produced. 
• Outcome reporting bias—The selective reporting of outcomes due to their significance, 
magnitude, or direction is termed outcome reporting bias and has been widely documented across 
the trial literature (39). Outcomes specified in the protocol may be completely omitted from the 
published report. When an outcome is measured using multiple scales or at multiple time points, 
and analysed in various ways (such as intention-to-treat and per-protocol analysis, unadjusted and 
adjusted for covariates), the choice of which data to present may be influenced by the results. Non-
significant results may be partially reported (such as reporting an effect estimate with no measure of 
variation), resulting in insufficient data to include in a meta-analysis. All of these examples of 
selectively reported outcome data in primary studies can bias (and sometimes, overestimate) the 
results of systematic reviews (39, 26, 43). !
Empirical evidence of selective outcome reporting bias in trials exists. A systematic review of 16 
cohorts of clinical trials comparing outcomes reported in trial protocols with the published reports 
found that at least one primary outcome was omitted, introduced, or changed in 4-50% of reports 
(44). In a landmark study, Chan and colleagues found that statistically significant outcomes had 
higher odds of being fully reported in trial publications compared with non-significant outcomes for 
efficacy (pooled odds ratio 2.4 (95% confidence interval 1.4 to 4.0)) and safety (pooled odds ratio 
4.7 (1.8 to 12)) (37). 
Detecting or correcting for publication bias in a systematic review is difficult. 
Recommendations regarding appropriate graphical methods (such as funnel plots) and statistical 
methods (such as Egger’s test) to assess small study effects have been proposed (45). 
However, publication bias is only one of several possible explanations for small study effects, and 
the interpretation of such tests can be problematic (45). Authors should report their planned testing 
strategy to assess publication bias in detail. 
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For some trials, reviewers might assume that it is likely that an outcome was measured even if it 
was not reported, based on knowledge of the clinical area (such as when systolic, but not diastolic, 
blood pressure is reported) (46). Authors may use the Outcome Reporting Bias in Trials (ORBIT) 
classification system (47). A sensitivity analysis to assess the impact of selective reporting on meta-
analytic results may also be considered (48). 
For systematic reviews/meta-analysis the PRISMA-statement is recommended, as it gives the reader 
for a better understanding of the selection process (49) 
In conclusion evidence based medicine is an important part of medicine and primary trials are the 
basis for higher level evidence trials and clinical decisions. 
In future the use of trial registration for minimizing publication bias (50), mechanisms to allow 
easier access to the scientific literature and improvement in the peer review process are 
recommended. The use of checklists like PRISMA is likely to improve the reporting quality of a 
systematic review and provides substantial transparency in the selection process of papers in a 
systematic review. !
 2.3 The PRISMA Statement: 
A systematic review is a review of a clearly formulated question that uses systematic and explicit 
methods to identify, select, and critically appraise relevant research, and to collect and analyze data 
from the studies that are included in the review. Statistical methods (meta-analysis) may or may not 
be used to analyze and summarize the results of the included studies. Meta-analysis refers to the use 
of statistical techniques in a systematic review to integrate the results of included studies. 
The conduct of a systematic review depends heavily on the scope and quality of included studies, 
thus systematic reviewers may need to modify their original review protocol during its conduct. 
Any systematic review reporting guideline should recommend that such changes can be reported 
and explained without suggesting that they are inappropriate.  
The PRISMA Statement acknowledges this iterative process. Aside from Cochrane reviews, all of 
which should have a protocol, only about 10% of systematic reviewers report working from a 
protocol. Without a protocol that is publicly accessible, it is difficult to judge between appropriate 
and inappropriate modifications.  
PRISMA stands for Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(www.prisma-statement.org). It is an evidence-based minimum set of items for reporting in 
systematic which comes from a revision of the QUORUM checklist together with the addition of a 
flow diagram done during a three-day meeting held in Ottawa, Canada, in June 2005. Here, an 
international survey of review authors, consumers, and groups commissioning or using systematic 
reviews and meta-analyses was completed, including the International Network of Agencies for 
Health Technology Assessment (INAHTA) and the Guidelines International Network (GIN). The 
survey aimed to ascertain views of QUOROM, including the merits of the existing checklist items. 
The results of these activities were presented during the meeting and are summarized on the 
PRISMA Web site (http:// www.prisma-statement.org/) (49).  
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Shortly after the meeting a draft of the PRISMA checklist was circulated to the group. A disposition 
file was created containing comments and revisions from each respondent, and the checklist was 
subsequently revised 11 times. The group approved the checklist, flow diagram, and a summary 
paper was written (49).  
The PRISMA Statement consists of a 27-item checklist (Table 1) and a four-phase flow diagram 
(Figure 1) (51). !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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Table 1. Preferred reporting items for systematic review and meta-analysis protocols 2015 
checklist: recommended items to address in a systematic review protocol. !
 !!!!
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Table 2| PRISMA-P (preferred reporting items for systematic review and meta-analysis protocols) 2015 checklist: recommended items to
address in a systematic review protocol
Checklist itemItem NoSection and topic
Administrative information
Title:
Identify the report as a protocol of a systematic review1aIdentification
If the protocol is for an update of a previous systematic review, identify as such1bUpdate
If registered, provide the name of the registry (such as PROSPERO) and registration number2Registration
Authors:
Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of
corresponding author
3aContact
Describe contributions of protocol authors and identify the guarantor of the review3bContributions
If the protocol represents an amendment of a previously completed or published protocol, identify as such and list
changes; otherwise, state plan for documenting important protocol amendments
4Amendments
Support:
Indicate sources of financial or other support for the review5aSources
Provide name for the review funder and/or sponsor5bSponsor
Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol5cRole of sponsor or funder
Introduction
Describe the rationale for the review in the context of what is already known6Rationale
Provide an explicit statement of the question(s) the review will address with reference to participants, interventions,
comparators, and outcomes (PICO)
7Objectives
Methods
Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such
as years considered, language, publication status) to be used as criteria for eligibility for the review
8Eligibility criteria
Describe all intended information sources (such as electronic databases, contact with study authors, trial registers
or other grey literature sources) with planned dates of coverage
9Information sources
Present draft of search strategy to be used for at least one electronic database, including planned limits, such that
it could be repeated
10Search strategy
Study records:
Describe the mechanism(s) that will be used to manage records and data throughout the review11aData management
State the process that will be used for selecting studies (such as two independent reviewers) through each phase
of the review (that is, screening, eligibility and inclusion in meta-analysis)
11bSelection process
Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate),
any processes for obtaining and confirming data from investigators
11cData collection process
List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned
data assumptions and simplifications
12Data items
List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes,
with rationale
13Outcomes and prioritization
Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at
the outcome or study level, or both; state how this information will be used in data synthesis
14Risk of bias in individual studies
Describe criteria under which study data will be quantitatively synthesised15aData synthesis
If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data
and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s
τ)
15b
Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression)15c
If quantitative synthesis is not appropriate, describe the type of summary planned15d
Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within
studies)
16Meta-bias(es)
Describe how the strength of the body of evidence will be assessed (such as GRADE)17Confidence in cumulative evidence
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;349:g7647 doi: 10.1136/bmj.g7647 (Published 2 January 2015) Page 24 of 25
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Figure 1. Flow of information through the different phase of a systematic review. !
 !!!!!!!!!!!
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The new PRISMA checklist differs in several respects from the QUOROM checklist, and the 
substantive specific changes are highlighted in Table 2.  !
Table 2. 
 
Generally, the PRISMA checklist ‘‘decouples’’ several items present in the QUOROM checklist 
and, where applicable, several checklist items are linked to improve consistency across the 
systematic review report. 
The flow diagram has also been modified. Before including studies and providing reasons for 
excluding others, the review team must first search the literature. This search results in records. 
Once these records have been screened and eligibility criteria applied, a smaller number of articles 
will remain. The number of included articles might be smaller (or larger) than the number of 
studies, because articles may report on multiple studies and results from a particular study may be 
published in several articles. To capture this information, the PRISMA flow diagram now requests 
information on these phases of the review process. 
The aim of the PRISMA Statement is to help authors improve the reporting of systematic reviews 
and meta-analyses. PRISMA can also be used as a basis for reporting systematic reviews of other 
types of research, particularly evaluations of interventions and it may also be useful for critical 
appraisal of published systematic reviews. However, the PRISMA checklist is not a quality 
assessment instrument to gauge the quality of a systematic review. !
3. Laryngeal lesions: !
 3.1 Epithelial precursor lesions 
 3.1.1 Definition 
Precursor lesions are defined as altered epithelium with an increased likelihood for progression to 
squamous cell carcinoma (SCC). The altered epithelium shows a variety of cytological and 
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remain. The number of included articles might be smaller
(or larger) than the number of studies, because articles
may report on multiple studies and results from a particular
study may b published in several articles. To capture this
information, the PRISMA flow diagram now requests infor-
mation on these phases of the review process.
6. Endorsement
The PRISMA Statement should replace the QUOROM
Statement for those journals that have endorsed QUOROM.
We hope that other journals will support PRISMA; they
can do so by registering on the PRISMA Web site. To
underscore to authors, and others, the importance of transpar-
ent reporting of systematic reviews,we encourage supporting
journals to reference the PRISMA Statement and include the
PRISMAWeb address in their Instructions to Authors. We
also invite editorial organizations to consider endorsing
PRISMA and encourage authors to adhere to its principl s.
7. The PRISMA Explanation and Elaboration Paper
In addition to the PRISMA Statement, a supporting
Explanation and Elaboration document has been produced
[18] following the style used for other reporting guidelines
[19e21]. The process of completing this document
included developing a large database of exemplars to high-
light how best to report each checklist item, and identifying
a comprehensive evidence base to support the inclusion of
each checklist item. The Explanation and Elaboration
document was completed after several face to face meet-
ings and numerous iterations among several meeting partic-
ipants, after which it was shared with the whole group for
additional revisions and final approval. Finally, the group
formed a dissemination subcommittee to help disseminate
and implement PRISMA.
8. Discussion
Th quality of rep ting of system tic reviews is still not
optimal [22e27]. In a recent review of 300 systematic
reviews, few authors reported assessing possible publication
bias [22], even though there is overwhelming evidence both
for its existence [28] and its impact on the results of system-
atic reviews [29]. Even when the possibility of publication
bias is assessed, there is no guarantee that systematic re-
viewers have assessed or interpreted it appropriately [30].Al-
though the absence of reporting such an assessment does not
necessarily indicate that it was not done, reporting an assess-
ment of possible publication bias is likely to be a marker of
the thoroughness of the conduct of the systematic review.
Several approaches have been developed to conduct sys-
tematic reviews on a broader array of questions. For exam-
ple, systematic reviews are now conducted to investigate
cost-effectiveness [31], diagnostic [32] or prognostic ques-
tions [33], genetic associations [34], and policy making
[35]. The general concepts and topics covered by PRISMA
are all relevant to any systematic review, not just those
whose objective is to summarize the benefits and harms
Table 2
Substantive specific changes between the QUOROM checklist and the PRISMA checklist (a tick indicates the presence of the topic in QUOROM or
PRISMA).
Section/Topic Item QUOROM PRISMA Comment
Abstract O O QUOROM and PRISMA ask authors to report an abstract. However,
PRISMA is not specific about format.
Introduction Objective O This new item (4) addresses the explicit question the review
addresses using the PICO reporting system (which describes the participants,
interventions, comparisons, and outcome(s) of the systematic review),
together with the specification of the type of study design (PICOS); the item
is linked to Items 6, 11, and 18 of the checklist.
Methods Protocol O This new item (5) asks authors to report whether the review has
a protocol and if so how it can be accessed.
Methods Search O O Although reporting the search is present in both QUOROM and
PRISMA checklists, PRISMA asks authors to provide a full description
of at least one electronic search strategy (Item 8). Without such information
it is impossible to repeat the authors’ search.
Methods Assessment of risk of
bias in included studies
O O Renamed from ‘‘quality assessment’’ in QUOROM. This item (12)
is linked with reporting this information in the results (Item 19).
The new concept of ‘‘outcome-level’’ assessment has been introduced.
Methods Assessment of risk
of bias across studies
O This new item (15) asks authors to describe any assessments of
risk of bias in the review, such as selective reporting within the included studies.
This item is linked with reporting this information in the results (Item 22).
Discussion O O Although both QUOROM and PRISMA checklists address the discussion
section, PRISMA devotes three items (24e26) to the discussion. In PRISMA
the main types of limitations are explicitly stated and their discussion required.
Funding O This new item (27) asks authors to provide information on any sources of funding
for the systematic review.
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architectural changes that have traditionally been grouped under the term dysplasia. Rarely, 
malignant transformation can develop even from morphologically normal epithelium. Atypia is not 
considered synonymous with dysplasia (Table 3). !
Table 3. Classification schema that histologically categorizes precursors and related lesions. 
!
Atypia has been used in the context of inflammatory and regenerative changes particularly referring 
to cytologic features. In this text, the term atypia refers to cytological change that may or may not 
be pre-malignant. Various classifications have evolved to describe the spectrum of histological 
changes in relation to their malignant potential (52).  !
 3.1.2 Epidemiology 
The entire spectrum of laryngeal and hypopharyngeal precursor lesions are mostly seen in the adult 
population and affect men more often than women. This gender disparity is especially pronounced 
after the sixth decade (53). Mean ages for the first precursor lesion diagnosis are reported from 
48.0-56.5 years (53,54). The incidence varies worldwide with the magnitude and manner of 
carcinogen exposure.  !
 3.1.3 Etiology 
Precursor lesions are strongly associated with tobacco smoking and alcohol abuse, and especially a 
combination of these two (55-58). The risk of developing these lesions increases with duration of 
smoking, the type of tobacco and the practice of deep inhalation.  
Additional etiological factors are: industrial pollution, specific occupational exposures, nutritional 
deficiency and hormonal disturbance (54, 55, 59-61). The role of human papilloma virus (HPV) 
infection is still unsolved (62).  !
 3.1.4 Localization 
Precursor lesions appear mainly along the true vocal cords. Two thirds of vocal cord lesions are 
bilateral (53). They can extend over the free edge of the vocal cord to the subglottic surface. An 
2005 WHOClassification Squamous Intraepithelial 
Neoplasia (SIN)
Ljubljana Classification Squamous 
Intraepithelial Lesions (SIL)
Squamous cell hyperplasi Squamous cell (simple) hyperplasia
Mild dysplasia SIN 1 Basal/Parabasal cell hyperplasia*
Moderate dyplasia SIN 2 Atypical hyperplasia**
Severe dysplasia SIN 3*** Atypical hyperplasia**
Carcinoma in-situ SIN 3*** Carcinoma in-situ
* Basal/parabasal cell hyperplasia may histologically resemble mild dysplasia, but the former is 
conceptually benign lesion and the latter the lower grade of precursor lesions; 
** “Risky epithelim”; the analogy to moderate and severe dysplasia is approximate; 
*** The advocates of SIN combine severe dysplasia and carcinoma in-situ.
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origin in, or extension along the upper surface. of the vocal cord is less common (54,63). The 
commissures are rarely involved (53). !
 3.1.5 Clinical features 
Most patients with precursor lesions give a history of a few months or more of symptoms, but may 
be asymptomatic (53). Symptoms depend on the location and severity of the disease and include 
fluctuating hoarseness, throat irritation, sore throat, and/or chronic cough. Precursor lesions can be 
either sharply circumscribed and grow exophytically, or be predominantly flat and diffuse, related in 
part to the amount of keratin present. !
 3.1.6 Macroscopy 
Precursor lesions have a clinically diverse appearance, variously described as leukoplakia (white 
patch), chronic hyperplastic laryngitis or rarely erythroplasia/erythroplakia (red patch). A 
circumscribed thickening of the mucosa covered by whitish patches, or an irregularly growing, 
well-defined warty plaque may be seen. A speckled appearance of lesions can also be present, 
caused by unequal thickness of the keratin layer. However, the lesions are commonly more diffuse, 
with a thickened appearance, occupying a large part of one or both vocal cords. Their surface is 
rough, may be muddy brown to red (erythroplasia), perhaps with increased visible vascularity, or 
coated with diffuse or dispersed circumscribed whitish plaques (speckled leukoplakia) (54). Few 
white patches are ulcerated (6.5%) or combined with erythroplasia (15%) (53). Leukoplakia, in 
contrast to erythroplasia, tends to be well demarcated. In general, leukoplakia has a lower risk of 
malignant transformation than mixed white and red lesions, or speckled leukoplakia, which has an 
intermediate risk, and pure erythroplasia which has the highest risk of cancer development (64). 
However, no one clinical appearance is reliably diagnostic of any histologic grade of precursor 
lesion. Occasionally precursor lesions may appear clinically normal. !
 3.1.7 Histopathology 
The epithelium of all precursor lesions is generally thickened. However, in a minority of cases 
patchy atrophy, thinning of the viable cellular layers, may be present. By definition there is no 
evidence of invasion. The magnitude of surface keratinization is of no importance. Allocation to 
categories within each of the classifications requires consideration firstly of architectural features 
and then of cytology.	

- Hyperplasia: 
describes increased cell numbers. This may be in the spinous layer (acanthosis) and/or in the basal/
parabasal cell layers (progenitor compartment), termed basal cell hyperplasia. The architecture 
shows regular stratification and there is no cellular atypic (Figure 2). !!
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Figure 2. Squamous cell hyperplasia (simple hyperplasia). There is an increased number of 
ordinary- arranged, otherwise normal cells in the spinous layer. A keratin layer is present on 
the surface. !
  !
- Dysplasia (intraepithelial neoplasia, atypical epithelial hyperplasia potentially malignant 
lesions): 
When architectural disturbance is accompanied by cytologic atypia the term dysplasia applies 
(Table 4). !
Table 4. Criteria used for diagnosing dysplasia. 
!
There is a challenge in the recognition of the earliest manifestations of dysplasia, and no single 
combination of the above features allows for consistent distinction between hyperplasia and the 
earliest stages of dysplasia as well as in attempting to rigidly divide the spectrum of dysplasia into 
mild, moderate and severe categories: !
  
Architecture Cytology
Irregular epithelial stratification Abnormal variation in nuclear size (anisonucleosis)
Loss of polarity of basal cells Abnormal variation in nuclear shape (nuclear 
pleomorphism)
Drop-shape rete ridges Abnormal variation in cell size (anisocytosis)
Increased number of mitotic figures Abnormal variation in cell shape (cellular pleomorphism)
Abnormal superficial mitoses Increased nuclear-cytoplasmic ratio
Premature keratinization in single cells (dyskeratosis) Increased nuclear size
Keratin pearls within rete pegs Atypical mitotic figures
Increased number and size of nucleoli
Hyperchromasi
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Definition
Precursor lesions are defined as altered
epithelium with an increased likelihood
for progression to squamous cell carci-
noma (SCC). The altered epithelium
shows a variety of cytological and archi-
tectural changes that have traditionally
been grouped under the term dysplasia.
However, other classifications, e.g.
squamous intraepithelial neoplasia (SIN)
and squamous intraepithelial lesions
(SIL, Ljubljana classification) have also
proven to be useful {222,504,846,1054,
1055,1253,1254,1711,2317}. Rarely, ma -
lig nant transformation can develop even
from morphologically normal epithelium. 
Atypia is not considered synonymous
with dysplasia. Atypia has been used in
the context of inflammatory and regener-
ative changes particularly referring to
cytologic features. In this text, the term
atypia refers to cytological change that
may or may not be pre-malignant.
Various classifications have evolved to
describe the spectrum of histological
changes in relation to their malignant
potential {222,504,846,1054,1055,1253,
1254,1711,2317}. 
Epidemiology
The entire spectrum of laryngeal and
hypopharyngeal precursor lesions are
mostly seen in the adult population and
affect men more often than women. This
gender disparity is especially pro-
nounced after the sixth decade {245}.
Mean ages for the first precursor lesion
diagnosis are reported from 48.0-56.5
years {243,1253}. The incidence varies
worldwide with the magnitude and man-
ner of carcinogen exposure. 
Etiology
Precursor lesions are strongly associated
with tobacco smoking and alcohol
abuse, and especially a combination of
these two {221,566,766,1607,1608,
1800,2564}. The risk of developing these
lesions increases with duration of smok-
ing, the type of tobacco and the practice
of deep inhalation. 
Additional etiological factors are: indus-
trial pollution, specific occupational
exposures, nutritional deficiency, and
hormonal disturbance {766,1253,1255,
1256,1608,1982}.
The role of human papillomavirus (HPV)
infection in laryngeal carcinogenesis
remains unsolved {2412}. The preva-
lence of HPV in laryngeal carcinoma
varies significantly among various stud-
ies, ranging from 0% to 54.1% {2517}.
Although the overall prevalence of HPV
infection found in 9 studies of precursor
lesions {97,276,793,853,927,928,1522,
2065,2172} was 12.4%, HPV DNA was
detected in a clinically and histologically
normal larynx in 12-25% of individuals
{1912,2172}. Thus, definite evidence of
an etiologic role of HPV in precursor
lesions, at least at present, is lacking,
and HPV infection in precursor lesions
may represent an incidental HPV colo-
nization rather than true infection of the
laryngeal mucosa.
Localization
Precursor lesions appear mainly along
the true vocal cords. Two thirds of vocal
cord lesions are bilateral {243}. They can
extend over the free edge of the vocal
cord to the subglottic surface. An origin
in, or extension along the upper surface
N. Gale
B.Z. Pilch
D. Sidransky
W.H. Westra
J. Califano
Epithelial precursor lesions 
Table 3.5 Classification schemas that histologically categorize precursor and related lesions 
2005 WHO Classification Squamous Intraepithelial Ljubljana Classification 
Neoplasia (SIN) Squamous Intraepithelial 
Lesions (SIL)  
Squamous cell hyperplasia Squamous cell (simple) 
hyperplasia
Mild dysplasia  SIN 1  Basal/parabasal cell 
hyperplasia*
Moderate dysplasia SIN 2 Atypical hyperplasia**
Severe dysplasia  SIN 3*** Atypical hyperplasia**
Carcinoma in-situ SIN 3*** Carcinoma in-situ  
* Basal/parabasal cell hyperplasia may histologically resemble mild dysplasia, but the former is conceptually 
benign lesion and the latter the lower grade of precursor lesions.
** ’Risky epithelium’. The analogy to moderate and severe dysplasia is approximate.
*** The advocates of SIN combine severe dysplasia and carcinoma in-situ.
Fig. 3.38 Microlaryngoscopic view of laryngeal
leukoplakia. Both vocal cords are moderately
thickened; an exophytic, well-circumscribed, white
plaque is seen in the left vocal cord.
Fig. 3.39 Squamous cell hyperplasia (simple hyper-
plasia). There is an increased number of ordinary-
arranged, otherwise normal cells in the spinous
layer. A keratin layer is present on the surface.
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 Mild dysplasia 
In general architectural disturbance limit- ed to the lower third of the epithelium accompanied by 
cytological atypia define the minimum criteria of dysplasia (Figure 3a,b). 
 Moderate dysplasia 
Architectural disturbance extending into the middle third of the epithelium is the initial criterion for 
recognizing this category. However, consideration of the degree of cytologic atypia may require 
upgrading (Figure 3c,d) 
 Severe dysplasia 
Recognition of severe dysplasia starts with greater than two thirds of the epithelium showing 
architectural disturbance with associated cytologic atypia. However, architectural disturbance 
extend- ing into the middle third of the epithelium with sufficient cytologic atypia may be upgraded 
from moderate to severe dysplasia (Figure 3e). 
 Carcinoma in-situ 
The theoretical concept of carcinoma in- situ is that malignant transformation has occurred but 
invasion is not present. It is not always possible to recognize this morphologically. The following is 
recommended for the diagnosis of carcinoma in-situ: full thickness or almost full thick- ness 
architectural abnormalities in the viable cellular layers accompanied by pronounced cytologic 
atypia. Atypical mitotic figures and abnormal superficial mitoses are commonly seen in carcinoma 
in-situ (Figure 3f). !
Figure 3. Types of dysplasia: a) Mild dysplasia (SIN1): note the increased number of basal-
parabasal cells with hyperchromatic, uniform nuclei, perpendicularly oriented to the basement 
membrane. The upper part of the epithelium shows a regular spinous layer and thin parakeratotic 
layer on the surface; b) Mild dysplasia (SIN1): Increased number of uniform, slightly enlarged 
basal and parabasal cells, perpendicularly oriented to the basement membrane. Increased number of 
regular mitoses are evident. At the right corner (lower half) the epithelial cells show minimal 
cytologic atypia. The upper half of the epithelium is composed of regular spinous cells, which 
become flattened toward the surface. A thin parakeratotic layer is present on the surface; c) 
Moderate dysplasia (SIN2): the epithelium is slightly thickened. More than half of the epithelium is 
occupied by increased number of slightly to moderately polymorphic epithelial cells with 
hyperchromatic nuclei and increased mitotic activity. The upper third shows spinous cell 
differentiation; prominent granular and keratotic layer is evident on the surface; d) Moderate 
dysplasia (SIN2): Hyperplastic epithelium with increased number of slightly to moderately 
polymorphic epithelial cells extending up to two thirds of the epithelium. A thin parakeratotic and 
keratotic layer is present on the surface; e) Severe dysplasia (SIN 3, atypical hyperplasia). The 
atypical epithelial cells occupy two thirds of the epithelial thickness. Note partially preserved 
epithelial stratification, expressed cytologic atypia and increased mitotic activity. Keratin layer is 
present on the surface; f) Carcinoma in-situ (SIN 3): prominent architectural disarray, marked 
cytologic atypia and increased mitotic figures with pathologic forms. 
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 3.1.8 Differential diagnosis 
Reactive, regenerative or reparative squamous epithelium (for example in response to trauma, 
inflammation, irradiation or ulceration) may manifest atypical cytology or architectural disturbance. 
Nutritional deficiencies such as iron, folate, and vitamin B12, can also simulate dysplasia. Such 
lesions are not considered precursor lesions and should be distinguished from them. Clinical history 
is helpful, and morphologic changes suggestive of the inciting event (e.g. ulceration, inflammation, 
haemorrhage, radiation-induced mesenchymal and/or endothelial nuclear enlargement and 
hyperchromasia) may be present. The epithelial changes in these cases are generally less 
pronounced than in severe dysplasia/atypical hyperplasia or CIS, atypical mitoses are almost never 
present, and the epithelium may be thinned, or, if thickened, stratification and maturation often 
develop as the regenerative/ reparative process matures. !!!
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of the vocal cord is less common
{1253,1332}. The commissures are rarely
involved {243}. Hypopharyngeal precur-
sor lesions are rarely identified as the
common presentation is established
malignancy {2661}. No good data exist
regarding tracheal precursor lesions.
Clinical features
Most patients with precursor lesions give
a history of a few months or more of
symptoms, but may be asymptomatic
{243}. Symptoms depend on the location
and severity of the disease and include
fluctuating hoarseness, throat irritation,
sore throat, and/or chronic cough.
Precursor lesions can be either sharply
circumscribed and grow exophytically, or
be predominantly flat and diffuse, related
in part to the amount of keratin present. 
Macroscopy
Precursor lesions have a clinically
diverse appearance, variously described
as leukoplakia (white patch), chronic
hyperplastic laryngitis or rarely erythro-
plasia/erythroplakia (red patch). A cir-
cumscribed thickening of the mucosa
covered by whitish patches, or an irregu-
larly growing, well-defined warty plaque
may be seen. A speckled appearance of
lesions can also be present, caused by
unequal thickness of the keratin layer.
However, the lesions are commonly more
diffuse, with a thickened appearance,
occupying a large part of one or both
vocal cords. Their surface is rough, may
be muddy brown to red (erythroplasia),
perhaps with increased visible vasculari-
ty, or coated with diffuse or dispersed cir-
cumscribed whitish plaques (speckled
leukoplakia) {1253,1332}. Few white
patches are ulcerated (6.5%) or com-
bined with erythroplasia (15%) {243}.
Leukoplakia, in contrast to erythroplasia,
tends to be well demarcated. In general,
leukoplakia has a lower risk of malignant
transformation than mixed white and red
lesions, or speckled leukoplakia, which
has an intermediate risk, and pure ery-
throplasia which has the highest risk of
cancer development {2759}. However,
no one clinical appearance is reliably
diagnostic of any histologic grade of pre-
cursor lesion. Occasionally precursor
lesions may appear clinically normal. 
Histopathology
The epithelium of all precursor lesions is
generally thickened. However, in a minor-
ity of cases patchy atrophy, thinning of
the viable cellular layers, may be pres-
ent. By definition there is no evidence of
invasion. The magnitude of surface kera-
tinization is of no importance. 
Allocation to categories within each of
the classifications requires consideration
firstly of architectural features and then of
cytology.
1. Hyperplasia
Definition: Hyperplasia describes
increased cell numbers. This may be in
the spinous layer (acanthosis) and/or in
the basal/parabasal cell layers (progeni-
tor compartment), termed basal cell
hyperplasia. 
The architecture shows regular stratifica-
tion and there is no cellular atypia. 
Fig. 3.40 Mild dysplasia (basal-parabasal cell hyperplasia, SIN1). A Note the increased number of basal-parabasal cells with hyperchromatic, uniform nuclei, per-
pendicularly oriented to the basement membrane. The upper part of the epithelium shows a regular spinous layer and thin parakeratotic layer on the surface. B
Increased number of uniform, slightly enlarged basal and parabasal cells, perpendicularly oriented to the basement membrane. Increased number of regular
mitoses are evident. At the right corner (lower half) the epithelial cells show minimal cytologic atypia. The upper half of the epithelium is composed of regular spin-
ous cells, which become flattened toward the surface. A thin parakeratotic layer is present on the surface. 
BA
Table 3.6 Criteria used for diagnosing dysplasia
Architecture Cytology
Irregular epithelial stratification Abnormal variation in nuclear size 
(anisonucleosis)
Loss of polarity of basal cells Abnormal variation in nuclear shape 
(nuclear pleomorphism)
Drop-shaped rete ridges Abnormal variation in cell size (anisocytosis)  
Increased number of mitotic figures Abnormal variation in cell shape 
(cellular pleomorphism)
Abnormal superficial mitoses Increased nuclear-cytoplasmic ratio
Premature keratinization in single cells Increased nuclear size  
(dyskeratosis)
Keratin pearls within rete pegs Atypical mitotic figures
Increased number and size of nucleoli
Hyperchromasia   
BB9_2a_126-150.ps - 6/15/2007 8:48 AM
142 Tumours of the hypopharynx, larynx and trachea
2. Dysplasia (intraepithelial neoplasia,
atypical epithelial hyperplasia potentially
malignant lesions)
Definition: When architectural distur-
bance is accompanied by cytologic
atypia the term dysplasia applies. 
There is a challenge in the recognition of
the earliest manifestations of dysplasia,
and no single combination of the above
features allows for consistent distinction
between hyperplasia and the earliest
stages of dysplasia as well as in attempt-
ing to rigidly divide the spectrum of dys-
plasias into mild, moderate and severe
categories. 
Mild dysplasia
In general architectural disturbance limit-
ed to the lower third of the epithelium
accompanied by cytological atypia
define the minimum criteria of dysplasia.
Moderate dysplasia
Architectural disturbance extending i to
the middle third of the epithelium is the
initial criterion for recognizing this cate-
gory. However, consideration of the
degree of cytologic atypia may require
upgrading. 
Severe dysplasia
Recognition of severe dysplasia starts
with greater than two thirds of the epithe-
lium showing architectural disturbance
with associated cytologic atypia.
However, as noted in the previous para-
graph, architectural disturbance extend-
ing int  the middle t ird of the epithelium
with sufficient cytologic atypia may be
upgraded from moderate to severe dys-
plasia. 
Carcinoma in-situ 
The theoretical concept of carcinoma in-
situ is that malignant transformation has
occurred but invasion is not present. It is
not always possible to recognize this
morphologically. The following is recom-
mended for the diagnosis of carcinoma
in-situ: full thickness or almost full thick-
ness architectural abnormalities in the
viable cellular layers accompanied by
pronounced cytologic atypia. Atypical
mitotic figures and abnormal superficial
mitoses are commonly seen in carcino-
ma in-situ. 
Differential diagnosis
Reactive, regenerative or reparative
squamous epithelium (for example in
response to trauma, inflammation, irradi-
ation or ulceration) may manifest atypical
cytology or architectural disturbance.
Nutritional deficiencies such as iron,
folate, and vitamin B12, can also simu-
late dysplasia. Such lesions are not con-
sidered precursor lesions and should be
distinguished from them. Clinical history
is helpful, and morphologic changes
suggestive of the inciting event (e.g.
ulceration, inflammation, haemorrhage,
radiation-induced mesenchymal and/or
endothelial nuclear enlargement and
hyperchromasia) may be present. The
epithelial changes in these cases are
generally less pronounced than in severe
dysplasia/atypical hyperplasia or CIS,
atypical mitoses are almost never pres-
ent, and the epithelium may be thinned,
or, if thickened, stratification and matura-
tion often develop as the regenerative/
reparative process matures. 
Somatic genetics 
In studies addressing the genetic
changes underlying pre-malignant
lesions of the head and neck, the larynx
and hypopharynx are often dealt with in a
broader anatomic context including the
oral cavity. True to current models of car-
cinogenesis, malignant transformation of
the mucosa lining the larynx and other
Fig. 3.41 Moderate dysplasia (atypical hyperplasia, SIN 2). A The epithelium is slightly thickened. More than
half of the epithelium is occupied by increased number of slightly to moderately polymorphic epithelial cells
with hyperchromatic nuclei and increased mitotic activity.  The upper third shows spinous cell differentia-
tion; prominent granular and keratotic layer is evident on the surface.  B Hyperplastic epithelium with
increased number of slightly to moderately polymorphic epithelial cells extending up to two thirds of the
epithelium. A thin parakeratotic and keratotic  layer is present on the surface.
B
A
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2. Dysplasia (intraepithelial neoplasia,
atypical epithelial hyperplasia potentially
malignant lesions)
Definition: When architectural distur-
bance is accompanied by cytologic
atypia the term dysplasia applies. 
There is a challenge in the recognition of
the earliest manifestations of dysplasia,
and no single combination of the above
features allows for consistent distinction
between hyperplasia and the earliest
stages of dysplasia as well as in attempt-
ing to rigidly divide the spectru  of dys-
plasias into mild, moderate and severe
categories. 
Mild dysplasia
In general architectural disturbance limit-
ed to the lower third of the epithelium
accompanied by cytological atypia
define the minimum criteria of dysplasia.
Moderate dysplasia
Architectural disturbance extending into
the middle third of the epithelium is the
initial criterion for recognizing this cate-
gory. However, consideration of the
degree of cytologic atypia may require
upgrading. 
Severe dysplasia
Recognition of severe dysplasia starts
with greater than two thirds of the epithe-
lium showing architectural disturbance
with associated cytologic atypia.
However, as noted in the previous para-
graph, architectural disturbance extend-
ing into the middle third of the epithelium
with sufficient cytologic atypia may be
upgraded from moderate to severe dys-
plasia. 
Carcinoma in-situ 
The theoretical concept of carcinoma in-
situ is that malignant transformation has
occurred but invasion is not present. It is
not always possible to recognize this
morphologically. The following is recom-
mended for the diagnosis of carcinoma
in-situ: full thickness or almost full thick-
ness architectural abnormalities in the
viable cellular layers accompanied by
pronounced cytologic atypia. Atypical
mitotic figures and abnormal superficial
mitoses are commonly seen in carcino-
ma in-situ. 
Differential diagnosis
Reactive, regenerative or reparative
squamous epithelium (for example in
response to trauma, inflammation, irradi-
ation or ulceration) may manifest atypical
cytology or architectural disturbance.
Nutritional deficiencies such as iron,
folate, and vitamin B12, can also simu-
late dysplasia. Such lesions are not con-
sidered precursor lesions and should be
distinguished from them. Clinical history
is helpful, and morphologic changes
suggestive of the inciting event (e.g.
ulceration, inflammation, haemorrhage,
radiation-induced mesenchymal and/or
endothelial nuclear enlargement and
hyperchromasia) may be present. The
epithelial changes in these cases are
generally less pronounced than in severe
dysplasia/atypical hyperplasia or CIS,
atypical mitoses are almost never pres-
ent, and the epithelium may be thinned,
or, if thickened, stratification and matura-
tion often develop as the regenerative/
reparative process matures. 
Somatic genetics 
In studies addressing the genetic
changes underlying pre-malignant
lesions of the head and neck, the larynx
and hypopharynx are often dealt with in a
broader anatomic context including the
oral cavity. True to current models of car-
cinogenesis, malignant transformation of
the mucosa lining the larynx and other
Fig. 3.41 Moderate dysplasia (atypical hyperplasia, SIN 2). A The epithelium is slightly thickened. More than
half of the epithelium is occupied by increased number of slightly to moderately polymorphic epithelial cells
with hyperchromatic nuclei and increased mitot  ctivity.  The upper third shows spinous cell differentia-
tion; prominent granular and ke atotic layer is evident on the surface.  B Hyperplastic epithelium with
increased number of slightly to moderately polymorphic epithelial cells extending up to two thirds of the
epithelium. A thin parakeratotic and keratotic  layer is present on the surface.
B
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regions of the head and neck is funda-
m nt ly  ge etic pr ce s th t involv s
activation of key oncogenes and inacti-
vation of critical tumour suppressor
gen . These genetic alterations gen r-
ally occur in order of progression, how-
ever, it is fundamentally the net accumu-
lation of multiple genetic alterations tha
dictates the frequency and pace of pro-
gression to invasive carcinoma {318,
319}. Genetic progression does not imply
a uniform orderly progression through
vari us stages of histologic progression.
By some estimates, progression from
normal mucosa to invasive squamous
cell carcinoma requires as many as ten
independent genetic events {2156}.
Loss of heterozygosity studies indicate
that the earliest alterations appear to tar-
get specific genes located on chromo-
somes 3p, 9p21, and 17p13 {318}. These
alterations, particularly LOH at 9p21,
may precede histopathologic evidence
of dysplasia {317,2667}. Hyperplasia
without any histologic evidence of dys-
plasia has been found to represent clon-
al populations of cells sharing the same
genetic alterations found in SCC.
Alterations that tend to occur in associa-
tion with higher grades of dysplasia and
SCC can include cyclin D1 amplification,
pTEN inactivation, and LOH at 13q21,
14q32, 6p, 8, 4q27 and 10q23 {318,787}.
Advanced precursor lesions of the head
and neck demonstrate a spectrum of
genetic alterations that is qualitatively
and quantitatively similar to SCC {230,
294,2436}. 
For some of the chromosomal regions
commonly lost or amplified in precursor
lesions of the h ad and neck, the target-
ed genes have been identified. Two
tumour suppressor genes residing at
9p21: p16 (CDKN2/MTS1) inh bit c l
cycling via the Rb pathway, and
p14(ARF) inhibits cell cycling via the p53
pathway {1022}. The p53 tumour sup-
pressor gene resides at chromosome
17p13. 53 is involv d in several cellular
regulatory pathways including DNA
repair, cell cycle control, and apoptosis
{1115}. The cyclin D1 oncogene resides
on chromosome 11q13 and is amplified
in about a third of SCC {321,811}.
However, for most regions of common
chromosomal loss such as loss at chro-
mosome 3p, the targeted gene(s) have
not yet been well characterized. 
Retrospective studies examining the
prognostic value of molecular markers,
including LOH of chromosomes 3p,
9p21, and 17q13 as well as general ane-
uploidy, have demonstrated that genetic
alterations confer significant risk of
malignant progression of precursor
lesions. These precursor lesions includ-
ed clinically defined leukoplakia, with
corresponding histologic diagnoses
varying along the spectrum of benign to
precursor lesions mentioned above. In
some cases, retrospective genetic analy-
sis was able to define risk of malignant
progression in hyperplastic lesions
{1627,2201,2492}.
Prognosis and pr dictive f ctors
Some precursor lesions are self-limiting
and reversible, others persist and some
progress to SCC {503}. The histopatho-
logic d gree of severity of these lesions
can be a predictive factor {222,846,
1054,1689}. Simple and basal/parabasal
c ll hyperpla ias have a minimal likeli-
hood of malignant progression (0.9%).
These patients do not r quire close clini-
cal follow-up. Lesions classified as atyp-
ical hyperplasia (moderate to severe
dysplasia) have a 11% rate of malignant
transformation {1054}. Diagnosis of pre-
cursor lesions implies a need for close
follow-up and complete excision
depending on the clinical situation
{846,1054}. Patients with carcinoma in-
situ require more extensive manage-
ment, depending on the clinical circum-
stance {504,1253, 1808,2151,2432}.
Fig. 3.42 Severe dysplasia (SIN 3, atypical hyperplasia).  A The atypical epithelial cells occupy two thirds of the epithelial thickness. Note partially preserved epithe-
li l str tification, ex ressed cytologic atypia and increased mitotic activity. Keratin la er is present on the surface.  B Carcinoma in-situ (SIN 3). Prominent archi-
tectural disarray, marked cytologic atypia nd incr ased mitotic figures with pathologic forms.
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 3.1.9 Prognosis and predictive factors 
Some precursor lesions are self-limiting and reversible, others persist and some progress to SCC 
(65). The histopathologic degree of severity of these lesions can be a predictive factor (66). Simple 
and basal/parabasal cell hyperplasias have a minimal likelihood of malignant progression (0.9%). 
These patients do not require close clini- cal follow-up. Lesions classified as atypical hyperplasia 
(moderate to severe dysplasia) have a 11% rate of malignant transformation (66). Diagnosis of pre- 
cursor lesions implies a need for close follow-up and complete excision depending on the clinical 
situation (66). Patients with carcinoma in-situ require more extensive management, depending on 
the clinical circumstance (54,65).	
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 3.2 Laryngeal cancer 
 3.2.1 Epidemiology 
Laryngeal and hypopharyngeal squamous cell carcinoma (SCC) occur most frequently in the sixth 
and seventh decades, but some cases have been described in children (67,68). They are more 
common in men (69, 70) though the male:female ratio is decreasing in some countries; women are 
becoming increasingly affected because of increased prevalence of smoking over the last two 
decades (71). !
 3.2.2 Incidence 
SCC comprises about 95% of laryngeal malignancies. The majority originate from the supraglottic 
and glottic regions, although there are geographic variations in the relative ratio between these two 
sites. The incidence in men is high (10/100,000 pa or more) in southern and central Europe, 
southern Brazil, Uruguay and Argentina and among Blacks in the United States. The lowest rates 
(<1/100,000 pa) are recorded in South- East Asia and central Africa. The incidence in women is 
below 1/100,000 pa in most populations. An estimated 140,000 new cases occurred worldwide in 
1990, 86% of these patients were men (72,73). The incidence is slightly more common in urban that 
in rural areas (69, 70). 
There are also geographic differences in the topographic distribution of the laryngeal SCC. In 
France, Spain, Italy, Finland and the Netherlands, supraglottic SCC predominates, while in the 
United States, Canada, England and Sweden glottic SCC is more common. In Japan, SCC is 
approximately equally distributed between the two sites. Interpretation of incidence rates of 
hypopharyngeal cancer is probably complicated by absence or misclassifications within sub sites of 
the larynx. Recorded incidence is highest among men (>2.5/100,000 pa) in India, Brazil and Central 
and Western Europe, and is lowest (<0.5/100,000 pa) in East Asia, Africa and Northern Europe. 
Incidence among women is low (<0.2/100,000 pa) in most populations except India, where rates up 
to 1/100,000 pa are recorded (74). This is probably due to the fact that tobacco is more often 
chewed than smoked in India. The incidence of laryngeal and hypopharyngeal SCC is increasing in 
much of the world, both in men and in women. This increase is related to changes in tobacco and 
alcohol consumption (69).Primary prevention of laryngeal and hypopharyngeal SCC could be 
achieved by cessation of smoking and reduction of alcohol consumption (69). 
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 3.2.3 Etiology 
- Tobacco and alcohol: 
Most cases of laryngeal cancer in Western countries are related to smoking and alcohol abuse. The 
combined effect follows a multiplicative rather than additive model (75). The increased relative risk 
(RR) for alcohol consumption differs by site, and is higher for the supraglottis and hypopharynx and 
lower for the glottis and subglottis (76). The impact of increased RR (10x) for smoking is stronger 
for glottic than supraglottic SCC (76). Studies in several populations have shown a direct dose-
related response between smoking and SCC and the benefits of cessation. Smoking black tobacco 
cigarettes entails a stronger risk than smoking blond tobacco (77). Other smoking habits that 
increase the RR of laryngeal SCC include: smoking at a young age, long duration, high number of 
cigarettes per day, and deep smoke inhalation (78). The influence of tobacco on RR of laryngeal 
SCC is confirmed even for non-drinkers. Case controlled studies from Italy and Switzerland show 
an increased RR of 2.46 for heavy drinkers and laryngeal SCC. The RR for current smokers who do 
not drink is 9.38 (79). Avoiding cigarettes and alcohol could prevent about 90% of laryngeal and 
hypopharyngeal SCC. 
- Asbestos and occupational exposure: 
There is controversy regarding occupational asbestos exposure and increased risk for developing 
laryngeal SCC (80). However, there is evidence supporting other occupational exposures and 
increased risk of laryngeal SCC, such as polycyclic aromatic hydrocarbons, metal dust, cement 
dust, varnish, lacquer, etc. After adjustment for alcohol and tobacco consumption, the increased risk 
ranged from 1.8 for cement dust to 2.7 for polycyclic aromatic hydrocarbons. Significant 
associations are also found with ionizing radiation, diesel exhausts, sulphuric acid mists and 
mustard gas (60). 
- Diet and nutritional factors: 
A protective effect is probably exerted by high intake of fruits and vegetables (81). Specific 
evidence regarding carotenoids and vitamin C, is inadequate for a conclusion (82).  
- Gastropharyngeal reflux: 
Gastroesophageal reflux has been related to increased risk of laryngeal SCC, especially among 
patients who lack other major risk factors (83). Gastroesophageal reflux may act as a promoter in 
the presence of tobacco and alcohol (84). 
- Genetic susceptibility: 
There is no evidence of strong genetic factors in laryngeal carcinogenesis; however, polymorphisms 
for enzymes implicated in the detoxification of alcohol and tobacco, such as alcohol and aldehyde 
dehydrogenases, are likely to represent weak susceptibility factors, with relative risks in the order of 
1.5-2 (85). Bloom syndrome is an inheritable condition with a predisposition towards laryngeal and 
hypopharyngeal SCC. 
- Prognosis and predictive factors: 
Small glottic or supraglottic SCC can be treated conservatively by laser excision, limited resection, 
or primary radiotherapy (RT), with curative potential, and overall good survival. RT failures can be 
salvaged by conservative, potentially curative voice-sparing surgery. Glottic or supraglottic 
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carcinomas that fix the vocal cord(s) can be treated either by primary resection, with possible 
adjuvant RT, or organ sparing protocols (neoadjuvant chemotherapy with curative RT). If the 
carcinoma persists or recurs, overall survival is not compromised by delayed, salvage, total 
laryngectomy. 	

The TNM tumor classification (Table 5) consistently correlates, on multivariate survival analyses, 
with disease-free and overall survival. Among TNM stage IV patients, extensive cartilage invasion 
and/or bulky tumor volume are predictors of poor response to chemoradiotherapy; these patients are 
best treated with primary resection and possible adjuvant RT. Clinical comorbidities have been 
demonstrated to significantly affect survival over TNM prognosticators. The Washington University 
Head and Neck Comorbidity Index incorporates seven conditions (congestive heart disease, cardiac 
arrhythmia, peripheral vascular disease, pulmonary disease, renal disease, cancer controlled, and 
cancer uncontrolled) weighted according to severity, and is a significant predictor of survival. 	

Generally, histological classification (Table 6) and grading has limited impact on survival. By 
contrast, the pattern of tumor invasion at the advancing host/tumour interface has been 
demonstrated, by itself or in combination with other histological variables, to have predictive value 
for laryngeal carcinoma. Thus within T1/T2 laryngeal SCC, biopsy assessment of the pattern of 
invasion, may be utilized to predict which patients may respond to primary RT, versus which 
patients are better treated by primary resection. In multivariate analysis, overexpression of p53 is 
predictive of improved overall survival. p53 overexpression and elevated PCNA (proliferating cell 
nuclear antigen) index have been demonstrated to be significant independent predictors of 
successful organ preservation. !!!!!!!!!!!!!!!!!!!
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Table 5. TNM classification of carcinomas of the larynx.	
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Primary Tumor 
(T)
Supraglottis Glottis Subglottis
Tx Primary tumor cannot be assessed.
T0 There is no evidence of primary tumor
Tis Carcinoma is in situ.
T1 Tumor id limited to one sub site of the 
supra glottis, with normal vocal cord 
mobility. 
Tumor is limited to the 
vocal cords(s) (may involve 
anterior or posterior 
commissure), with normal 
mobility: T1a is limited to 
one vocal cord; T1b 
involves both vocal cords.
Tumor is limited to the 
subglottis.
T2 Tumor invades mucosa of more than 
one adjacent subsite of the 
supraglottis or glottis or region 
outside the supraglottis (e.g., mucosa 
of base of tongue, vallecula, medial 
wall of pyriform sinus), without 
fixation of the larynx. 
Tumor extends to the 
supraglottis and/or 
subglottis, and/or with 
impaired vocal cord 
mobility.
Tumor extends to the vocal 
cord(s), with normal or 
impaired mobility.
T3 Tumor is limited to the larynx with 
vocal cord fixation and/or invades any 
of the following: postcricoid area, pre-
epiglottic tissues, paraglottic space, 
and/or minor thyroid cartilage ero- 
sion (e.g., inner cortex) 
Tumor is limited to the 
larynx with vocal cord 
fixation and/or invades 
paraglottic space, and or 
minor thyroid cartilage ero- 
sion (e.g., inner cortex).
Tumor is limited to the 
larynx, with vocal cord 
fixation.
T4a Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., 
trachea, soft tissues of neck, including deep extrinsic muscle of the tongue, strap muscles, thyroid, 
or esophagus).
T4b Tumor invades pre vertebral space, encases the carotid artery, or invades mediastinal structures.
Neck Staging 
(N)
Supraglottis Glottis Subglottis
Nx Regional lymph nodes cannot be assessed
N0 There is no regional nodes metastasis
N1 Metastasis in a single ipsilateral lymph node, 3cm of less in greatest dimension
N2 Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest 
dimension; or metastasis is in multiple ipsilateral lymph nodes, none more that 6 cm in greatest 
dimension; or metastasis is in bilateral or contralateral lymph nodes, none greater than 6 cm in 
greatest dimension.
N2a Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest 
dimension.
N2b Metastasis in multiple ipsilateral lymph nodes, none more that 6 cm in greatest dimension
N2c Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
N3 Metastasis in a lymph node more than 6 cm in greatest dimension
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Table 6. WHO histological classification of tumors of the larynx.	

!
4. Laryngeal diagnostic systems and techniques. 
In patients with dysphonia, the diagnostic accuracy from history and physical exam, excluding 
laryngoscopy, is only 5% compared with a 68.3% accuracy following an initial endoscopic 
laryngeal evaluation (86). Because of the wide range of potential causes for the dysphonia, 
determining the precise etiology of the laryngeal/voice disorder is necessary to plan treatment. 
Since malignant transformation rate of premalignant lesions ranges from 6% to 22%, and it 
increases with the severity of the precancerous nature, their early detection is of paramount 
importance. 
For instance, survival rates are significantly higher for early stage carcinomas, therefore, it is 
essential to concentrate on the initial steps in tumor development in order to facilitate early 
detection and timely implementation of suitable therapy (87). Early detection and preoperative 
assessment are important to a curative and function-preserving therapy, because the treatment of 
laryngeal cancer and its precursor lesions has a great impact on important basic functions of daily 
life such as breathing, verbal communication and swallowing. Furthermore, delayed diagnosis, 
leading to loco-regional failure, and a high incidence of second primary are the two main reasons 
for poor outcome.  
From these observations, it is obvious that obtaining images of high quality and resolution, 
revealing the detailed morphology of the glottal structures, is one of the main tasks in laryngeal 
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108 Tumours of the hypopharynx, larynx and trachea
WHO histological classification of tumours of the hypopharynx, 
larynx and trachea
__________
1 Morphology code of the International Classification of Diseases for Oncology (ICD-O) {821} and the Systematized Nomenclature of Medicine (http://snomed.org). 
Behaviour is coded /0 for benign tumours, /3 for malignant tumours, and /1 for borderline or uncertain behaviour.
Malignant epithelial tumours
Squamous cell carcinoma 8070/3
Verrucous carcinoma 8051/3
Basaloid squamous cell carcinoma 8083/3
Papillary squamous cell carcinoma 8052/3
Spindle cell carcinoma 8074/3
Acantholytic squamous cell carcinoma 8075/3
Adenosquamous carcinoma 8560/3
Lymphoepithelial carcinoma 8082/3
Giant cell carcinoma 8031/3
Malignant salivary gland-type tumours
Mucoepidermoid carcinoma 8430/3
Adenoid cystic carcinoma 8200/3
Neuroendocrine tumours
Typical carcinoid 8240/3
Atypical carcinoid 8249/3
Small cell carcinoma, neuroendocrine type 8041/3
Combined small cell carcinoma, neuroendocrine type 8045/3
Benign epithelial tumours
Papilloma 8050/0
Papillomatosis 8060/0
Salivary gland-type adenomas
Pleomorphic adenoma 8940/0
Oncocytic papillary cystadenoma 8290/0
Soft tissue tumours
Malignant tumours
Fibrosarcoma 8810/3
Malignant fibrous histiocytoma 8830/3
Liposarcoma 8850/3
Leiomyosarcoma 8890/3
Rhabdomyosarcoma 8900/3
Angiosarcoma 9120/3
Kaposi sarcoma 9140/3
Malignant peripheral nerve sheath tumour
Synovial sarcoma 9040/3
Borderline tumours / LMP
Inflammatory myofibroblastic tumour 8825/1
Benign tumours
Schwannoma 9560/0
Neurofibroma 9540/0
Lipoma 8850/0
Leiomyoma 8890/0
Rhabdomyoma 8900/0
Hemangioma 9120/0
Lymphangioma 9170/0
Granular cell tumour 9580/0
Haematolymphoid tumours
Tumours of bone and cartilage
Chondrosarcoma 9220/3
Osteosarcoma 9180/3
Chondroma 9220/0
Giant cell tumour 9250/1
Mucosal malignant melanoma 8720/3
Secondary tumours
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imaging. Such images are essential in making correct diagnosis and choosing the treatment to gain 
the best result. 
Nowadays, there is a wide choose of different diagnostic tools, but each of them presents specific 
properties and limits that influence their usage in common practice. Herein a summary of their 
characteristic. !
 4.1 Endoscopy 
Over time, laryngeal photography was perfected, which enhanced diagnostic accuracy, 
documentation, and education. Shortly thereafter, in 1895, both stroboscopy and direct 
laryngoscopy were introduced, which dramatically advanced laryngoscopy and laryngology (88). In 
the early 20th century, direct laryngoscopy and endolaryngeal surgery migrated to the operating 
room for the promise of improved surgical precision (89). 
In laryngological and phoniatric diagnostics, white light laryngoscopy (WL) is the key procedure 
for functional investigation and early detection of neoplastic tissue (90).  In fact, at present, white 
light laryngoscopy combined with biopsy is the standard diagnostic procedure in the assessment of 
laryngeal cancer and precancerous lesions. However, white light laryngoscopy provides poor 
quality images and has difficulty identifying minute epithelial changes and directly differentiating 
benign from malignant tumors in vivo. 
Furthermore, with imprecise laryngeal diagnostics and lack of clinical experience, very early stages 
of malignant lesions, such as dysplasia or carcinoma in situ (CIS), can be overlooked, because they 
often present themselves as low-contrast mucosal changes with superficial roughness or reddening 
and rarely have an obviously characteristic malignant aspect (91). !
 4.2 Stroboscopy 
Stroboscopy is considered to be an important part of diagnosing patients with laryngeal dysplasia. 
Nevertheless, we must note that a strict correlation between a vocal fold vibratory pattern and a 
certain type of lesion does not exist. Vocal fold pathology may produce changes in the appearance 
and vibratory patterns observed during stroboscopic examination. Interpreting the stroboscopic 
examination involves systematic judgment and describing the different vibratory pattern signs. 
These signs, which were first identified by Hirano and Bless (92) included the fundamental 
frequency and periodicity, amplitude of horizontal excursion, glottal closure, symmetry of bilateral 
movement, mucosal wave, and non vibrating portions of the vocal fold.  
Quantitative characterization of the vibratory behavior of the vocal folds is a pivot task to add to the 
diagnostic step. A well-known drawback of video-laryngo-stroboscopy (VLS) is the reliance on 
quasi-periodic voice signals (93) when producing a real-time slow-motion stroboscopic effect. 
Objective measurements of the vocal fold vibration pattern date back to the initial high-speed 
cinematography recordings of vocal fold vibration from the works of Timcke, von Leden, and 
Moore (94-97).  
Nowadays, because of the multiple factors related to the complex vocal fold vibratory system the 
actual clinical application of objective measurements has not yet been achieved. 
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Several indices, describing the glottal wave form, are usually used for the characterization. They 
provide mainly the ‘‘functional information’’ about the vibratory function of the vocal folds and the 
glottal closure, and when they are matched with direct endoscopic images, they provide together 
more detailed information about structural and morphological peculiarities which are both 
fundamental in making the correct diagnosis. In fact, this tool is able to reveal a number of 
abnormalities, including abnormalities of laryngeal structure, absence of vibration, and vibratory 
asymmetry. Flashing light is used to illuminate an object in stroboscopy. When the flashes are 
synchronized with the vocal fold vibrations, a stationary view of the vocal folds is obtained. 
However, the single-flash-timing laryngeal videostroboscopy has a limitation that it is effective only 
when vocal fold vibrations exhibit only one single fundamental frequency. Multiple tones 
(fundamental frequencies) may be recorded in the presence of some diseases, such as polyps, 
nodules, cysts or precancerous lesions (98).  
Quantitative measures of motion and geometry of vocal folds can provide objective information and 
may be useful in planning medical treatment and tracing progress over time. Few studies have 
indicated which stroboscopic signs are more significant than others in evaluating the vibratory 
pattern of vocal folds with premalignant lesions. Despite there some known features that cannot be 
imaged with stroboscope, such as voice breaks, diplophonia, vocal function during voice onset and 
voice offset, vocal tremor and spasms, extremely rough voice quality, alternate laryngeal and 
pharyngeal sources of oscillation (99), the main limitation with the VLS remains the subjective 
nature of the interpretation of laryngeal phonatory function examination results, which significantly 
reduces the reproducibility and the use of VLS as a research tool or even as a quantitative 
instrument for comparing outcomes of treatment of voice and laryngeal disorders. In fact, there is a 
lack of data in the literature about the specificity and sensitivity of VLS parameters discriminating 
normal and pathological voices.  
The discrepancy in diagnosis with VLS seems to be linked to certain key points: (1) during office 
endoscopy, tangential views of the medial surface of the glottis limit the diagnostic sensitivity; (2) 
sulci and mucosal bridges are most subject to this limitation; (3) informed consent should address 
the potential need for a change in intraoperative management. It is advisable to discuss the 
possibility for dissection in both vocal folds, even if a unilateral lesion is observed in the office; (4) 
suspension microlaryngoscopy (SML) is the final diagnostic step in the evaluation of glottic 
pathology (100). !
 4.3 Contact endoscopy 
Contact endoscopy (CE), first described in 1979 by Hamou (101), offers an additional in vivo 
diagnostic procedure based on the staining of the superficial mucosal layer and direct in vivo and in 
situ examination of the epithelial cells. The basic technique of CE involves staining of the 
superficial cells of the mucosa with 1% of nontoxic methylene blue before the magnification of the 
suspected areas through the direct contact of the tip of an endoscope to the mucosal surface to 
obtain cytological images (102). CE enables visualization of the laryngeal mucosa pathology 
through high magnification and therefore detailed examination of cells and blood vessels without 
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requiring tissue biopsy. This non invasive method allows in vivo visualization of vascular alterations 
of the mucosa and rates either as benign or malignant.  
The microvascular architectural changes seen with CE are generally classified in five different 
vascular patterns described in Table 7. !
Table 7. Enhanced contact endoscopy vascular patterns. 
 
The use of contact endoscopy in otolaryngology was first described in 1995 by Andrea et al 
(103,104), however, up to now, only a few groups have evaluated this technique for in vivo 
histology (105,106). In fact, expansion of squamous epithelium from the vocal fold edges to the 
areas of columnar epithelium can be clearly visualized by contact endoscopy; hyperkeratosis (i.e. 
deposits of anuclear cells on the epithelial surface) or leukoplakia are clearly observed on contact 
endoscopy, and the grade of dysplasia that may occur in association with them is generally indicated 
by the impaired nucleus/cytoplasm ratio, nuclear hyperchromasia, and variation in the number and 
appearance of the nucleoli (107).  
False negative results may occur in case of incomplete penetration of the stain throughout the 
epithelial thickness thus hindering the identification of the grade of dysplasia; in this setting the 
presence of secretion decreases stain penetration, while the secretion itself precludes any direct 
contact between the endoscope and the mucosa epithelium. Another situation that may influence the 
incidence of false negative is the diagnosis of carcinoma in situ. Carcinoma in situ is characterized 
by heterogeneity of the cell population; however, angiogenesis is not present because the tumor 
process does not cross the basement membrane. It is therefore difficult to differentiate carcinoma in 
situ from invasive carcinoma. The finding of angioneogenesis definitely indicates carcinoma, 
whereas its absence does not exclude the possibility of invasive carcinoma (i.e.: the diagnosis of 
carcinoma in situ cannot be made with certainty). Finally, the presence of abundant necrosis in case 
of large tumor mass could cause bleed when touched by the endoscope thus impairing tissue 
staining and analysis of cell population. 
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chorion. CE alone offers a noninvasive, rapid, and
repeatable in vivo assessment of the cytological architec-
tur . It provides immediate re ults, with the possibility
of examining multiple mucosal areas. It appears to have
good Se (79.6%–94.7%), Sp (81%–95.5%), and Ac (88%–
94%) in the larynx8,29,30 for distinguishing between
benign and malignant mucosal lesions. CE can examine
only limited cellular arch tecture of the epithelium. This
is due to the poor penetration of methylene blue, which
only dyes superficial layers and potential optical arti-
facts at high magnification due to glare from light
reflected from cells that are not in focus (the focal dis-
tance of the endoscope is 80 mm at 603 magnification
and 30 mm at 1503 magnification).31 These limitations
can be overcome by coupling CE with IEE, enhancing
the microvascular pattern rather than the cellular archi-
tecture, even without the need for vital staining, as we
observed in the present study. The abnormal vasculature
within the chorion with ECE can also be enhanced dif-
ferently depending on whether NBI or SPIES is used.
We have seen that NBI results in a loss of the typical
blue-green color with CE, whereas when using SPIES
and switching from the Clara1Chroma to Spectra A
and B and vice versa, the vasculature toward the surface
is obvious. When abnormal blood vessels are found, in
the majority of cases there is more than one abnormal-
ity, because extension, dilation, weaving, and differing
shapes coexist. These vascular changes become progres-
sively more consistent from the typical “bobby-pin”
archit cture of hyperplasia (Fig. 1) to mild dysplasia
(Fig. 2) passing through the corkscrew shape of the
high-grade dysplasia through the complete subverted
vascular architecture of the SCC (Fig. 3 and Fig. 4).
Hyperplasia and mild-to-moderate dysplasia are typi-
cally visible at only IEE as low-density dark spots (Fig.
5) still with a regular arrangement. Therefore, ECE
allows precise investigation of the spots usually seen
with traditional NBI, showing a dynamic morphology
when the endoscope is moved on the mucosal surface so
that the interpretation of the vascular changes,
enhanced by the SPIES modes (Clara1Chroma and
Spectra A-B) and NBI systems coupled with CE, become
easier. Although ECE allows precise detection of vascu-
lar changes, differential diagnosis between hyperplasia
(pattern type II) and low and mild dysplasia (pattern
type III) ca be difficult. In our seri s, the Se and Sp
rates were 97.6% because three cases were misinter-
preted: case 21 was interpreted as dysplasia (pattern
type III) but was at histology hyperplasia (pattern type
II), case 24 was interpreted as SCC (pattern type IV)
TABLE II.
Enhanced Contact Endoscopy Vascular Patterns.
Vascular Pattern Diagnosis Description
Type 0 Normal mucosa Thin-end regular subepithelial vessels connecting with a thicker and deeper
arborescent vascular network running parallel to the epithelium.
Type I Inflammation The subepithelial vessels are increased in number and size, with irregular and
sometimes crossing directions.
Type II Hyperplasia When the hyperplasia is at the initial stage, intra-CLs are visible running toward
the surface. In this phase, CLs are generally still very thin and short, arising
from the underlying inflammatory vasculature, with a scattered distribution,
but in case of mature hyperplasia, the deeper inflammatory vascular network
is not visible, and only the elongated CLs can be easily seen. In the case of
vegetating keratosis, the deeper inflammatory vascular network is often not
visible, and the elongated CLs are difficult to see. A particular type of
“bobby-pin” can be seen in laryngeal papillomatosis, where we found the
typical papilla encasing the “bobby-pin” inside the papilloma.
Type III Mild–moderate dysplasia Vascular changes become progressively more consistent, with elongated small
vessels in the typical “bobby-pin” shape, but some arborescence appears at
the end of the CLs.
Type IV High-grade dysplasia/carcinoma
in situ/invasive carcinoma
The vascularity of the chorion is more evident, and CLs appear significantly
dilated, with various shapes and a wide range of vascular architectural
changes such as corkscrews or tree-like patterns.
CLs5 capillary loops.
Fig. 1. Patient 3, hyperplasia. Enhanced contact endoscopy
(Spectra A mode 603) view of type II vascular pattern. Hyperpla-
sia is at the initial stage, with relatively short intracapillary loops
running toward the surface. [Color figure can be viewed in the
online issue, which is available at www.laryngoscope.com.]
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For all these reasons, the reliability of contact endoscopy in literature is reported within 75% to 
88% (108-110). 
In summary, CE can examine only limited cellular architecture of the epithelium. This is due to the 
poor penetration of methylene blue, which only dyes superficial layers and potential optical artifacts 
at high magnification due to glare from light reflected from cells that are not in focus (the focal 
distance of the endoscope is 80 mm at 603 magnification and 30 mm at 1503 magnification) (111). 
In specific, difficulties of interpretation of the vascular patterns increase in the follow-up of the 
upper aero-digestive tract (UADT) cancers due to the changes of the surrounding tissues as a 
consequence of previous treatments such as radiotherapy. In order to improve these lacks, Storz 
Professional Image Enhancement System (SPIES) (KARL STORZ GmbH & Co., Tuttlingen, 
Germany) has been recently proposed as a novel digital technique providing specific color 
renderings that pronounce the spectral separation of the recorded broad visible spectrum within the 
high-definition camera system and it does not require a narrow band light source. SPIES enhances 
the appearance of the mucosal surface structures and subepithelial vasculature by selected 
wavelengths of light, providing in addition to the standard mode using white light (WL), five 
different defined spectral ranges (Clara, Clara1- Chroma, Chroma, Spectra A, Spectra B). The main 
target of analysis of these techniques is neoangiogenesis, a prerequisite for the progression of 
precancerous and cancerous lesions of the upper aero-digestive tract (UADT) (102). SPIES, as well 
as narrow band imaging (NBI), allow for the recognition of the superficial changes of 
neoangiogenesis, and they require a certain degree of experience to avoid false positives, because 
the typical mucosal “spots” are not univocal and are challenging for clinical interpretation. It 
appears to have good sensibility (79.6%–94.7%), specificity (81%–95.5%), and accuracy (88%– 
94%) in the larynx (105) for distinguishing between benign and malignant mucosal lesions. !
 4.4 Autofluorescence 
Autofluorescence (AF) is defined as natural fluorescence emission of tissue arising from 
endogenous fluorophores after exposure and activation by radiation of a suitable wavelength. In its 
resting state, a fluorophore is at a stable energy level at which it does not fluoresce. When a 
fluorophore is illuminated, its electrons are promoted to a higher energy level. In this excited state, 
the fluorophore is unstable and will quickly revert to a slightly more stable lower energy level by 
releasing heat. To return to its baseline the fluorophore emits light. Since some energy has already 
been released as heat, the emitted light is of lower energy and longer wavelength than that of the 
illuminating light (112). Fluorophores are present at different concentrations in healthy and 
neoplastic laryngeal mucosa; for example, nicotinamide adenine dinucleotide (NADH) 
predominates within neoplastic cells in its dehydrogenated nonfluorescent form (113,114). Several 
fluorophores are normally found within laryngeal mucosa including prophyrins, elastin, collagen, 
and NADH (115,116). 
Because each fluorophore has a specific wavelength at which its electrons are maximally excited, it 
is possible to target specific fluorophores, such as NADH, using an illuminating light of a single 
wavelength (monochromatic). The underlying fundamental principle of different fluorescence 
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emission in AF is related to neoplasia-induced changes in terms of tissue morphology, optical 
properties, and concentration of endogenous fluorophores (117). Autofluorescence diagnosis is 
based on the ability of oxidised flavin mononucleotide (FMN) in the normal cells to emit green 
fluorescence when exposed to blue light. Nicotinamide adenine dinucleotide plus hydrogen 
(NADH) and flavin adenine dinucleotide (FAD) are important intracellular fluorophores found in all 
tissue layers; their concentration is nearly 100 times lower in malignant tissue than in benign tissue 
(118), therefore, malignant cells do not have fluorescence to the same degree as benign cells (119). 
At present, autofluorescence endoscopy (AFE) is increasingly being used for early detection of 
malignant mucosal changes in diverse areas of localization and various medical specialties 
(120-121). It is argued that the advantage of AFE compared to conventional white light endoscopy 
is based on the fact that premalignant and malignant lesions might be differentiated clearly from 
normal tissue because of decreased AF.  
In 1924, Policard (122) observed the ability of tissue to fluoresce under certain conditions. Alfano et 
al., in 1984 (123), reported the possibility of differentiating between healthy and malignant tissue 
by means of their fluorescent characteristics. In 1933, Sutro and Burmann described the 
phenomenon of the different fluorescences of normal and tumor tissue. 
Harris et al. (124) first used autofluorescence to identify neoplastic cells within the laryngeal 
mucosa, he demonstrated in a pilot study of eight cases with carcinoma of the vocal folds concluded 
that the technique can increase the accuracy of staging of cancer of the larynx and allows earlier 
diagnosis of tumors and their recurrence. In the same year Chissov et al. (125) reached the same 
conclusion. Malzhan et al. (116) reported a sensitivity of 97.3% and specificity of 83.8% for this 
technique in detecting precancerous and cancerous lesions in 127 patients. Beneficial role for AF 
has been ask reported by other works (126,127), even if it has been identified a high rate of false 
positive results, as well (128).  
In summary, despite promising literature evidence for this technique, there are, however, several 
limitations to autofluorescence examination. First, the illuminating light does not penetrate through 
diseased epithelium (119,129). As a result, epithelial hyperkeratosis may hide neoplastic changes 
within the basal mucosal layer (130). Second, granulation tissue and teleangiectasia produce a 
similar reduction in bright-green fluorescence, attributed to the absorbative properties of a heme 
molecule, which makes them indistinguishable from neoplasia by autofluorescence (116). Third, 
scar tissue, necrosis, and inflammation can unpredictably alter mucosal fluorescence (116,126,129). 
Thus, several conditions in the larynx may produce false positive and false negative findings. 
In conclusion, further studies to increase the sensitivity and specificity and investigation of 
technical solutions to reduce the number of false negative and false positive cases are required. !
	
 4.5 Narrow band imaging (NBI) 
Narrow band imaging (NBI) is an optical image enhancement technology that enhances vessels in 
the surface of mucosa using the characteristics of the light spectrum (131). The NBI system consists 
of the same components as conventional videoendoscopic systems: a light source, a camera unit, 
and a camera head or chip-equipped videoendoscope. Additionally, the NBI system contains a 
special image processor and a lighting unit with special filters that narrow the frequency range of 
!31
emitted light to 400-430 nm (centered at 415 nm, blue) and 525-555 nm (centered at 540 nm, green) 
bands. Since the blue light wavelength (415 nm) is absorbed by hemoglobin the capillary blood 
vessels are seen brown in the summary picture. Currently, available evidence indicates that NBI 
may be a promising approach in the diagnosis of laryngeal cancer. It allows to visualize the 
structure of the intraepithelial blood vasculature which cannot be seen with conventional white light 
(132). In fact, the emitted light has less penetration and less scattering and is highly absorbed in 
hemoglobin, thus enhancing the image resolution. The reflection is captured by a charge-coupled 
device chip (CCD), and an image processor creates a composite pseudocolor image, which is 
displayed on a monitor, enabling NBI to enhance mucosal contrast without the use of dyes (133). 
The detection of surface mucosal changes that are characteristic of neoplastic lesions (e.g., 
dysplasia, in situ carcinoma, and carcinoma), epithelial abnormalities (thickening and changes in 
the surface layer), and vascular changes can be best achieved with NBI. 
In the NBI mode, normal laryngeal mucosa consists of submucosal vessels (appearing green) 
connecting with an arborescent vascular network (appearing dark brown). Abnormalities of these 
intraepithelial papillary capillary loop (IPCL), located beneath the basement membrane of 
epithelium, are usually classified in accordance with their shape changes; such changes have been 
found to predict the depth of superficial cancer invasion (134,135). 
Classification of laryngeal lesions has been reported in Figure 4. !
Figure 4. Diagrams of microvasculature and endoscopic views of vocal folds, illustrating 
classification of intraepithelial papillary capillary loop features using narrow band imaging. 
Type I (A1): thin, oblique and arborescent vessels are interconnected and intraepithelial papillary 
capillary loops are almost invisible. Type II (B1): diameter of oblique and arborescent vessels is 
enlarged, and intraepithelial papillary capillary loops are almost invisible. Type III (C1): 
intraepithelial papillary capillary loops are obscured by white mucosa. Type IV (D1): intraepithelial 
papillary capillary loops can be recognized as small dots. Type Va (E1): intraepithelial papillary 
capillary loops appear as solid or hollow, with a brownish, speckled pattern and various shapes. 
Type Vb (F1): intraepithelial papillary capillary loops appear as irregular, tortuous, line-like 
shapes. Type Vc (G1): intraepithelial papillary capillary loops appear as brownish speckles or 
tortuous, line-like shapes with irregular distribution, scattered on the tumor surface. !!!!!!!!!!
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In type I, the intraepithelial papillary capillary loops are almost invisible, and oblique and 
arborescent vessels of small diameter can be clearly seen. In type II, the intraepithelial papillary 
capillary loops are also almost invisible, but the diameter of the clearly observed oblique and 
arborescent vessels is enlarged. In type III, the mucosa is white and the intraepithelial papillary 
capillary loops cannot be seen; if the white patch is thin, the oblique and arborescent vessels may be 
seen indistinctly, but if the white patch is thick the vessels will be obscured. In type IV, the mucosal 
intra- epithelial papillary capillary loops are visible with a relatively regular arrangement and low 
density, the capillary terminals are bifurcated or slightly dilated, and the intraepithelial papillary 
capillary loops appear as scattered, small, dark brown spots; the oblique and arborescent vessels are 
usually not visible. 
Type V changes are subdivided into types Va, Vb and Vc according to the shape, regularity and 
distribution of vessels. In type Va, intraepithelial papillary capillary loops are significantly dilated 
and of relatively high density, and appear to be solid or to have hollow, brownish, speckled features 
and various shapes. In type Vb, the intraepithelial papillary capillary loop itself is destroyed, with 
its remnants presenting in a snake-, earthworm-, tadpole- or branch-like shape, and the microvessels 
are dilated, elongated and ‘woven’ in appearance. In type Vc, the lesion surface is covered with 
necrotic tissue, and the intraepithelial papillary capillary loops present as brownish speckles or 
tortuous shapes of uneven density which are irregularly scattered on the tumor surface. 
Lesions viewed under NBI are usually recorded as: (1) malignant (i.e. type V); (2) suspected 
malignant (i.e. protuberant or ulcerative lesions covered with necrotic tissue, or leukoplakia of 
unknown type); or (3) benign (types I to IV) (135).  
In the literature, there exist only a few publications on the exclusive use of NBI in laryngology 
(135-142). However, several studies assessed the value of NBI in the head and neck also including 
the larynx (132,137,143-148). 
NBI has shown in the larynx, over last years, improved sensitivity 61-91% and specificity 87-92% 
(146,149) but false positives and false negatives have been reported, especially in the larynx, and 
increase with a short learning curve.  
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states, ranging from benign to malignant, using narrow
band imaging, and also to evaluate the value of narrow
band imaging in the early detection of laryngeal cancer
and its precursor lesions.
Patients and methods
Patients
We enrolled a total of 85 consecutive patients with sus-
pected precancerous or cancerous laryngeal lesions
who were seen in the endoscopy unit of the Cancer
Institute and Hospital, Chinese Academy of Medical
Sciences, between December 2008 and May 2009.
Exclusion criteria included: allergy to lidocaine;
severe, uncontrollable dyspnoea; unstable angina; hae-
morrhagic disease; and inability to understand and sign
an informed consent form.
The study was approved by the medical ethics com-
mittee of the above hospital, and informed consent was
obtained from each patient prior to inclusion.
Endoscopic laryngeal examination
and narrow band imaging
Narrow band imaging was performed using the
Olympus Evis Lucera 260 system and a BF-6C260
video-bronchoscope (Olympus Medical Systems,
Tokyo, Japan). The Evis Lucera 260 system provides
white light illumination and also narrow band illumina-
tion with central wavelengths at 415 and 540 nm. The
BF-6C260 video-bronchoscope has a high resolution
colour charge coupled device and can provide high
quality images in both white light and narrow band
imaging modes.
Prior to endoscopic examination, the patients’ nasal
cavity surfaces were anaesthetised and lubricated with
2 per cent lidocaine hydrochloride gel. The patient
was placed in a supine position. The endoscope was
introduced into the nasal passages. The nasopharynx,
oropharynx, hypopharynx and larynx were examined
in sequence. All endoscopies were performed by the
same experienced endoscopist.
The entire larynx was initially visualised with stan-
dard white light, followed by visualisation using the
narrow band imaging mode. The anatomical location
of each patient’s laryngeal lesion(s) was documented
as follows: epiglottis, arytenoids, aryepiglottic folds,
false vocal folds, true vocal folds (left or right) or sub-
glottic region. Representative images were recorded for
analysis. Endoscopic biopsy of laryngeal lesions was
also performed; tissue was fixed in 10 per cent formalin
for histological analysis.
Classification of laryngeal lesions
In the white light mode, laryngeal lesions were classi-
fied into three types according to their endoscopic fea-
tures, as follows: (1) malignant lesion (i.e. protuberant
or ulcerative tumour); (2) suspected malignant lesion
(i.e. uneven or rough surface, slight protrusion or
white patch on lesion); or (3) benign lesion (i.e. hyper-
aemia, oedema, leukoplakia, nodule or polyp).
In the narrow band imaging mode, normal laryngeal
mucosa was observed to consist of submucosal vessels
(appearing green) connecting with an arborescent vas-
cular network (appearing dark brown) (Figure 1, A3).
These arborescent vessels were interconnected and
ran parallel to the epithelium, before branching out
FIG. 1
Diagrams of microvasculature and endoscopic views of vocal folds, illustrating classification of intraepithelial papillary capillary loop features
using narrow band imaging. Type I (A1, A2 and A3): thin, oblique and arborescent vessels are interconnected and intraepithelial papillary capil-
lary loops are almost invisible. Type II (B1, B2 and B3): diameter of oblique and arborescent vessels is enlarged, and intraepithelial papillary
capillary loops are almost invisible. Type III (C1, C2 and C3): intraepithelial papillary capillary loops are obscured by white mucosa. Type IV
(D1, D2 and D3): intraepithelial papillary capillary loops can be recognised as small dots. Type Va (E1, E2 and E3): intraepithelial papillary
capillary loops appear as solid or hollow, with a brownish, speckled pattern and various shapes. Type Vb (F1, F2 and F3): intraepithelial papil-
lary capillary loops appear as irregular, tortuous, line-like shapes. Type Vc (G1, G2 and G3): intraepithelial papillary capillary loops appear as
brownish speckles or tortuous, line-like shapes with irregular distribution, scattered on the tumour surface.
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states, ranging from benign to malignant, using narrow
band imaging, and also to evaluate the value of narrow
band imaging in the early detection of laryngeal cancer
and its precursor lesions.
Patients and methods
Patients
We enrolled a total of 85 consecutive patients with sus-
pected precancerous or cancerous laryngeal lesions
who were seen in the endoscopy unit of the Cancer
Institute and Hospital, Chinese Academy of Medical
Sciences, between December 2008 and May 2009.
Exclusion criteria included: allergy to lidocaine;
severe, uncontrollable dyspnoea; unstable angina; hae-
morrhagic disease; and inability to understand and sign
an informed consent form.
The study was approved by the medical ethics com-
mittee of the above hospital, and informed consent was
obtained from each patient prior to inclusion.
Endoscopic laryngeal examination
and narrow band imaging
Narrow band imaging was performed using the
Olympus Evis Lucera 260 system and a BF-6C260
video-bronchoscope (Olympus Medical Systems,
Tokyo, Japan). The Evis Lucera 260 system provides
white light illumination and also narrow band illumina-
tion with central wavelengths at 415 and 540 nm. The
BF-6C260 video-bronchoscope has a high resolution
colour charge coupled device and can provide high
quality images in both white light and narrow band
imaging modes.
Prior to endoscopic examination, the patients’ nasal
cavity surfaces were anaesthetised and lubricated with
2 per cent lidocaine hydrochloride gel. The patient
was placed in a supine position. The endoscope was
introduced into the nasal passages. The nasopharynx,
oropharynx, hypopharynx and larynx were examined
in sequence. All endoscopies were p rformed by the
same experienced endoscopist.
The entire larynx was initially visualised with stan-
dard white light, followed by visualisation using the
narrow band imaging mode. The anatomical location
of each patient’s laryngeal lesion(s) was documented
as foll ws: epiglot is, arytenoids, ary piglottic folds,
false vocal folds, true vocal folds (left or right) or sub-
glottic region. Representative images were recorded for
analysis. E doscopic biopsy of laryn eal lesions was
also performed; tissue was fixed in 10 per cent formalin
for histological analysis.
Classification of laryngeal lesions
In the white light mode, laryngeal lesions were classi-
fied i to three types according to their endoscopic fea-
tures, as follows: (1) malignant lesion (i.e. protuberant
or ulcerative tumour); (2) suspected malignant lesion
(i.e. uneven or rough s rf ce, slight protrusion or
white patch on lesion); or (3) benign lesion (i.e. hyper-
aemia, oedema, leukoplakia, nodule or polyp).
In the narrow band imaging mode, normal laryngeal
mucosa was observed to consist of submucosal vessels
(appearing green) connecting with an arborescent vas-
cular network (appearing dark brown) (Figure 1, A3).
These arborescent vessels were interconnected and
ran parallel to the epithelium, before branching out
FIG. 1
Diagrams of microvasculature and endoscopic views of vocal folds, illustrating classification of intraepithelial papillary capillary loop features
using narrow band imaging. Type I (A1, A2 and A3): thin, oblique and arborescent vessels are interconnected and intraepithelial papillary capil-
lary loops are almost invisible. Type II (B1, B2 and B3): diameter of oblique and arborescent vessels is enlarged, and intraepithelial papillary
capillary loops are almost invisible. Type III (C1, C2 and C3): intraepithelial papillary capillary loops are obscured by white mucosa. Type IV
(D1, D2 and D3): intraepithelial papillary capillary loops can be recognised as small dots. Type Va (E1, E2 and E3): intraepit elial papillary
capillary loops appear as solid or hollow, with a brownish, speckled pattern and various shapes. Type Vb (F1, F2 nd F3): intr epithelial papil-
lary capillary loops appear as irregular, tortuous, line-like shapes. Type Vc (G1, G2 and G3): intraepithelial papillary capillary l ops appear as
brownish speckles or tortuous, line-like shapes with irregular distribution, scattered on the tumour surface.
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This approach is promising for better discrimination of malignant and benign lesions as part of 
“prehistologic diagnosis” or “optical biopsy” (140). Nevertheless, there is no ultrathin, zooming, 
flexible videoendoscope available for ENT purposes; therefore, a combination of rigid telescopes 
and an HDTV camera head must be used to achieve sufficient resolution and ultrahigh 
magnification (150). Although most authors concur that NBI with or without HDTV is a valid 
diagnostic tool, this method has some limitations. The most relevant is certainly the possibility of 
generating, at least in the early phase of the learning curve, an increased number of false positives 
with consequently unjustified biopsies. This is mostly related to acute inflammation and chronic 
post-RT changes. Therefore, we believe that the incidence of false positive findings was mainly 
related to the experience of the examiners more than to specific mucosal changes. !
 4.6 Ultrasound 
Over the past 15 years, there has been an effort by head and neck surgeons to bring optical imaging 
technology from the research laboratory into the operating theater to improve their ability to 
identify the tumor margin in vivo to guide surgical excision (112). 
Sonography is regarded as the first imaging method routinely used for detecting cervical lymph 
node metastases from head and neck tumors (151,152) but it has rarely been used as an imaging 
technique for investigation of the larynx. Previous studies in the literature have yielded promising 
results for high-frequency sonography in diagnosis of laryngeal carcinoma (153-155) However, the 
use of sonography in tumor staging is still limited.  
Since the 1970s, B-mode US imaging has been used with some success in the laryngeal area to 
identify mass and cystic lesions at the vocal folds (156) and to detect vocal fold paralysis (157,158); 
moreover, ultrasonography has been also used to evaluate laryngeal tumors in a few studies, and 
some of these have proved that ultrasonography could assist tumor staging in patients with 
advanced laryngeal cancer (155,159,160). 
It has been demonstrated that ultrasound has a similar role in the visualization of hypopharyngeal 
tumor to CAT (161), thus  whether ultrasonography has similar ability in evaluating laryngeal 
cancer is worthy to be investigated.  Thyroid cartilage, pre-epiglottic space, paraglottic space, 
thyroid and cervical soft tissues, lying in the larynx anteriorly or superficially, are easy to be imaged 
with a high-frequency probe. Commonly, these structures are isoechoic or hyperechoic, which 
provide a contrast with a hypoechoic invading tumor (159). Hence, a high sensitivity and specificity 
has been achieved by ultrasonography in the evaluation of involvement of these structures and 
reported in literature (160,162,163). 
For instance, Kraft et al. (164) established anatomical landmarks for laryngeal endosonography (see 
Table 8) in order to allow a correct interpretation of sonographic images of its structures, and its 
known capacity to visualize critical regions such as the pre-epiglottic and paraglottic space 
endoscopically.  !!
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Table 8. Description of normal sonoanatomy of the larynx correlated to horizontal whole 
organ sections of scanned speciments. !
!  !
Therefore, endolaryngeal ultrasonography seems to be able to predict the exact extension of a 
laryngeal tumor before surgery is performed, and to assist in finding the best therapeutic solution 
for the patient (165). 
Furthermore, given its noninvasive nature and minimal disturbance to normal voice production, 
medical US imaging should be an ideal tool for studying vocal fold vibration. However, only a few 
studies have used dynamic US imaging to investigate the vibrating vocal folds (166,167). The body 
motion of the vocal fold, which is ruled by mechanical process described by Hirano (168,169), 
presents a vibration frequency (f) >70 Hz which is higher than the frame rate (fs) of dynamic B-
mode US (<50 Hz). Under this condition, real-time dynamic motion pictures of vocal fold vibration 
cannot be obtained using B-mode imaging. If the phonation frequency is tuned to be close to an 
integer multiple of fs, a slow motion montage of vocal fold vibration may be obtained with B-mode 
US imaging. Such motion pictures may provide valuable data for analyzing vocal fold vibration 
especially in the body. This unique method has been described for the first time by Tsai et al. (170) 
who first attempted to represent a dynamic B-mode image of vocal fold vibration. 
In conclusion, endosonography of the larynx produces horizontal slice images comparable with 
computed axial tomography (CAT) or magnetic resonance imaging (MRI) scans but with a higher 
resolution (170). During the imaging process, it is essential to position the probe as centrally as 
possible, avoiding contact with the laryngeal wall, it allows to directly measure the antero-posterior 
and medio-lateral diameters of the laryngeal neoplasm. The orotracheal tube, together with 
laryngeal structures such as cricoid and thyroid cartilages, are useful anatomical landmarks. Hence, 
direct observation of sonographic images help in orientation, too. !
 4.7 Computed axial tomography (CAT) and Magnetic resonance imaging (MRI) 
The radiologist makes a valuable contribution to the staging of laryngeal cancer and this has a direct 
influence on treatment planning. Since approaches with both computed axial tomography (CAT) 
and magnetic resonance imaging (MRI) are acceptable, the choice in practice depends on machine 
availability and local expertise as well as the ability of the patient to tolerate a prolonged MRI 
examination. Cross sectional imaging provides information on tumor volume, extension to and 
necessary before endosonography may routinely
be applied as a complementary tool in the diag-
nostic investigation of laryngeal pathologies.
The objectives of the present study were to
demonstrate normal sonoanatomy of the larynx,
to establish anatomical landmarks for endoso-
nography, and to correlate them to horizontal
whole-organ sections of the scanned specimens.
MATERIALS AND METHODS
In an experimental study, a total of 32 normal
human larynges obtained at the time of routine
autopsy were xamined endosonographically in
accord with the Helsinki Declaration of 1975 as
revised in 1983. For this purpose, a Hitachi
EUB-6500 ultras nograph (Hitachi Medical
Systems Europe, Zug, Switzerland) with a 360!
radial scanning EUP-R54AW-19 endocavity
probe was used. This rigid 10-MHz transducer
provides an outer diameter of 12 mm and a
length of 190 mm. First, the excised larynges
were placed in a bowl f water to obtain appro-
priate tissue connection for endosonography.
Then, the probe was inserted into the cadaver
specimens and its actual position was con-
trolled through direct visualization. A standar-
dized examination was performed in a real-
time mode, which started in the trachea and
slowly moved upward. In each specimen, the
most important anatomical landmarks were
identified nd documented by sonograms.
Finally, the larynges were cut in horizontal
whole-organ sections and were documented by
photographs. In such a manner, the c assical
landmarks as seen in the sonograms could be
Table 1. Normal sonoanatomy of the larynx.
Anatomical structure Endosonographic appearance
Trachea Horseshoe shape; inner and outer perichondrium hyperechoic; elastic cartilage hypoechoic;
membranous portion and tracheal mucosa normoechoic with homogeneous echopattern
Cricoid Closed ring, interrupted anteriorly by cricothyroid membrane in its upper part; inner and outer
perichondrium hyperechoic; elastic cartilage hypoechoic; ossified cartilage normoechoic to hyperechoic;
cricoidal mucosa normoechoic with homogeneous echopattern
Thyroid Triangular shape, interrupted anteriorly by thyroid notch in its upper part; inner and outer perichondrium
hyperechoic; elastic cartilage hypoechoic; ossified cartilage normoechoic to hyperechoic
Vocal fold Paraglottic space and vocal muscle hypoechoic (directly adjacent to thyroid); vocal ligament and overlying
mucosa hyperechoic (situated more medially to vocal muscle)
Ventricular fold Connective tissue of ventricular fold and preepiglottic space hyperechoic with rough echopattern;
paraglottic space and laryngeal ventrical hypoechoic; arytenoid hyperechoic
Epiglottis Inner and outer perichondrium hyperechoic; elastic cartilage hypoechoic; epiglottic mucosa normoechoic
with homogeneous echopattern
Note: All laryngeal specimens (n ¼ 32) showed a similar and reproducible sonoanatomy, which could be verified consistently on corresponding histo-
logical cross sections in the horizontal plane, as illustrated in Figures 1 to 5.
FIGURE 1. Trachea. Correlation between endosonography and corresponding histological cross section (hematoxylin-eosin stain, origi-
nal magnification #1). IP, inner perichondrium of trachea; OP, outer perichondrium of trachea; EC, elastic cartilage; MP, membranous
portion of trachea; MU, tracheal mucosa.
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across the laryngeal ventricle, infiltration of pharynx, para-glottic, pre-epiglottic and extra-laryngeal 
spaces, all of which impact on the potential for voice conserving partial laryngectomies and 
response to radiotherapy. Together with an assessment of nodal and systemic metastases, this 
enables the radiologist to play an integral role in the multidisciplinary selection of treatment 
options. 
In specific, radiologists have to describe if the clinical laryngeal lesions presents a deeper extension 
and if this extension affect main laryngeal structures. They do this by analyzing different parameters 
as following: 
- Relationship of the tumor to the ventricular complex. 
In order to define the tumor as supraglottic, glottic or subglottic the radiologist must determine the 
level of the ventricular complex (comprising the true cord, false cord and the intervening ventricle). 
These landmarks are essentially mucosal, and usually they are assessed endoscopically, however, 
sometimes a bulky tumor could hide its distal visualization. The superior aspect of the ventricular 
complex is defined by the superior margin of the arytenoids cartilages (Figure 5a). The inferior 
aspect of the ventricular complex is defined by the true cords; radiologically identified by the 
transition of para-glottic fat to soft tissue in the wall of the larynx. This soft tissue represents the 
thyroarytenoid muscle (Figure 5b). In addition, the true cord lies at the upper margin of the cricoid 
cartilage (at the level of the anteriorly pointing vocal processes of the arytenoid cartilages). The 
posterior commissure is seen between the arytenoids cartilages. The subglottic region has a 
characteristic appearance where the cricoid cartilage is seen as a complete ring providing the 
foundation of the laryngeal skeleton (Figure 5c) Any soft tissue at the subglottic level is abnormal. 
The presence of an enlarged delphian node anterior to the trachea also indicates subglottic 
involvement. 
- Involvement of the submucosal spaces. 
An understanding of the pre-epiglottic and para-glottic spaces allows the radiologist to predict and 
identify patterns of tumor spread which have a critical impact on therapeutic decisions. Submucosal 
involvement of the pre-epiglottic and para-glottic spaces is difficult to evaluate clinically and 
endoscopically. The fatty C-shaped pre-epiglottic space is bounded anteriorly by the thyroid 
cartilage and thyrohyoid membrane and posteriorly by the epiglottis and quadrangular membrane 
(Figure 5a).  !
Figure 5. Axial CT scan through (a) false cords, (b) true cords, (c) subglottis to illustrate 
normal anatomy. (a) The tip of the arytenoids cartilages (white arrowhead) indicates the level of 
the false cords (open arrowhead) and also the superior aspect of the ventricular complex. (b) The 
anteriorly pointing vocal processes of the arytenoids (arrow) and the thyroarytenoid muscle (white 
arrowhead) are effacing the para-glottic fat within the wall of the larynx. This defines the level of 
the true cords and also the inferior aspect of the ventricular complex. The anterior and posterior 
(open arrowhead) commissures should only be represented by a thin mucosal layer. (c) There 
should be no soft tissue seen internal to the ring of the cricoid cartilage at subglottic level.  
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The pre-epiglottic space is continuous laterally with the paired para-glottic spaces (Figure 6). !
Figure 6. The medial relations of the para-glottic fat (o) are seen to be the vestibule, the ventricle 
(long arrow) and the conus elasticus more inferiorly (curved arrow). Laterally it is related to thyroid 
cartilage and cricothyroid membrane. The true vocal cord is indicated (*). 
CT and MRI are 88-93% accurate in the assessment of tumor extension within these spaces (171). 
- Anterior and posterior extension. 
In addition to defining the craniocaudal extension within the submucosal spaces relative to the 
ventricular complex landmarks, it is important to evaluate the anterior and posterior extension of 
tumor. This is particularly important at the level of the glottis, where usually glottic carcinoma, 
grows towards the anterior commissure which is frequently associated with thyroid cartilage 
involvement of the base of epiglottis (Figure 7). 
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the patient to tolerate a prolonged MRI examination. MR
imaging is most frequently used if there is uncertainty in
assessing cartilage involvement, when this is critical
to therapeutic decisions. It may also better define the
margin between the tumour and thyroarytenoid muscle
and involvement of the tongue base.
Ultrasound with FNA may be routinely used in some
centres for the assessment of nodal metastasis. Although
it may be used to visualise the anterior laryngeal struc-
tures[6], it is not sufficient for adequate primary tumour
staging. Endolaryngeal high frequency ultrasound has
been evaluated as a diagnostic tool[7].
Positron emission tomography (PET) and CT-PET
may also be useful for the detection of recurrent
tumour and in distinguishing this from post radiotherapy
change[8]. A negative PET scan excludes recurrence with
a high certainty. Positive PET scan findings should be
assessed with biopsy and follow up PET imaging if this
is negative. It should be noted that physiological uptake
of [18F]fluorodeoxyglucose ([18F]FDG) is observed due
to vocal cord activity, so a ‘silent protocol’ should be
employed.
Key imaging considerations
Tumour volume
Tumour volume is a critical factor in predicting tumour
control following radiotherapy. Supraglottic tumours
measuring less than 6ml and T3 glottic tumours measur-
ing less than 3.5ml have been demonstrated to have
improved local control following radiotherapy[9,10].
There is also some data which suggests that tumour
volume is strongly associated with local control following
surgery[11]. Although tumour volume is closely asso-
ciated with T stage and other findings such as cartilage
invasion, it does appear to act as an independent
predictor of survival.
Relationship of the tumour to the ventricular
complex
A key component of the imaging assessment is to define
the three anatomical sites of supraglottis, glottis and
subglottis. The glottis includes the true vocal cord,
anterior and posterior commissures and is defined as
stretching from the ventricle to a plane 1 cm below the
free margin of the vocal cord. Below this, the glottis
merges with the subglottis which extends inferiorly to
the caudal aspect of the cricoid cartilage. Above this, the
supraglottis spans the laryngeal segment from the tip of
the epiglottis to the ventricle. Its components are the
epiglottis, false cord, ventricle, aryepiglottic folds and
arytenoids cartilages. Transglottic is a term used to des-
cribe tumours encroaching on both glottis and supraglot-
tis with or without subglottic components and when the
site of origin is unclear (these usually develop from
glottic tumours).
In order to define the tumour as supraglottic, glottic or
subglottic, the radiologist must determine the level of the
ventricular complex (comprising the true cord, false cord
and the intervening ventricle). These landmarks are
essentially mucosal, and the endoscopist will frequently
be able to make this assessment. However, bulky tumours
may hinder distal visualisation (particularly in the sub-
glottic region) and tumour may not be seen endoscopi-
cally beneath an intact mucosa. The superior aspect of
the ventricular complex is defined by the superior margin
of the arytenoids cartilages (Fig. 1a). The false cords are
seen at this level running parallel and superior to the true
cords. The inferior aspect of the ventricular complex
is defined by the true cords. This is located radiologically
by identifying a transition of paraglottic fat to soft tissue
Figure 1 Axial CT scans through (a) false cords, (b) true cords, (c) subglottis to illustrate normal anatomy. (a) The tip
of the arytenoids cartilages (white arrowhead) indicates the level of the false cords (open arrowhead) and also the
superior aspect of the ventricular complex. (b) The anteriorly pointing vocal processes of the arytenoids (arrow) and the
thyroarytenoid muscle (white arrowhead) are effacing the paraglottic fat within he wall of the larynx. This defines
the level of the true cords and also the inferior aspect of the ventricular complex. The anterior and posterior
(open arrowhead) commissures should only be represented by a thin mucosal layer. (c) There should be no soft tissue
seen internal to the ring of the cricoid cartilage at subglottic level.
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the patient to tolerate a prolonged MRI examination. MR
imaging is most frequently used if there is uncertainty in
assessing cartilage involvement, when this is critical
to therapeutic decisions. It may also better define the
margin between the tumour and thyroarytenoid muscle
and involvement of the tongue base.
Ultrasound with FNA may be routinely used in some
centres for the assessment of nodal metastasis. Although
it may be used to visualise the anterior laryngeal struc-
tures[6], it is not sufficient for adequate primary tumour
staging. Endolaryngeal high frequency ultrasound has
been evaluated as a diagnostic tool[7].
P sitro emission tomograp y (PET) and CT-PET
may also be useful for the detection of recurrent
tumour and in distinguishing this from post radiotherapy
change[8]. A negative PET scan excludes recurrence with
a high certainty. Positive PET scan findings should be
assessed with biopsy and follow up PET imaging if this
is negative. It should be noted that physiological uptake
of [18F]fluorodeoxyglucose ([18F]FDG) is observed due
to vocal cord activity, so a ‘silent protocol’ should be
employed.
Key imaging considerations
Tumour volume
Tumour volume is a critical factor in predicting tumour
control following radiotherapy. Supraglottic tumours
measuring less than 6ml and T3 glottic tumours measur-
ing less than 3.5ml have been demonstrated to have
improved local control following radiotherapy[9,10].
There is also some data which suggests that tumour
volume is strongly associated with local control following
surgery[11]. Although tumour volume is closely asso-
ciated with T stage and other findings such as cartilage
invasion, it does appear to act as an independent
predictor of survival.
Relationship of the tumour to the ventricular
complex
A key component of the imaging assessment is to define
the three anatomical sites of supraglottis, glottis and
ubglottis. The glottis includes the true vocal cord,
anterior and posterior commissures and is defined as
stretching from the ventricle to a plane 1 cm below the
free margin of the vocal cord. Below this, the gl ttis
merges with the subglo tis which extends inferiorly to
the caudal aspect of the cricoid cartilage. Above this, the
supraglottis spans the laryngeal segment from the tip of
the epiglottis to the ventricle. Its components are the
epiglottis, false cord, ventricle, aryepiglottic folds and
arytenoids cartilages. Transglottic is a term used to des-
cribe tumours encroaching on both glottis and supraglot-
tis with or without subglottic components and when the
site of origin is unclear (these usually develop from
glottic tumours).
In order to define the tumour as supraglottic, glottic or
subglottic, the radiologist must determine the level of the
ventricular compl x (comprising the true cord, fa se cord
and th intervening ventricle). These landmarks are
essentially mucosal, and the ndoscopist ill frequently
be able to make this assessment. However, bulky tumours
may hinder distal visualisation (particularly in the sub-
glottic region) and tumour may not be seen endoscopi-
cally beneath an intact mucosa. The superior aspect of
the ventricular complex is defined by the superior margin
of the arytenoids cartilages (Fig. 1a). The false cords are
seen at this level running parallel and superior to the true
cords. The inferior aspect of the ventricular complex
is defined by the true cords. This is located radiologically
by identifying a transition of paraglottic fat to soft tissue
Figure 1 Axial CT scans through (a) false cords, (b) true cords, (c) subglottis to illustrate normal anatomy. (a) The tip
of th arytenoids cartil ges (white arrowhead) indicates th level of the false cords (open rrowhead) a d also the
superior aspect of the ventricular complex. (b) The a teriorly pointing vocal processes of the arytenoids (arrow) and the
thyroarytenoid muscle (white arrowhead) are effacing the paraglottic fat within the wall of the larynx. This defines
the level of the true cords and also the inferior aspect of the ventricular complex. The anterior and posterior
(open arrowhead) commissures should only be represented by a thin mucosal layer. (c) There should be no soft tissue
seen internal to the ring of the cricoid cartilage at subglottic level.
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the patient to tolerate a prol nged MRI examination. MR
imaging is most frequently used if ther is uncertainty in
asse sing cartilage involvement, when this is critical
to therapeutic decisions. It may also bett r define the
margin between the tumour and thyroarytenoid muscle
and involvement of the tongue base.
Ultrasound with FNA may be routinely used in some
centres for the asse sment of nodal metastasis. Although
it may be used to visualise the anterior laryngeal struc-
tures[6], it s not sufficient for adequate primary tumour
staging. Endolaryngeal high frequency ultrasou has
been ev luated as a diagnostic tool[7].
Positron emission tomography (PET) and CT-PET
may also be useful for the detection of recurrent
tumour and in dist nguishing this from post radiotherapy
change[8]. A negative PET scan excludes recurrence with
a high certainty. Positive PET scan findings hould be
asse sed with biopsy and foll w up PET imaging if this
is negative. It should be noted that physiol gical uptake
of [18F]fluor deoxyglucose ([18F] DG) is observed ue
to vocal cord activity, so a ‘silent prot c l’ should be
employed.
Key imaging considerations
Tumour volume
Tumour volume is a critical factor in predicting tumour
control foll wing radiotherapy. Supraglottic tumours
measuring less than 6ml and T3 glottic tumours measur-
ing less than 3.5ml have been demonstrated to have
improved local control foll wing radiotherapy[9,10].
Ther is also some dat which suggests that umour
volume is strongly associated with local control foll wing
surgery[11]. Although tumour volume is closely asso-
ciated with T stage and other findings uch as cartilage
invasion, it does appear to act as an indep ndent
predictor of survival.
Relationship of th umour to the ventricular
complex
A key compone t of the imaging asse sment is to define
the three an tomical sites of supraglottis, glottis and
subglottis. The glottis includes the true vocal cord,
anterior and posterior com issures and is defined as
stretching from the ventricle to a plane 1 cm b low the
free margin of the vo al cord. Bel w this, the glottis
merge with the subglottis which extends inf riorly to
the caudal spect of the cri oid cartilage. Above this, the
supraglottis spans the laryngeal segment from the tip of
the piglottis to the ventricle. Its compone ts are the
epiglottis, false cord, ventricle, aryepiglottic folds and
arytenoids cartilages. Transglottic is a term used to des-
cribe tumours encroaching on both glottis and supraglot-
tis with or without subglottic ompone ts and when the
site of origin is unclear (thes us ally dev lop from
glottic tumours).
In order to define the tumour as supraglottic, glottic or
subglottic, the r diol gist must determi e t l v l of the
ventricular complex (comprising the true cord, false cord
and the i erveni g ventricle). Thes landmarks are
essentially muc sal, and the ndoscopist will frequently
be able to make this asse sment. Howev r, bulky tumours
may hinder distal visualisation (particularly in the sub-
glottic region) and tumour may not be seen endoscopi-
cally ben ath an intact mucosa. The superior aspect of
the ventricular complex is defined by the superior margin
of the arytenoids cartilages (Fig. 1a). The false cords are
seen at this lev l runni g par lle and superior to the true
cords. The inferior aspect of the ventricular complex
is defined by the true cords. This located radiol gically
by identifying a transition of par glottic fat t soft tissue
Figure 1 Axial CT scans through (a) false cords, (b) true cords, (c) subglottis to illustrate normal n tomy. (a) The tip
of the arytenoids cartilages (white arrowhead) indicates the lev l of the false cord (open a rowhead) and lso the
superior aspect of the ventricular complex. (b) The anteriorly pointi g vocal processe of the arytenoids (arrow) and the
thyroarytenoid muscl (whit rr whead) are ff cing he par glottic fat wi hin the wall of the larynx. This d fines
the lev l of the true cords and also the inferior aspect of the ventricular complex. The anterior and posterior
(open arrowhead) com issures should only be repres nted by a thin mucosal layer. (c) Ther should be no soft tissue
seen internal to the ring of the cricoid cartilage at subglottic lev l.
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Figure 3 (a) Axial, (b) sagittal reformatted CT images with (c) and (d) T1-w coronal MR images illustrating the
submucosal laryngeal spaces. (a) The pre-epiglottic space (open arrowhead) and paraglottic space (white arrowhead) are
seen in continuity. (b) More superiorly the pre-epiglottic space (white arrowhead) is bound anteriorly by the thyrohyoid
membrane (see also (a)) whereas the thyroid cartilage is present anteriorly at a more inferior level (see also Fig. 1a).
The epiglottis is present posteriorly. Soft tissue seen within the superior aspect of the pre-epiglottic space
(open arrowhead) corresponds to the hyoepiglottic ligament. (c) The medial relations of the paraglottic fat (o) are seen to
be the vestibule, the ventricle (long arrow) and the conus elasticus more inferiorly (curved arrow). Laterally it is related
to thyroid cartilage and cricothyroid membrane. The true vocal cord is indicated (*).
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Figure 7. Axial CT scan shows thickening of the anterior commissure by glottic tumor 
(arrowhead). 
!
The cartilage is prone to invasion at this site because the internal perichondrium is deficient and the 
external perichondrium is thinner. The perichondrium covering the cartilage acts as a resistant 
barrier to invasion by tumor (171). It has been shown that cartilage invasion mainly occurs where 
the attachment of the collagen bundles interrupts the perichondrial barrier. As the cancer cells 
multiply, they separate the collagen bundles, forming linear passageways through the 
perichondrium. Thus, the sites of attachment of the strongest membranes, such as the anterior 
commissure tendon, are also the most frequent sites of invasion. Invasion of the cartilage 
framework invariably takes place at the site of ossified or calcified cartilage (172). Non-ossified 
cartilage is resistant to tumor infiltration due to its capacity to release proteins that inhibit tumor 
angiogenetic factor and collagenases (173). Recent published reports have shown that CT may yield 
acceptable sensitivity for detecting neoplastic invasion of laryngeal cartilage if the diagnostic 
criteria are selected and combined appropriately (174). 
However, cartilage invasion is still sometimes overestimated, resulting in unnecessary total 
laryngectomies in some patients (175). 
Previous studies using single-slice spiral CT scanners have concluded that the CT criteria used for 
determining neoplastic invasion of the thyroid cartilage include erosion, lysis, and transmural extra-
laryngeal tumor spread (176-180) (Figure 8). !
Figure 8. Drawing to illustrate the criteria for evaluation of thyroid cartilage invasion. 
Erosion is defined as invasion beyond the inner cortex without reaching the outer cortex (less 
than half of the cartilage width), lysis is defined as almost reach- ing the outer cortex but with 
preservation of the cortex, and extra-laryngeal spread is defined as all-layer invasion through 
both the inner and outer cortex (penetration) of the cartilage, including the extra-laryngeal 
soft tissues (175). !
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the paraglottic fat and extend beneath the cricoid
cartilage to the upper oesophagus from the subglottis.
Laryngeal cartilage invasion
Predicting the presence of laryngeal cartilage invasion is
a key aspect of the imaging assessment. The presence of
significant laryngeal cartilage invasion has been consid-
ered a negative indicator for conservative therapeutic
strategies such as primary modality radiotherapy or
partial laryngectomy, however recent studies have shown
that tumours with limited cartilage involvement may be
cured with radiotherapy[17]. The laryngeal cartilage may
be evaluated with CT or MRI. CT signs of erosion
(Fig. 7a,b) and extralaryngeal tumour of the thyroid,
cricoid and arytenoid cartilages together with sclerosis
(Fig. 7c) of the cricoid and arytenoid cartilages result in
a sensitivity of 64!72% and specificity of 86!94% for
cartilage involvement[18!20]. Sclerosis is the most
sensitive criterion but this often corresponds to reactive
inflammation, particularly with respect to the thyroid
cartilage. MRI criteria for cartilage involvement by
tumour are high signal on fat suppressed T2-w images
and/or enhancement on post gadolinium fat suppressed
T1-w images in the cartilage adjacent to the tumour, or
the presence of extralaryngeal tumour. The most recent
studies describing radiological!pathological correlation
demonstrated slightly improved sensitivity of 89!95%
and reduced specificity of 74!84% relative to CT[18!21].
The accuracy of both techniques is approximately 80%
Figure 5 (a) Axial CT image demonstrates extension of paraglottic tumour to widen the thyroarytenoid gap and invade
the piriform sinus submucosally. (b) Axial T1-w image illustrates how a bulky paraglottic tumour may extend laterally
into the soft tissues of the neck through the thyrohyoid and cricohyoid membranes or through cartilage invasion. This
tumour lies close to but does not encroach on the carotid sheath.
Figure 6 Axial CT scan shows thickening of the anterior
commissure by glottic tumour (arrowhead).
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Tumor may also extend from the anterior commissure to an extra-laryngeal location caudal to the 
thyroid cartilage (via the cricothyroid membrane) and inferiorly to the subglottis. CAT is 75% 
accurate in predicting anterior commissure involvement (181). Predicting the presence of laryngeal 
cartilage invasion is a key aspect of the imaging assessment.  
CAT and MRI are generally used to supplement microlaryngoscopy (MLS) in staging laryngeal 
cancer. Ideally, imaging should be able to predict the tumor size, the exact extension, a possible 
midline crossing, and cartilage infiltration in these lesions. Although CT proved to be helpful in the 
investigation of advanced malignancies (T2–T4), it often fails to show early cancer (Tis, T1 < 10 
mm) due to the almost identical density of tumor tissue and the vocal muscle. With MRI, the same 
difficulties are encountered in demonstrating smaller tumors (Tis, T1 < 9 mm), but the latter can 
better differentiate cancer from muscle tissue and depict invasion of the laryngeal framework (182). 
However, CT and MRI are expensive and cannot be performed during MLS. Further disadvantages 
are the radiation load of CT, the long acquisition times for MRI, and the need for contrast agents in 
both methods. !
- CAT: 
CAT is the preferred imaging method for staging of laryngeal and hypopharyngeal cancer. 
Multislice CAT allows the radiologist to evaluate almost all the relevant imaging issues. Voltage of 
120-140 kVp, tube current of at least 180 mAs, display matrix of 512x512 pixels and a collimation 
of approximately 1 mm should be used. A single bolus of contrast medium is effective, however a 
biphasic contrast enhancement protocol may be employed. The images are obtained with the patient 
supine and during quiet respiration (not while holding the breath). The neck should be in slight 
extension, and the head is aligned along the cephalocaudal axis to allow comparison of symmetrical 
structures. A longitudinal field of view extends from the skull base to the sterno-clavicular joints 
with the patient breathing quietly and not swallowing. Malpositioning may create an appearance 
that simulates disease. Every effort should be made to make the patient feel comfortable. It may be 
helpful to perform an additional examination focused on the tumor with e-phonation (for better 
assessment of the laryngeal ventricle, anterior commissure and aryepiglottic folds) or modified 
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Fig. 2. (A) Drawing to illustrate the criteria for evaluation of thyroid cartilage inva-
sion. Erosion is defined as invasion beyond the inner cortex without reaching the
outer cortex (less than half of the cartilage width), lysis is defined as almost reach-
ing  the outer cortex but with preservation of the cortex, and extralaryngeal spread
is defined as all-layer invasion through both the inner and outer cortex (penetra-
tion)  of the cartilage, including the extralaryngeal soft tissues. (B) Positive finding of
invasion through the outer cortex of the thyroid cartilage in a 56-year-old man  with
glottic cancer. Axial contrast-enhanced CT image at the level of the vocal cords shows
tumor invasion into the thyroid cartilage, spreading into the extralaryngeal soft tis-
sue (white arrows). (C) Positive finding of thyroid cartilage lysis in a 69-year-old
man  with hypopharyngeal cancer. Axial contrast-enhanced CT image at the glottic
level shows a tumor mass arising from the left piriform sinus. The inner cortex of the
left thyroid cartilage shows disappearance of a thin hypo-attenuated line between
the  tumor and the cartilage (arrows), and substitution of cartilage with tumor tissue
as demonstrated by CT attenuation (arrowheads).
Fig. 3. (A) Drawing to illustrate the criteria for negative thyroid cartilage invasion
based  on two  concurrent findings: (1) perfect or almost continuously defined thin
hypo-attenuated line between the tumor and the cartilage (arrows), (2) difference in
CT attenuation between non-ossifying cartilage and the tumor (asterisks). (B) Nega-
tive finding of thyroid cartilage invasion in a 67-year-old man  with hypopharyngeal
cancer.  Axial contrast-enhanced CT image at the level of the false vocal cords shows
a tumor mass arising from the left piriform sinus, but preservation of a dark line
between the tumor and the cartilage is evident (arrows). (C) Negative finding of
thyroid cartilage invasion in a 61-year-old man  with hypopharyngeal cancer. Axial
contrast-enhanced CT image at the supraglottic level shows a tumor mass arising
from  the left piriform sinus. CT attenuation of the non-ossifying cartilage (arrows)
is different from that of the tumor (T).
Valsalva (for better assessment of the priform sinus and post cricoid regions) manoeuvres (175). In 
addition to soft tissue windows, the bone windows (reconstructed with a bony algorithm) should be 
routinely evaluated if the tumor contacts ossified laryngeal cartilage. It should be ensured that axial 
images are reformatted in the plane of the larynx. 
Spiral CAT is entirely dependent on the emergence of “slip ring” technology, which allows 
electrical energy to be transmitted to the gantry as it passes along the patient, allowing acquisition 
of CAT data in a helical fashion. It is also a faster process, with less discomfort to the patient and it 
is dynamic, with high resolution giving slices in continuity (183).  
CAT provides a clearer illustration of bony structures and calcification than does MRI. Moreover, it 
is less expensive, faster and less susceptible to motion artifacts.Sclerosis is the most sensitive 
criterion but this often corresponds to reactive inflammation, particularly with respect to the thyroid 
cartilage. For instance, CAT signs of erosion and extra-laryngeal tumor of the thyroid, cricoid and 
arytenoid cartilages together with sclerosis of the cricoid and arytenoid cartilages result in a 
sensitivity of 64-72% and specificity of 86-94% for cartilage involvement, with an accuracy value 
of approximately 80% (177,184,185). !
- MRI: 
MRI is best performed with a high field MRI scanner. The MR examination requires a neck coil to 
obtain adequate resolution. Section thickness should be 4-5 mm for the neck coverage and 2-3 mm 
(0.1-0.2 mm interslice gap) for the focused study of the larynx. The display matrix size is 170 x 256 
pixels minimum. A combination of T2-w sequences with fat saturation, T1-w sequences and T1-w 
fat saturated sequences with gadolinium, should be used in axial and coronal planes. The sagittal 
plane is also useful to assess potential tongue base involvement. Patients are asked to refrain from 
coughing and swallowing during the acquisition and MRI may produce poor results in the 
breathless or restless patient who is compromised by the tumor.  
MR imaging is most frequently used if there is uncertainty in assessing cartilage involvement, when 
this is critical to therapeutic decisions. It may also better define the margin between the tumor and 
thyroarytenoid muscle and involvement of the tongue base.  
MRI scanning has become increasingly involved as a sensitive imaging modality for detecting 
neoplastic involvement of the thyroid cartilage, primarily because of its high negative-predictive 
value. However, recently has been demonstrated MRI low positive-predictive value (68-71%), due 
to its failure in distinguish edema and inflammation surrounding the tumor from the true cartilage 
invasion (174,177,178). In addition, it could overestimate cartilage invasion (186). MRI criteria for 
cartilage involvement by tumor are high signal on fat suppressed T2-w images and/or enhancement 
on post gadolinium fat suppressed T1-w images in the cartilage adjacent to the tumor, or the 
presence of extra-laryngeal tumor. The most recent studies describing radiological-pathological 
correlation demonstrated slightly improved sensitivity of 89-95% and reduced specificity of 
74-84% relative to CAT; but accuracy still demonstrates value of about 80% as CAT 
(177,178,184,185). Moreover, MRI can be a lengthy and expensive procedure. Ana patient motion 
as simple as swallowing may generate significant artifacts.  
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Moreover, high-resolution MRI had been used to construct a three-dimensional anatomical model of 
the cartilages of the human larynx (187), providing an anatomical framework for registering 
different larynges to the same coordinate space. Lately, a three-dimensional educational computer 
model of the larynx was developed from MRI scans (188). Two recent studies opened new 
directions for applying MRI for laryngeal imaging: MR microimaging of excised larynges 
confirmed valid high-resolution imaging of laryngeal tissue microstructure (189), and dynamic MRI 
of laryngeal and vocal fold vibrations was realized for the first time for measuring of laryngeal 
structures and glottal parameters in dynamic function (190). !
 4.8 Positron emission tomography (PET, CT/PET) 
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an increasing 
roll in the assessment of head and neck cancer, both for primary staging and for post-therapy 
management (191). PET is a functional imaging modality assessing the metabolic status of tumors 
and has proved superior to CT and MRI in differentiating recurrence from post-radiation effects or 
scar in patients with carcinoma of the larynx (191,192). A negative PET scan excludes recurrence 
with a high certainty. Positive PET scan findings should be assessed with biopsy and follow up PET 
imaging if this is negative. It should be noted that physiological uptake of [18F]fluorodeoxyglucose 
([18F]FDG) is observed due to vocal cord activity, so a “silent protocol” should be employed. 
Recent advances in technology make it possible to fuse anatomical images with functional images. 
The use of combined 18F-FDG PET/CT (PET/CT) fusion images has been shown to improve 
diagnostic accuracy (1-3). For head and neck cancers, the reported sensitivity of PET/CT is 98%, 
specificity of 92%, with an accuracy of 94% for the identification of a malignancy of the head and 
neck; this is a higher accuracy than with PET or CT alone (193). Due to its high costs its use is 
advocated in case of uncertain results of CAT or MRI, and to complete pretreatment neck staging or 
in case of suspect for post-radiotherapy recurrence. !
5. Objective of the review. 
The clinical diagnosis of laryngeal pathology is important, as this primarily determines the next step 
towards the treatment. Unfortunately, it is not uncommon for different clinicians to use different 
nomenclature or to identify different stage for the same laryngeal lesion. This obviously makes 
evaluation and comparison among specialists indications difficult, and it does affect the treatment.  
In order to make this inter-observer variability as much lower as possible, attempts should be made 
to improve diagnostic technology, stricter/more universally accepted definitions and supervised 
training of junior doctors in a voice clinic environment. This should in turn lead to useful outcome 
data and treatment recommendations. 
The objectives of this systematic review and meta-analysis were to synthesize the key diagnostic 
management for laryngeal lesions through a review of the latest advances in laryngeal imaging 
modalities published in the past 10 years. !!
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6. Methods. 
The systematic review was performed using independently developed search strategies by the first 
author in literature review methodology. The databases interrogated included PubMed Clinical 
Queries www.ncbi.nlm.nih.gov. Reference lists from identified articles were searched and cross-
referenced to identify additional relevant articles, which we also include in this review, and relevant 
opinion leaders were contacted. 
The search terms included the following various combinations to maximize the yield: larynx, 
laryngeal precancerous lesions, laryngeal cancer, white light endoscopy (WLE), stroboscopy, 
contact endoscopy (CE), autofluorescence endoscopy (AFE), ultrasound (US), narrow band 
imaging (NBI), computed axial tomography (CAT), magnetic resonance imaging (MRI), positron 
emission tomography (PET-CAT/PET).  
The search was performed for the first time on January 2014 and was set to automatically update 
periodically until April 2015. 
First, duplicates were removed electronically. Then, abstracts were reviewed to exclude obviously 
irrelevant articles. Experimental studies and papers dealing with pathologies other than 
precancerous and cancerous lesions of the larynx were excluded.  
The inclusion criteria were deliberately kept wide to encompass as many articles as possible without 
compromising the validity of the results, and they are listed in Table 9. !
Table 9. Inclusion criteria list. 
!
We filtered the studies to ensure that only data from centers that had published on at least 10 
patients were included in the review; this was done as a quality assurance measure as there are 
several case series in the literature, which have published the results of small numbers of cases 
spanning several years. Non-English language papers and duplicates were excluded. 
The search excluded articles that were published before 2005 because we believe that it was 
pragmatic to include articles that were published on each diagnostic technique at least in the last 
decade, allowing time for the learning curve to be climbed for method such as narrow band imaging 
(NBI), came into clinical practice since 1997, and in order to try to compare data as much more 
Inclusion criteria for paper selected for the review
1 Articles published from 2005 onward;
2 Published series of ≥ 10 patients;
3 Sensitivity and specifity clearly shown or detachable;
4 Clear description of selection criteria;
5 Diagnostic methods including: ultrasound analysis, autofluorescence and fluorescent 
analysis, contact endoscopy, endoscopy, stroboscopy, narrow band imagind (NBI), 
computed axial tomography (CAT), magnetic resonant imaging (MRI), positron emission 
tomography (PET);
!42
recent as possible, due to the latest technology progression and the entrance in usage of more 
advanced instruments as magnetic resonance imaging (MRI) with high-resolution or diffusion-
weighted imaging (DWI) MRI. 
All data were independently extracted by two authors and quality assessed. Eligibility for inclusion 
was separately assessed and when in doubt discussed and decided by consensus. 
A first qualitative and descriptive review-analysis of selected articles was carried on; whilst, 
exclusively, publications comparing diagnostic imaging findings with definitive histopathology 
results were included in our meta-analysis. For articles not reporting raw data, letters were sent to 
the corresponding authors requesting them, otherwise they were excluded from the quantitative 
analysis. 
Raw data from the meta-analysis were entered into the appropriate contingency tables to allow 
calculation of sensitivity, specificity, accuracy, Jounden's index, positive and negative predictive 
values for each diagnostic imaging technique.  
In accordance with the literature, malignant (i.e., carcinoma in situ, invasive cancer) were classified 
as positive whereas premalignant lesions (i.e., moderate and severe dysplasia) were classified as 
negative; benign lesions (inclusive of simple hyperplasia and/or mild dysplasia) were calculated as 
negative, as well.  
Similar analyses were performed for the procedure type. Each diagnostic technique was evaluated 
for its capacity in distinguish premalignant from cancerous laryngeal lesions; when possible, every 
method was analyzed for its accuracy in identifying advanced stage cancers from early stages. 
For this reason, in order to fulfill the need to identify the best diagnostic technique for every 
diagnostic step, we made two different meta-analysis: 
1. On articles reporting diagnostic techniques able to make a differential diagnosis between 
preneoplastic and cancerous lesions; 
2. On those diagnostic methods that allow a more accurate analysis of tumor’s volume and 
extension in order to refine the staging phase. !
 6.1 Study characteristics and quality assessment 
To our knowledge, no widely accepted measures of quality assessment of case series exist; here, all 
included papers were graded using the NICE scoring scale for retrospective case series (Available 
at:http://www.nice.org.uk/nicemedia/pdf/Appendix_04_qualityofcase_series_form_preop.pdf). This is a 
scoring scale with eight items, with each item scoring zero or one based on the study methods 
(Yes=1; No=0). Scores of ≥ 6 are considered to indicate a good quality study, scores between four 
and five as fair and those studies with a score of three are treated as poor quality (Table 10). !!!!!!
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Table 10. Quality assessment scale. 
 6.2 Statistics 
Fisher’s exact test was used for statistical analysis of categorical data for the descriptive review, and 
a value of p <.05 was considered significant. 
Then, all the included studies for the meta-analysis, provided sufficient data (true-positive [TP], 
false-positive [FP], true-negative [TN], and false-negative [FN]) to permit calculation of sensitivity 
(Se) and specificity (Sp). Sensitivity and specificity at a 95% confidence interval (CI) were then 
pooled using a bivariate regression approach (194) 
Data were abstracted into Microsoft Excel (Microsoft Corporation, One Microsoft Way Redmond, 
WA 98052-6399) and statistical package R version 2.9 was used for all analyses (The R Foundation 
for Statistical Computing, Vienna, Austria).  
We constructed hierarchical summary receiver operating characteristic (SROC) curves to assess the 
interaction between sensitivity and specificity. The areas under the ROC curves (AUCs) were used 
to analyze the diagnostic precision of each diagnostic technique for differentiation of precancerous 
lesions from cancers and for distinguish advanced star tumors from early stage cases.  
Thereafter, the effect of publication and other bias was assessed visually using a funnel plot, and the 
I2 statistic was calculated (195). This is a measure of heterogeneity between the studies and ranges 
from 0% to 100%; high figures indicate greater heterogeneity in the data.  
When studies have low heterogeneity (pragmatically, I2 < 25%), the differences between reported 
outcomes can be explained simply by the observed natural differences between patients. In this case 
we can consider that all patients are part of the same larger pool. A fixed-effects meta-analysis is 
appropriate in which each patient is given approximately equal weight. However, with high 
heterogeneity, the studies differ by more than can be explained by intrapatients effects. This implies 
that there were differences in the patients studies, in the treatment interventions, or in the outcome 
measures. In this case, a random-effects meta-analysis is appropriate in which each study is given 
more equal weight. 
Quality assessment for case series
1 Case series collected in more than 1 center (i.e.: a multicentric study)
2 Is the hypothesis/aim/objective of the study clearly described?
3 Are the inclusion and exclusion criteria (case definition) celarly reported?
4 Is there a clear definition of the outcomes reported?
5 Were data collected prospectively?
6 Is there an explicit statement that patients were recruited consecutively?
7 Are the main findings of the study clearly described?
8 Are outcomes stratified (i.e.: by disease stage, abnormal test results, patient characteristics)?
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7. Results. 
The search strategy identified 7215 articles in Medline from 1950s to the search date. 3616 articles 
published after the 2005 were selected, imported into Endnote, and the duplicates were removed. 
The removal of duplicates, non-English language works and of articles about other items rather than 
precancerous and cancerous laryngeal lesions yielded a total of 214 publications. 
These 214 publications were considered for the qualitative systematic review of the literature, on 
the other hand, only 41 out of 241 were selected for the meta-analysis. 
The various stages of systematically assessing the abstracts and reasons for exclusion from the 
review are described in Figure 9. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!45
Figure 9. This flow chart illustrates the process that was used to select articles for the review. !
 
!
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Systematic review in April 2015: 
search through MEDLINE
7215 publications obtained
3895 publications excluded because 
published before 2005
3616 titles underwent second review
156 abstracts excluded after initial 
assessment. 
Reasons for exclusion: 
• Not clearly describing aim/objective 
• Not clearly reporting inclusion and 
exclusion criteria 
• Letter, 
• Previously published work, 
• Statistical data not clearly shown or 
detachable;
214 abstracts assessed for eligibility
214 studies included in qualitative synthesis
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3402 publications excluded after initial 
assessment. 
Reasons for exclusion: 
• Focus on other topics: 2975 
• Duplicates: 88 
• Foreign language articles: 339
41 studies included in quantitative synthesis 
(meta-analysis)
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23 articles (I group) out of 41 were addressed towards the differential diagnosis among 
precancerous and cancerous lesions, whilst the remaining 18 articles (II group) were analyzed for 
the assessment of the identification of advanced stage cancers reporting cartilage involvement 
against the diagnosis of early staged laryngeal tumors. 
Quality score assessment and each article clinical characteristics selected for the meta-analysis are 
summarized in Table 11 and 12. !
Table 11. Various contributions of the article selected for the meta-analysis addressed towards 
the definition of the diagnostic precision of white light endoscopy (WLE) (yellow), stroboscope 
(white), contact endoscopy (CE) (light blue), autofluorescence endoscopy (AFE) (grey), 
narrow band imaging (NBI) (red), computed axial tomography (CTA) (orange), magnetic 
resonance imaging (MRI) (green) for laryngeal cancer against precancerous lesions. 
(Some articles analyzed more than one system and they are indicated by * or °;). 
Author Quality 
score
Number of 
study years
Number 
of 
patients
Number 
of 
diseased 
patients
Sensitivity 
(Se)
Specificity 
(Sp)
Younden’s 
Index (J) 
(Se+Sp-1)
Bertino G. et al, 
2015^^^^
5 2 217 143 98.7% 33% 0.20
Kraft M et al., 2014* 6 1 205 57 79% 95% 0.74
Dobre M et al., 2014** 5 1 56 16 85% 75% 0.06
Caffier PP et al, 
2013***
7 1 32 17 100% 94% 0.94
Shang DS et al., 
2013****
6 2 50 33 81.8% 64.7% 0.46
Crosetti E et al., 2012° 7 2 140 62 85.0% 40.0% 0.25
Piazza C et al., 2011°° 5 2,5 444 279 41% 92% 0.33
Ni XG et al., 2011°°° 7 0.5 85 45 68.9% 90% 0.59
Baletic N., 2010°°°° 5 1 45 37 73% 98% 0.71
Piazza C et al., 2010^ 4 1 279 110 33.0% 95.0% 0.28
Watanabe et al., 2008^^              6 1 667 221 51.1% 99.7% 0.51
Saetti R et al., 2007^^^ 6 2 46 23 57.1% 84.8% 0.42
Uloza V et al., 2013 6 2 159 34 85.3% 85.3% 0.60
Puxeddu et al., 2015 4 0,5 44 21 97.6% 97.6% 0.95
Warnecke A et al., 2010 7 1 42 10 90.0% 94% 0.84
Cikojevic D et al., 2008 5 1 142 49 79.59% 100% 0.79
Dobre M, 2014** 5 1 56 16 92% 87% 0.08
Kraft M et al., 2014* 6 1 205 57 91% 84% 0.75
Succo G., 2014 4 4 286 73 96.5% 98.5% 0.95
Caffier PP et al., 
2013***
7 1 32 17 94% 69% 0.63
Crosetti E et al., 2012° 7 2 140 62 86.6% 41% 0.27
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Table 12. Various contributions of the article selected for the meta-analysis addressed towards 
the definition of the diagnostic precision of ultrasound (US) (yellow), computed axial 
tomography (CTA) (orange), magnetic resonance imaging (MRI) (green) and position 
emission tomography (PET-CAT/PET) (purple) for advanced laryngeal tumors with cartilage 
involvement against early staged cancers. 
(Some articles analyzed more than one system and they are indicated by * or °;) 
Baletic N., 2010°°°° 5 1 45 37 89% 78% 0.67
Saetti R et al., 2007^^^ 6 2 46 23 94.3% 91.3% 0.85
Arens C et al., 2006 6 1,5 42 30 97% 82% 0.79
Bertino G. et al., 
2015^^^^
5 2 217 143 97.4%% 85% 0.82
Lukes P et al., 2014 5 3 109 43 100% 82% 0.82
Zobrodsky M et al., 
2014
4 4 66 14 92% 76% 0.68
Kraft M et al., 2014* 6 1 205 57 97% 96% 0.93
Piazza C et al., 2011°°° 5 2,5 444 279 97% 84% 0.81
Ni XG et al., 2011°°° 7 0.5 85 45 89% 93.2% 0.82
Irjala H. et al., 2011 4 0.12 73 35 55% 98% 0.53
Piazza C et al., 2010^ 4 1 279 110 98.0% 90.0% 0.88
Watanabe et al., 2009              6 1 34 23 91,30% 91,60% 0.83
Watanabe et al., 2008^^              6 1 667 221 97.7% 98.9% 0.97
Beser M et al., 2009 7 1 38 11 88% 50% 0.38
Shang DS et al., 
2013****
6 2 50 33 91% 76.5% 0.67
Quality 
score
Number of 
study years
Number 
of 
patients
Number 
of 
diseased 
patients
Sensitivity 
(Se)
Specificity 
(Sp)
Younden’s 
Index (J) 
(Se+Sp-1)
Author
Author Quality 
score
Number of 
study years
Number 
of 
patients
Number 
of 
diseased 
patients
Sensitivity 
(Se)
Specificity 
(Sp)
Younden’s 
Index (J) 
(Se+Sp-1)
Xia CX et al., 2013* 6 3 79 40 91.6% 95.6% 0.87
Hu Q et al., 2012** 6 1 36 26 88.6% 85.5% 0.74
Kraft M et al., 2013*** 7 1 760 308 84% 93% 0.77
Allegra E et al. 
2014****
6 2 20 4 50% 100% 0.50
Han MW et al. 2013 5 12 32 21 57% 94% 0.51
Hartl DM et al. 2013 6 16 236 19 10.5% 94% 0.04
Kraft M et al. 2013*** 7 1 510 228 68% 84% 0.52
Xia CX et al. 2013* 6 3 79 40 72.7% 66.7% 0.40
Hu Q et al. 2012** 6 1 36 26 82.9% 91.6% 0.74
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- I group articles: cancerous vs. precancerous lesions assessment. 
The I group of articles reported an equal number of good (12) and fair (11) quality, in terms of 
determination of laryngeal cancerous lesions against precancerous lesions, a mean value for Se of 
84.425 ± 19.098 SD (95% CI 78.640-90.210, median 90.5%) together with a similar mean value of 
83.031 ± 17.559 SD for Sp (95% CI 77.089-88.972, median 88.5%). These results are referring to a 
good pool of laryngeal lesions analyzed (3301) with a total amount of 1386 cancerous lesions 
identified overall the studied populations. Any statistical significance was found among continuos 
data (p=0.7818). 
In specific, results about WLE precision on identify and distinguish superficial cancerous lesions 
from superficial precancerous lesions reported a very high I2 value for both Se and Sp (81.38% and 
70.82%, respectively), but with a AUC value of 91% (Figure 10). !
Celebi I et al. 2012 6 1 27 18 88.9% 88.9% 0.77
Beitler JJ et al. 2010 7 10 104 41 49% 92% 0.41
Tino Just et al 2010 5 2 35 15 87% 95% 0.82
Beser et al. 2009 6 1 38 26 88% 50% 0.38
Jeong HS et al. 2008 7 2 114 55 82.5% 82.7% 0.65
de Souza RP et al. 2007 7 5 60 14 100% 93.5% 0.93
Fernandes R et al. 2006 5 1 27 15 80% 92% 0.72
Gordin A et al. 2006° 6 2 51 25 88% 38% 0.04
Allegra E et al. 
2014****
6 2 20 4 100% 100% 1
Banko B et al. 2014 6 2 40 19 79% 47% 0.26
Kraft M et al. 2013*** 7 1 150 70 63% 89% 0.52
Kinshuck AJ et al. 2012 5 10 31 22 64% 67% 0.31
Banko B et al. 2011 7 1 34 5 100% 93% 0.93
Becker M et al. 2008 6 1 121 49 96% 75% 0.71
J.Wedman et al. 2009 4 1 10 7 90% 85% 0.75
Gordin A et al. 2006° 6 2 112 66 96% 61% 0.57
Quality 
score
Number of 
study years
Number 
of 
patients
Number 
of 
diseased 
patients
Sensitivity 
(Se)
Specificity 
(Sp)
Younden’s 
Index (J) 
(Se+Sp-1)
Author
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Figure 10. SROC curve from bivariate model of WLE for cancerous lesions vs. precancerous 
lesions identification. 
In regard to the diagnostic utility of WLE, Caffier et al. (196) showed a higher accuracy for WL 
(97% vs. 81%) than AFE and AFE data analysis provided a reduction in specificity of 25% in 
comparison to WLS, together with a high false positive value (31%). These findings were in 
accordance with literature reports (197,198). On the other hand, even if Crosetti et al (199) 
confirmed that sensitivity and specificity of AFE in distinguish between benign and dysplastic/
neoplastic lesions are negatively impacted by different features (i.e.: hypertkeratosis-leucoplakia, 
abnormal hyperplasia, hypervascularized lesions, chronic laryngitis and lesions with bacterial 
infections or previously treated by surgery or radiotherapy), their results were completely different 
from those reported by Caffier et al. (196), indicating a very low accuracy in diagnostics for both 
these single used methods. They concluded supporting their hypothesis that a combination of both 
diagnostic tools allows a rise in sensitivity and specificity of about more than 35% and 25%, 
respectively. Thus, they proposed to combine endoscopic tools through a multistep system, in order 
to obtain a greater sensitivity and specificity, to improve definition in direct microlaryngoscopy and 
in follow-up searching for synchronous/metachronous tumors.  
Only one full text article were selected for the qualitative and quantitative analysis of the 
stroboscope diagnostic methods, confirming the lack of a statistical and accurate analysis of this 
technique in literature. Uloza et al. (200) found moderate-to-high rates of sensitivity (55.9– 85.3%) 
and moderate rates of specificity (51.1–60.0%) of the basic VLS parameters discriminating 
laryngeal carcinoma and other mass lesions of vocal folds. However, optimum system of four 
following VLS variables—regularity, mucosal wave on the affected side, symmetry of vibration, 
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and symmetry of glottal image— increased the sensitivity up to 85.3% and specificity up to 74.4%, 
and a final J index of 0.60. 
Few studies on CE were selected, as well. A recent article published by Puxeddu et al. (102) 
observed an accuracy of CE in the differential diagnosis between normal tissue and dysplasia versus 
carcinoma of 97.6%. Warnecke and colleagues (106) declared a sensibility and specificity achieved 
by CE of 90% and 93.75%, respectively. But among these, only one study compared contact 
endoscopy with frozen section histopathology in 142 patients with lesions of the larynx, where CE 
yielded a sensitivity of 79.59% and a specificity of 100%, with a J index of 0.79 (107). In summary 
we obtained a mean value of 89.0633 ± 9.0415 SD (95% CI 66.6031-111.5236, median 90%) for Se 
and of 97.200 ± 3.020 SD (95% CI 89.689-104.702, median 97.6%) for Sp, with a p value of 
0.3992, showing anyway a higher NPV (97%) than PPV (82%) for CE. 
About 10 years later the introduction of CE into the clinical practice, few publications about 
autofluorescence in laryngology came out; it was 1995 when Harries et al. (124) demonstrated 
through their pilot  in vivo study the autofluorescence properties of the laryngeal tissue and the 
potential accuracy of this system of performing earlier diagnosis and staging of laryngeal tumors. 
Considering at least one decade to allow the flatting of the learning curve, our selected articles 
showed values of Se and Sp of 92.550 ± 3.611 SD (95% CI 89.531-95.569, median 93%) and of 
78.850 ± 17.624 SD (95% CI 64.116-93.584, median 83%), respectively; with a not quite statically 
significant p value of 0.0583. We constructed hierarchical SROC curve to assess the interaction 
between Se and Sp and these were 93% and 80%, respectively with a AUC of 94%. (Figure 11). !
Figure 11. SROC curve from bivariate model of AFE for cancerous lesions vs. precancerous 
lesions identification. 
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Our results confirmed data previously reported by Kraft et al. in their meta-analysis in 2011 (198). 
We performed an up-date of Kraft’s results (198) and we obtained from their combination a final Se 
of 93% (95% CI 0.86-0.97) and a value of 80%  (95% CI 0.68-0.89) for Sp, reporting a lower I2 
value for Se (67%) than for Sp (77%). (Figure 12). !
Figure 12. Meta-analysis of sensitivity and specificity of AFE. 
In specific, Succo et al. (201) highlighted evidence of advantages in allowing precise calibration of 
the entity of superficial resection during trans-oral laser surgery (TLS) as already reported by 
Lucioni and colleagues (202). Kraft et al. (198) through their review of literature found a lower J 
value for AF (0.75) in comparison to the latest publications, but they concluded that FAE is highly 
effective in the early diagnosis of laryngeal cancer and its precursor lesions, and that can be applied 
in the primary detection of these lesions providing a better evaluation of their horizontal extension 
and delineation. However, it is equally recognized that this tool is not as yet qualified to substitute 
for histological work-up. Baletic et al. (203) evidenced many conditions impacting AF features of 
laryngeal mucosa; while Rydell and colleagues (204) confirmed a high value of J index for AF 
(0.89). Saetti et al. (205) revealed a high sensitivity of the AF by the presence of demarcation of the 
cancer limits, with an increase in contrast between the normal and pathological mucosa. Here, the 
gap in sensitivity, between WL and AFE, resulted even more evident, about 37%, than as reported in 
literature; in fact, comparing confident intervals, AFE revealed a significantly higher sensitivity 
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than standard WL (p<0.05). Nevertheless, they insisted in specifying the need of a long learning 
curve and that risks are greatly operator-dependent. 
The most recent diagnostic technique that has been introduced in the clinical practice is represented 
by the Narrow Band Imaging (NBI), in fact, first publications about this method are dated 2007. 
NBI has progressively showed very promising results of both Se and Sp for the differential 
diagnosis of laryngeal precancerous and cancerous lesions in the larynx thanks to its schematic 
classification of abnormalities of the intraepithelial papillary capillary loop (IPCL), that seems to 
have a direct matching with histological features, so far. In fact, Ni and colleagues (135) through 
their proposal of classification of ICPL, obtained a J index for NBI much higher than WLE (0.82 vs. 
0.59), reaching statistical significance in terms of accuracy (p=0.028), sensitivity (p=0.020), and 
negative predictive value (p=0.048), in comparison to WL mode. Greater results, in terms of 
sensitivity, specificity and accuracy of NBI were obtained by Bertino et al. (138), who demonstrated 
the validity of this technique based on lesions’ vascular pattern proposed by Ni and colleagues. Also 
Lukes and coll. confirmed high values of sensitivity and specificity for squamous cell carcinoma 
(100% and 82%, respectively) when IPCL were visible (130); and Kraft et al. (206) confirmed the 
capacity of NBI to easily detect and distinguish malignant and premalignant tumors from benign 
lesions, with a final accuracy of 97%, with a J value of 0.93. Watanabe et al. (136) achieved in their 
cohort of patients a high sensitivity for the NBI, almost equal to AFE (91.3%), but showed a higher 
specificity (91.6%) compared with AF method. In addition, they demonstrated that NBI system can 
evaluate recurrent laryngeal cancers as well as newly developed superficial cancers, which are one 
of the drawbacks to using autofluorescence endoscopy (207). These results were confirmed by 
Zabrodsky et al. recently, in 2014 (208).  
Irjala and coll. (132) supported same results about benefits of NBI accuracy by the addition of high-
definition television (HDTV). In this respect, Piazza et al. (137) showed that the use of high 
definition television (HDTV) NBI system, helped in increasing the rate of diagnosis significantly, 
from 20.8% (without HDTV) to 42.7%, where the sensitivity rase up to 98% starting from 61%, and 
specificity increased by 3%, with a value of accuracy of 92% and a global J index of 0.88, almost 
doubled in comparison to NBI alone. Thus, it seems that HDTV-NBI proves a significant accuracy 
in recognizing true positives and in distinguishing, at the same time, true negatives. 
From our study we can affirm that values of Se and Sp of 91.44 ± 13.279 SD (95% CI 
81.941-100.939, median 97%) and of 89.470 ± 7.529 SD (95% CI 84.084-94.856, median 90.8%), 
respectively; with a difference between Se and Sp not statically significant (p=0.5527). We 
constructed hierarchical SROC curve to assess the interaction between Se and Sp and these were 
94% and 93%, respectively with a AUC of 97%. (Figure 13). !
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Figure 13. SROC curve from bivariate model of NBI for cancerous lesions vs. precancerous 
lesions identification. 
!
Then, we obtained from their combination a final 95% CI 0.83-0.98 for Se and a value of 95% CI 
0.88-0.96 for Sp, reporting a lower I2 value for Sp (61.3%) than for Sp (87.48%). Here the 
hypothesis of hegemony among these different studies was about to be statistically significant (p= 
0.04) (Figure 14). 
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Figure 14. Meta-analysis of sensitivity and specificity of NBI. 
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By comparing AFE and NBI values we can affirm that there is no statistical significancy in terms of 
both Se (p=0.7268) and Sp (p=0.1543), even if the AUC values revealed a slightly higher 
percentage for NBI (97%) than for AFE (94%).  
If we make a comparison between AFE and WL, NBI and WL, we obtain interesting results. In fact, 
in terms of Se AFE showed a higher mean value of 91.914 ± 3.383 SD than WL (71.133 ± 21.579 
SD) with a significant p value of 0.0229; while Sp did not show any statistical significant difference 
(p=0.8699), with a mean value of 78.400 ± 18.987 SD for AFE and of 80.100 ± 22.750 SD for WL. 
If we make the same comparison between NBI and WL, there was a significant difference in terms 
of Se (p=0.0283), referring to values of 88.422 ± 7.171 SD for NBI and of 71.133 ± 21.579 SD of 
WL; but, Sp did not show any statistical significance as well (p=0.3056) where Sp of NBI (89.470 ± 
7.529 SD) was higher than that one of WL (80.100 ± 22.750 SD).  !
- II group articles: advanced stage laryngeal tumor with cartilage involvement vs. early staged 
tumors assessment. 
This group counted a higher number of good quality articles (13 vs. 5), where Se and Sp for 
determination of advanced laryngeal cancers with cartilage involvement presented a mean value of 
78.268 ± 20.611 SD (95% CI 69.760-86.776, median 84%) and 82.140 ± 17.335 SD (95% CI 
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74.984-89.296, median 89%), respectively, calculated on a global number of patients of 1136 with 
an amount of 497 diseased populations (people with cartilage involvement). Any statistical 
significance was found among continuos data (p=0.3855). !
In the search for alternative imaging techniques, which could be performed by the treating 
physician, endosonography has become an important diagnostic tool from the 1960s’.  
Preliminary results have reported a sensitivity of ultrasound in the assessment of laryngeal cancer of 
84%, with a specificity of 93% and an accuracy of 89%; these values were statistical significant in 
comparison to CAT and MRI (p < 0.0001) in accordance with Kraft’s results (209).  
Recent investigations on human laryngeal endosonography, have demonstrated a penetrating depth 
of 10 to 25 mm (depending on the applying frequency) and a high tissue resolution. In fact, in 1994, 
Zech et al. (210) were first to report on this subject on cadavers; some years later, Arens et al. 
(127,165,211) published an experimental study on sonographic anatomy of the larynx and the first 
clinical experiences with this promising method in a variety of laryngeal lesions through the use of 
a flexible miniprobes, with a frequency of 10-30 MHz and a 360 field of view. Independently, 
Tamura et al. (212,213) published similar clinical and experimental studies with the same probe. 
Tsui and colleagues (214) in 2011 first characterized the lamina propria and the vocal muscle by 
ultrasound in order to describe biochemical properties of the vocal folds. 
Thus the promising properties of ultrasonography of the larynx, some authors made comparison 
among this emergent tool and standard diagnostic images acquisition. In fact, Hu et al. compared 
sonography to MRI (163) and CAT (160) in the evaluation and staging of glottic carcinoma, and 
their results revealed that there was no statistical difference among these two technique in pre-
therapeutic staging accuracy (80% vs. 76.7%; p>0.99), and (83.3% vs. 88.8%; p=0.735) 
respectively, suggesting ultrasonography as a noninvasive complementary modality for detection 
and initial staging of glottic carcinoma. In fact, when landmarks, i.e. ventricular bands and vocal 
cords, for localization are clearly identified by ultrasonography, laryngeal tumors could be correctly 
located (p=0.392) (162). Moreover, they showed the utility of ultrasonography in diagnosing the 
neoplastic spread to the paraglottic space, evidencing its significative higher specificity in 
comparison to CAT (94.9% vs. 66.7%; p=0.001). With a final J value for sonography of 0.907 
against a value of 0.667 for CAT. 
From our few selected articles we can affirm that we obtained a Se and Sp for US of 88.067 ± 3.828 
SD and of 91.367 ± 5.244 SD, respectively, accordingly to recent reports. 
About the predictability of CAT in the determination of laryngeal cartilage invasion it varies 
considerably among the most recent published reports (Table 13). With a low mean value for 
sensitivity of 64.194 ± 20.862 SD (95% CI 53.468-74-921, median 66%) in contrast to a higher 
mean value of 82.782 ± 22.289 SD for specificity (95% CI 72.322-95.242, median 91%). This 
comparison presents a significant p value of 0.0199. !!
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Table 13. Sensitivity and specificity of CAT in identifying laryngeal cartilage invasion, various 
reports. 
!
We can see how different reports are in contradiction; for instance, Gordin et al. (191) showed a 
CAT sensitivity in identifying cartilage involvement of 88%, with a very low specificity (8%); 
results that have been disproved by Allegra and colleagues (218) who found CAT values of 50% 
(sensitivity) and 100% (specificity), respectively for identification of cartilage invasion. Despite this 
conflicting final results, if we compare reports published before 2005 to the most recent works, we 
do not find any statistical significances among these two groups in terms of sensitivity (p=0.3367) 
and specificity (p=0.2574) for tumor cartilage involvement. 
From our analyzed studies (see Table 12) we can affirm that values of Se and Sp of 71.750 ± 23.428 
SD (95% CI58.223-85.277, median 81.25%) and of 83.029 ± 18.474 SD (95% CI 72.362-93.695, 
median 91.8%), respectively; with a difference between Se and Sp not statically significant 
(p=0.1691).  
The pooled sensitivity and specificity of CAT for advanced tumors with cartilage involvement rate 
were 74% and 84%, respectively, with a AUC of 85%. (Figure 15). !
Author Year Sensitivity (%) Specificity (%)
Castelijns et al. 1988 46 91
Sulfaro et al. 1989 47 88
Becker et al. 1995 66 94
Zbaren et al. 1996 67 87
Becker et al. 1997 61 92
Amilibia et al. 2001 54 91
Gordin et al. 2006 88 8
Fernandes et al. 2006 80 92
Jeong et al. 2008 83.3 83.3
Beser et al. 2009 88 50
Just et al. 2010 87 95
Beitler et al. 2010 49 92
Celebi et al. 2012 89 89
Kraft et al. 2013 68 84
Hartl et al. 2013 11 94
Han et al. 2013 57 94
Allegra et al. 2014 50 100
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Figure 15. SROC curve from bivariate model of CAT for advanced stage cancers with 
cartilage involvement vs. early staged cancers identification. 
The Figure 16 provides the forest plot of studies that contributed to these results and the spread data 
with 95% CI for each study represented by horizontal lines. We obtained from their combination a 
final 95% CI 0.51-0.88 for Se and a value of 95% CI 0.55-0.96 for Sp, reporting a very high I2 value 
for both Se (87.7%) and Sp (95.91%), where the lowest rates of Se were reported by Hartl et al. 
(220) and Allegra and colleagues (218), whilst Gordin and Beser (191,222) showed the lowest rate 
for Sp.  
Here the hypothesis of hegemony among these different studies was not statistically significant 
(Figure 16).  
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Figure 16. Meta-analysis of sensitivity and specificity of CAT. 
It is obvious that over the last decade the sensitivity of CAT has improved considerably, rising its 
median value by about 10% and thus canceling the previous reported significancy between Se and 
Sp of CAT in identifying laryngeal cartilage involvement.  !
From the 1980s’ the magnetic resonance imaging (MRI) saw it enter in clinical practice. 
Its predictability in the determination of laryngeal cartilage invasion varies considerably among 
published reports, as it has been shown of CAT as well (Table 14). With a mean value for sensitivity 
of 84.713 ± 14.958 SD (95% CI 72.207-97.218, median 87.85%) in contrast to a mean value of 
79.563 ± 17.007 SD for specificity (95% CI 63.344-93.781, median 82.75%) This comparison did 
not present a significant p value (0.3321). !!!!!!!
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Table 14. Sensitivity and specificity of MRI in identifying thyroid cartilage invasions, various 
reports. 
!
Those reports that were analyzed for the meta-analysis showed through the SROC curve an 
interaction between Se and Sp of 86% and 83%, respectively with a AUC of 91%. (Figure 17). !
Figure 17. SROC curve from bivariate model of MRI for advanced stage cancers with 
cartilage involvement vs. early staged cancers identification. 
!
The Figure 18 provides the forest plot of studies that contributed to these results and the spread data 
with 95% CI for each study represented by horizontal lines. The pooled sensitivity and specificity of 
MRI for advanced tumors with cartilage involvement rate were 86% and 83%, respectively, with a 
Author Year Sensitivity (%) Specificity (%)
Becker et al. 2008 96 75
Lim et al. 2011 84.8 89
Banko et al. 2011 100 93
Kinshuck et al. 2012 64 67
Kraft et al. 2013 63 89
Shang et al. 2013 90.9 76.5
Banko et al. 2014 79 47
Allegra et al. 2014 100 100
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final 95% CI 0.62-0.96 for Se and a value of 95% CI 0.64-0.93 for Sp. Moreover, heterogeneity of 
the studies included in this analysis was very high for both sensitivity (83.29%) and specificity 
(83.79%), where the lowest rates of Se were reported by Kraft et al. (209), whilst Banko et al. (224) 
showed the lowest rate for Sp. Here the hypothesis of hegemony among these different studies was 
not statistically significant, too. !
Figure 18. Meta-analysis of sensitivity and specificity of MRI. 
!
In the 1990s’ PET and CAT/PET entered into the clinical practice and Gordin et al. (191) showed 
how the combination of CAT and PET can reach a better sensitivity and specificity in comparison to 
PET study by itself (92% and 96% vs. 92% and 73%, respectively).But, for the first time, Jeong et 
al. (193) showed that PET/CT findings do not add to the conventional work-up for the initial 
evaluation of glottic cancer any further advantages that would support the additional cost of this 
exam. 
By comparing CAT and MRI values we can affirm that there is no statistical significancy in terms of 
both Se (p=0.1708) and Sp (p=0.6274), even if the AUC values revealed a higher percentage for 
MRI (91%) than for CAT (85%). !!
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8. Discussion. 
Advanced image analysis procedures are used in laryngeal diagnostics with increasing frequency. 
Nonetheless, the image analysis procedures used are quite often limited to image visualization, for 
example, in indirect autofluorescence laryngoscopy. Quantification of color, texture, and shape of 
lesions and normal tissue could help in a more accurate categorization of lesions as well as in 
follow-up procedures. !
- White light endoscopy and stroboscopy. 
WLE together with stroboscopy remain the clinical key element for detecting and assessing vocal 
fold lesions, representing the essential diagnostic technique for evaluation of laryngeal mucosa and 
vocal fold motion biomechanics. Videostroboscopy especially, is the most practical and useful 
procedure for clinical assessment of viscoelastic properties of the phonatory mucosa, seems to be 
the reason for the superior sensitivity and specificity of WLS in glottic lesions over other diagnostic 
methods with continuous non stroboscopic light sources such as AFE. It realizes beneficial 
visualization and quantification of mucosal wave properties and phonatory oscillations, allowing 
reliable conclusions in terms of clinical diagnosis.  
In this setting the article written by Cohen and colleagues (230) is worthy to be mentioned because, 
even if it did not meet all of the inclusion criteria to be enrolled for our meta-analysis, it showed a 
high quality score of 7 and gave the image of the actual skyline about general ear-nose-throat (ENT) 
practice in the U.S.A. analyzing factors influencing the common clinical practice and how this 
could engrave patients management.  
It is well known that stroboscope is critical in the diagnosis of voice disorders, it can alter the 
treatment decision in 14% to 33% of cases in otolaryngology practice (86). Djukic et al. (231) 
evidenced that the presence of some factors  at the stroboscopic analysis placed patients at higher 
risk of recurrence and progression of the disease.  
In clinical practice, decision-making is quite often based on subjective evaluation of video data, but 
stroboscopy will continue to be a useful tool for the clinical evaluation of the patient with dysphonia 
as long as the clinician is aware of the deficiencies of stroboscopy (99). In terms of quantitative 
evaluation of the VLS using basic parameters this tool seems to be reliable in clinical settings with 
high sensitivity and specificity distinguishing healthy and pathological voice patients groups, with a 
low  interclass correlation (ICC) value, ranging from 0.2 to 0.9 (232). Limitations of quantification 
of VLS variables originate from inherent restrictions of stroboscopic examination, which is 
basically an optical illusion made by the human eye, arising from the virtual reconstruction of 
adjacent phases of periodic oscillatory samples (200). 
Accordingly to these limits, a combination of VLS with other diagnostic procedures is advocated. 
Peretti et al. (233) in their study showed 82% specificity and 100% sensitivity of VLS in diagnostic 
of glottal carcinoma; however, the combination of VLS with saline infusion into Reinke space 
raised the values of specificity up to 89% and sensitivity up to 100%. Gugatschka et al. (91) 
demonstrated that the combination of cytology and pathological VLS allowed detection of glottic 
cancer with a sensitivity of 97%, in contrast to 74% as found by cytology alone. 
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- Contact endoscopy. 
CE allows for the detection of very early pathologic areas not visible with WL or not properly 
interpreted with image-enhanced endoscopy (IEE) alone by targeting biopsies, which reduces the 
chance of under treatment. Contact endoscopy has, in the hands of an experienced examiner, a high 
negative predictive value (97%); nevertheless, it must be measured against the current gold 
standard, the histopathological assessment of the biopsy samples.  
This technique has shown a number of advantages: (1) ensures a non invasive and safe repeatable 
method; (2) when performed pre-operatively it provides an insight into the microscopic margins of 
the laryngeal mucosa lesion; (3) it can be used intra-operatively to ensure that the lesion has been 
completely removed; (4) it allows visualization of the microvascular net, which can assist the initial 
diagnosis of early laryngeal lesions. As CE supplies intraoperative information on the type of 
laryngeal pathology, thus significantly influencing the subsequent operative course, the criteria for 
malignancy are set high in order to minimize the use of unnecessary operative procedures as already 
demonstrated by Puxeddu et al. (102), and by Ledda et al. (111), confirming the significant role of 
ECE for more comprehensive staging and management of early cancer of the UADT. In fact, false 
negative result will only delay optimal operative or other therapeutic intervention until 
histopathology results are obtained, whereas an operative procedure performed on the basis of a 
false positive result may imply major and irreversible error. In this view, CE can be very useful to 
the surgeon, and the operative procedure can be more safely continued on the basis of the findings 
obtained. 
Warnecke et al. (106), calculated the inter-rater reliability (k value) which was of 0.81 between the 
examiners rating contact endoscopic findings, thus showing an obvious correlation between the 
diagnosis of the experienced and inexperienced examiner. However, when compared to the current 
state-of-the-art diagnostic measure, histopathology, a stronger correlation with the otolaryngologist 
(kappa 0.81) than with the cytopathologist (kappa 0.61) was found. It is striking that the 
otorhinolaryngologist tended to overrate malignancies. 
On the base of Cikojevic results (107) obtained from contact endoscopy are therefore nearly as 
reliable as frozen section pathology. Intraoperative contact endoscopy shall be considered as an 
addition to histopathology rather than as a replacement. Accordingly, the advantages of contact 
endoscopy are the immediate results, its instant availability, and the possibility of examining many 
mucosal areas in a short time and directly during surgery. 
- Autofluorescence. 
When imaged with an autofluorescence system, healthy laryngeal mucosa fluoresces bright green, 
whereas neoplastic mucosa appears red-violet (234), probably as a result of the thickened neoplastic 
epithelium preventing the illuminating light from reaching the basement membrane and collagen, 
which would normally provide fluorescence. In 2006, Arens and his colleagues (130) affirmed that 
it is not possible to detect the responsible endogenous fluorophore from the remitted 
autofluorescence light because it is a summation spectrum, and in thickened precancerous and 
cancerous mucosa (>300 µm) the light beam is not able to penetrate. On the contrary, Wang et al. 
(235) described a penetration depth of blue light (400 nm) in mucosal tissue of 500 µm, whilst 
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Gottschalk (236) found a penetration depth of just 300 µm. Therefore, normal vocal fold mucosa 
with a thickness of 120 µm can easily be penetrated by the light beam. 
Several studies have demonstrated that autofluorescence endoscopy and spectroscopy are better at 
identifying invasive carcinoma when compared with microlaryngoscopy alone 
(116,119,204,128,129); but Dobre et al. (237), admitted to have problems in differentiating different 
grades of dysplasia, and to not be able to distinguish in situ carcinoma from invasive cancer. 
In summary, despite the reported higher sensitivity value (93%) of AFE, which compared to the 
white light endoscopy Se has improved in percentage showing a statistical significancy of 
p=0.0229, together with a better AUC value (94% for AFE vs. 91% for WLE), these mixed results 
of literature (116,126,128,130,238) image the high grade of heterogeneity found in our study, that 
could be linked the high incidence of false positive results with a still rather low Sp (80%). 
In fact, due to the high absorption of excitation light by haemoglobin, false positives (decreased 
autofluorescence with a nonmalignant histopathology) occurred more frequently in the presence of 
highly vascularized lesions such as telangiectasic polyps, granulation tissue, papillomas; while they 
were relatively common in case of scar tissue or pronounced local inflammatory reactions of the 
mucosa. Bacterial plaques and necrotic tissue can lead to a defect of autofluorescence that leads to 
false positive findings. 
On the other hand, false-negative findings [negative autofluorescence despite (pre)malignant 
histopathology] were generally rare and resulted mostly from pronounced hyperkeratosis of the 
examined areas that caused optical “masking” of clinically significant lesions. A dark field in an 
image may be the results of a shadow from an anatomic structure over this field. In attention to 
avoid false positive and false negative findings, we recommended simultaneous careful comparison 
of white light and autofluorescent images of same view. 
Both effects: (1) epithelial thickening of (pre)malignant tissue with inhibited penetration of exciting 
light into submucous layers and (2) the altered metabolism of tumor cells with lower concentration 
of NADH and FAD, are claimed to be mainly responsible for the reduced total AF in neoplastic 
laryngeal tissue (197). 
These considerations are basic as far as concerns the application field of this method. In accordance 
with Delank et al. (128), we consider that  AFE is not useful in the evaluation of “frankly benign” 
laryngeal lesions. 
- Narrow Band Imaging. 
The introduction of narrow band imaging (NBI, Olympus Medical System Corporation, Tokyo, 
Japan), already proven to be an useful screening method in other medical fields, has recently shown 
its potential in identifying carcinomas at an early stage in head and neck mucosal sites 
(136,139,239,240). The NBI filter sets (415 nm, which is the hemoglobin absorption band, and 540 
nm) are selected to obtain fine images of microvascular structures of different types tissue, which 
are necessary for diagnosing a tumor at early stage. 
Ni and colleagues (135) proposed a classification based on the superficial vascular patterns in 
laryngeal lesions enhanced with NBI, with a diagnostic accuracy of 90.4% (sensibility, specificity, 
and positive predictive value were respectively 88.9%, 93.2%, and 90.9%) in detecting malignant 
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lesions from carcinoma in situ to invasive carcinoma; they correlated the superficial spots to 
vascular anomalies, but the technique with only NBI offers only a partial and sometimes subjective 
interpretation of the patterns, not allowing to recognize the deepest changes of the vasculature in the 
chorion. Previous studies have not described intraepithelial papillary capillary loop features in 
detail, and their data analysis indicated that intraepithelial papillary capillary loop features were 
closely related to histopathological findings with a statistical significance. Thus, the classification of 
intraepithelial papillary capillary loop features may facilitate the prediction of laryngeal cancer or 
precancerous lesions. However, the presence of necrotic tissue or a thick white patch on lesions may 
affect the evaluation of intraepithelial papillary capillary loop features, especially for invasive 
carcinoma, resulting in false negative findings.  
From our results NBI showed a rise in Se in comparison to AFE (94% vs. 93%), together with an 
improvement of its Sp which increased of more than 10%, but without any statistical significancy 
(p=0.1543). This could be explain by the high grade of I2 for Sp (87.48% for NBI vs. 77% for AFE) 
which seems to be correlated to the unavoidable subjective interpretation of optical features 
requested by these two tools. If we compare Se of NBI and WL, a further significant result comes 
out (p=0.0283), highlighting the evident and promising improvement in sensitivity and false-
negatives incidence guaranteed by these two diagnostic techniques whose preliminary results have 
been first published in 1995 and 2007, respectively. Moreover, NBI showed a further increase in 
accuracy in comparison to AFE, reaching a value of AUC of 97%. 
In specific, AFE in comparison with NBI, presents a lower specificity because some benign lesions 
also display a loss of green fluorescence; in addition, mucosal scars and inflammation often cause 
false positive results (Johnson FL. Management of advanced premalignant laryngeal lesions. Curr Opin Otolaryngol Head 
Neck Surg 2003;11: 462–6;); in contrast, Ni et al. (135) indicated that these conditions, classified as type II 
or III under NBI, can be easily differentiated from type V lesions. Lukes et al. declared that their 
result may be influenced by very low numbers of benign lesions in their study group (150), and that 
some of the associated endoscopic characteristics to each single laryngeal lesions, such as the 
surface, the presence of multiple lesions, and the spread to both vocal cords, may be taken as the 
criteria used for a more accurate diagnosis.  
- Ultrasound. 
In the literature, there exist only a few publications on endosonography of the larynx. Most of them 
were purely experimental studies on cadaver specimens (210,211,213). In 1999, Arens et al. (165) 
published the first clinical experiences in 38 patients presenting with 23 laryngeal cancers and 15 
benign lesions. Two years later, Tamura et al. (212) performed a retrospective study of 16 patients 
with 2 malignant and 14 benign vocal fold lesions. Both authors used 360° radial scanning flexible 
miniprobes with a frequency of 10 to 30 MHz. Because the interpretation of endolaryngeal 
sonograms can be influenced strongly when the definitive histopathology is already known, the 
predictive value of endosonography can be depicted only if an investigation is performed in a 
prospective and blinded manner. To our knowledge, the study of Kraft et al. (209) is the only 
prospective clinical trial assessing the value of endosonography compared with CT and MRI in 
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staging laryngeal cancer. For this reason, a real comparison of our results with the literature is not 
possible. Generally, there are no contraindications to perform endosonography of the larynx.  
The two main limitations of laryngeal ultrasonography are the thyroid cartilage ossification and the 
air contained in the larynx (163). But modern real-time high-frequency sonography has remarkably 
improved the imaging resolution (241). Despite these limits, one study showed for sonography a 
sensitivity in detecting laryngeal cartilage invasion of 100% (242), which is a well known crucial 
concern for patients outcome. Rothberg et al. (243) stated that sonography was superior to 
unenhanced computed tomography for evaluation of cartilage invasion. Microscopic invasion of the 
cartilage may be missed at the ultrasonography. Several authors (159,160,163)reported an accuracy 
rate for detection of anterior commissure involvement of 86.7% for ultrasonography, 80% for MRI 
and 89% for CAT, without any statistical significance (p=0.688); together with accuracy values on 
sonography of 83.3%, 80%, and 83.3% for supraglottic, subglottic and paraglottic areas 
respectively, on MRI of 90%, 83.3%, and 86.7%, and on CAT of 94.4%, 88.9%, 91.7%  (p>0.99). 
Our results confirmed these promising prospectives showing a global Se value of 88% with a higher 
percentage of Sp (91%). 
- Computed Axial Tomography and Magnetic Resonance Imaging. 
Both CAT and MR imaging are routinely used for detection of subtle cartilage invasion, but there is 
still controversy about which modality can most accurately detect cartilage invasion, and both 
modalities have shortcomings (175).  
CAT continues to be widely used for diagnosing cartilage invasion. In fact, although MRI is 
significantly more sensitive, it is less specific than CAT in detecting neoplasm cartilage invasion 
(177,185). Advantages of MRI include superior soft tissue contrast and exact delineation of tumor 
margins (220,244), where the cartilage invasions is usually overestimated for anterior commissure 
tumor. 
Radiologic criteria for CAT diagnosis of cartilage invasion include sclerosis (increased density of 
the cartilage or high attenuation), lysis, erosion, and extra-laryngeal tumor spread (cartilage 
discontinuity with tumor extending through both the inner and outer cortices). When determining 
whether erosion or lysis is present or absent, differentiation from cartilage invasion may sometimes 
be difficult using conventional CT; some cases may be distinguished from erosion if two concurrent 
findings of negativity are identified: a perfect or almost continuously defined thin hypo-attenuating 
line between the tumor and the cartilage, and CT attenuation of non-ossifying cartilage that differs 
from that of the tumor. Demonstrating tumor invasion of non-ossified cartilage is problematic with 
CT due to similarity of the CT density (100 HU), making them almost indistinguishable, especially 
when the tumor is located adjacent to non-ossified cartilage. In addition, the appearance of 
laryngeal cartilage on CT varies widely according to differences in the proportions of hyaline 
cartilage (which ossifies with aging), cortical bone, and fatty marrow, which complicates 
interpretation. 
On the other hand, MRI is more sensitive (sensitivity up to 96%) in this situation since tumor is of 
increased T2-w signal relative to non-ossified cartilage (175). Unfortunately MRI has a tendency to 
overestimate cartilage involvement by tumor since it may be indistinguishable from that due to peri-
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tumoral inflammation. These changes are most commonly seen in the thyroid cartilage so 
specificity is lowest at this location. New criteria of moderately high T2-w signal and moderate 
enhancement as compared to the marked signal changes and gadolinium enhancement with 
inflammation, have been proposed to overcome this problem. Alternatively the lower specificity of 
MRI may be addressed by performing a corroborating CT scan in the presence of an MRI scan 
positive for cartilage invasion (245). The introduction of multi-slice CT has resulted in an increase 
of spatial and temporal resolution but has led to little progress in interpretation of cartilage invasion 
which is still sometimes overestimated. If the cartilage displays a signal intensity similar to that of 
the tumor, cartilage invasion should be suspected. Contrast-enhanced MR imaging is also useful 
when evaluations by CT alone are insufficient for excluding cartilage invasion, and have reached 
high  sensitivity (96%) and high negative predictive values of up to 96%, but still maintaining a low 
specificity (178,229). However, the MR findings suggestive of cartilage invasion are not specific, 
and therefore may lead to a number of false positive signs. The reason is that reactive inflammation, 
edema and fibrosis in the vicinity of a tumor may demonstrate diagnostic features similar to those of 
cartilage invasion. Inflammatory changes are most common in the thyroid cartilage, and therefore 
the specificity of MR imaging for detecting invasion of the thyroid cartilage is only 56–65% (229). 
Furthermore, due to motion artifacts that degrade images resolution, together with lacks of thin 
sections and the easier incidence of overestimation of tumor extension, MRI is not a satisfactory 
first choice for imaging of laryngeal and hypopharyngeal cancer (175). Despite these differences in 
Se and Sp, there is no statistical significance between CAT and MRI in cartilage invasion 
assessment (175).  
In literature, the pretherapeutic staging accuracy of laryngeal carcinoma has been reported to be 86 
and 87.5% with CAT and MRI, respectively (246); moreover, MRI is more sensitive than CAT and 
presents h a high negative predictive value for detection of neoplastic cartilage invasion (177,215). 
On the other hand, CAT is more specific, but less sensitive method than MRI for the detection of 
neoplastic cartilage invasion (229). In this respect, cartilage invasion is critical not only for tumor 
staging, but also for outcomes (229).  
Our results despite the higher accuracy value of MRI (91%) than of CAT (85%), no statistical 
significances were issued. This could be explain that further more accurate analysis on specific 
subgroup of patients with thyroid cartilage involvement should be carried on for both tools by using 
similar techniques and coils, especially for MRI. !
9. Limitations. 
All papers included in this study are retrospective works mainly from individual institutions and are 
prone to the bias involved with retrospective studies. While objections can be raised about the 
pooling of different diagnostic procedures under the same group and the high level of heterogeneity 
in the meta-analyses, the inclusion of over 4400 patients makes the results fairly robust. This study 
was unable to access non-English language papers owing to limited resources. The authors suspect 
that addition of this literature will not substantially alter the conclusions of this study, given the 
large numbers that have contributed to the results. 
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In addition a substantial cohort of patients in non-English language literature would have been 
duplicated in English language literature as these procedures are done by select centers who have 
published extensively in both English and non-English language. !
10. Conclusions. 
• Limitations of laryngoscopy and clinical examination include: submucosal intralaryngeal growth 
of tumors and invasion of the laryngeal cartilages and of the extralaryngeal soft tissues cannot be 
detected and large supraglottic and glottic tumors create difficulties in evaluating portions of the 
larynx more caudal in location.  
• The discrepancy in diagnosis between video-laryngo-stroboscopy (VLS) and suspension 
microlaryngoscopy (SML) highlights certain key points: (1) additional glottic lesions could be 
noted in less than 10% of cases; (2) SML does not alter diagnosis but might lead to undertake 
management changes; (3) accordingly, surgical consent must be exhaustive and specifically 
address the notion of ‘‘hidden’’ lesions, some of which may influence the extent of surgery 
performed. The patient age, treatment modality, and stroboscopic signs, such as abnormal 
amplitude of vocal fold vibration and the existence of non vibrating segment, can be considered as 
warning factors for recurrence and disease progression and discussion of possible contralateral 
vocal fold involvement is recommended.  
• In our opinion, the clinical experience of the examiner regarding precise application and 
evaluation of the available WLS appears to be more reliable in diagnosing vocal fold lesions than 
AFE, which is a relatively nonspecific method for diagnostics of mucosal tissue changes. AFE can 
be proposed as a promising noninvasive optical diagnostic procedure in more than 85% of cases, 
but the interpretation of its results requires knowledge of its basis principles and pitfalls of this 
technique. 
• Contact endoscopy offers a cost-saving, fast, repeatable, and risk-free examination that could 
considerably reduce the time to diagnosis or at least help to localize the region of interest to 
enable more specific biopsy sampling for histological evaluation. But, thus it gives information on 
only the three most superficial cell layers, due to the limitation in staining with methylene blue, 
further investigations are necessary to develop dyes that can also stain deeper cell layers.  
• The AFE procedure provides a better evaluation of the horizontal extension in cancerous lesions 
then WLE alone. It is short, easy to perform and without complication and biopsy is not required; 
thus, it could significantly improve the diagnostic efficacy of laryngeal pathology, due to a more 
precise assessment of boundaries of lesion with AFE, and the fact that AFE could serve as a guide 
for taking biopsy of lesion and endoscopic laser resection of laryngeal lesions. On the other hand, 
an intrinsic limit of the method is the impossibility to evaluate the extension of the carcinoma in 
the deeper tissues and, therefore, to differentiate between carcinoma in situ and invasive 
carcinoma.  
• NBI endoscopy can be performed during a normal daily work in outpatient clinic by pushing a 
fingertip control switch, without using special techniques, without drug application. The most 
prominent feature of this technology both in the pre- and intraoperative setting is a more accurate 
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definition of the neoplastic superficial spreading with consequent improvement of the peripheral 
margins control and modulation of the custom tailored endoscopic treatment. It is, however, 
important to understand that it is not black and white reading and therefore one still needs an 
experienced clinician on the field and, even with an expert, a learning curve of the new technique 
has to be taken into account. During this period one has to be prepared for more time-consuming 
examination and very likely for some extra biopsies before the eye is trained for the NBI.  
• US present irrefutable advantages in comparison to CAT and MRI scans, which count: a lower 
benefit-costs ratio, absence of swallowing artifacts due to the general anesthesia, a real-time and 
repeatable mode, a closer relationship between diagnostics and therapy thus the treating surgeon 
performs the diagnostic technique at the same time. Then, it is suggested as a noninvasive 
complementary modality for the detection and initial staging of glottic carcinoma. On the other 
hand, disadvantages such as its limited availability, the need of performing this procedure under 
general anesthesia, lesions smaller than 3mm are not detectable (anyway, still earlier than with 
CAT or MRI), together with its strong dependence on the examiner’s experience, make the use of 
this tool optional and not straightforward.  
• Imaging, conventionally with computed axial tomography (CAT) and/or magnetic resonance 
imaging (MRI), is nearly always required as endoscopic staging alone may underestimate the 
extent of the tumor. Both can enable the accurate prediction of the site, size, and spread patterns 
of laryngeal tumors. MRI is more indicated for unilateral lesions due to its higher Se (96%) and 
NPV (96%) than CAT in identifying cartilage involvement, even if MRI presents a higher 
incidence of false-positives. In these cases a CAT scan could be performed in order to increase the 
specificity of the study. In case of bilateral vocal cords lesions, CAT seems to improve its Se and 
it could be proposed as first line diagnostic pre-treatment tool. 
We could summarize this bullet list in the following flow-chart (Figure 19). !
Figure 19. This flow-chart images the diagnostic steps that would be suggested for the clinical 
assessment and management of laryngeal lesions suspicious for precancerosis or cancer. Two 
different types of scenario are reported: 1. Unilateral vocal cord lesion, and 1. Bilateral vocal cord 
lesion/s. Once white light endoscopy plus stroboscopic study represent standard office-based 
analysis, further following steps depends on the previous analysis result. The presence or absence of 
the mucosal wave at the stroboscopic test influences the management of the patient. In the first case 
an intraoperative phase is planned, on the other hand, the second scenario worths second level 
diagnostic tools, such as MRI and/or CAT. Then, an intraoperative superficial and/or three-
dimensional visualization of the lesions is mandatory. One tool among CE, AFE and NBI is 
suggested, even if the most accurate result should come out from the combination of at least two out 
of them tests. If US or OCT is available its use could help in the lesions’ volume identification, 
especially for bulky neoplasms that does not reach the inner cortex without any laryngeal movement 
impairment. The final resection margins check could be trust in CE or NBI help. For the clinical 
follow-up WLE and stroboscopic exams are always mandatory, together with a further second level 
instrumental diagnostic tool, which usually counts CAT and/or CT/PET, so far. 
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WLE + NBI
Clinical Follow-up
CAT or CT/PET
Instrumental Follow-up
1 vocal cord 
involved
both vocal cords 
involved
Mucosal wave 
present
Mucosal wave absent Mucosal wave absent Mucosal wave present
Intra-operative 
management
Pre-operative 
management
Pre-operative 
management
WLE + Stroboscopy
Intra-operative 
management
Diseased vc + contralateral 
vc superficial check: 
• CE: hyperkeratosis, 
leucoplakia, dysplasia, 
OR 
• AFE: more Se for 
carcinoma, 
plus 
• NBI; !
Diseased vc + contralateral vc 
depth check: 
•US or OCT;
Diseased vc + contralateral vc 
superficial check: 
• CE: hyperkeratosis, 
leucoplakia, dysplasia, 
OR 
• AFE: more Se for 
carcinoma, 
plus 
• NBI; !
Diseased vc + contralateral vc 
depth check: 
• US or OCT;
Intra-operative 
exeresis
Resection margins check: 
•CE or NBI;
Resection margins check: 
•CE or NBI;
MRI 
± CAT CAT
Anterior commissure check: 
• US or OCT;  !
Laryngeal mucosa superficial 
check: 
• AFE plus NBI;
Intra-operative 
exeresis
Intra-operative 
exeresis
Resection margins check: 
•CE or NBI;
Intra-operative 
management
11. Clinical implications. 
• To avoid any condition that will obstruct visualization during AFE, SAFE-3000 system and high 
definition white light endoscopy camera (HDTV camera) are worthy to be used. The learning 
curve is rather rapid, but there is the need, especially in indirect laryngoscopy, to avoid any 
condition in fact, anatomical sites variation, such as an omega-shaped or retrograde-positioned 
epiglottis could imitate AF defects at the anterior commissure and anterior third of vocal folds due 
to shadows from these structures. Artificial defects of the AF signal also can result from 
hypertrophic ventricular folds, creating shadows over the lateral part of the vocal folds.  
• Compact endoscopy is the latest modification of above techniques, which combines 
autofluorescence and contact endoscopy together.  
• The future objective should be to introduce the NBI technique into routine laryngoscopy and to 
use an internationally accepted endoscopic evaluation of the vascular patterns of lesions of the 
head and neck area. In this way, case studies can be compared based on the same classification, 
which can contribute to the further definition of the diagnostic validity of the technique, and to the 
identification of any misleading case. Despite the high benefit of NBI in distinguishing 
precancerous lesions from cancerous lesions, there is little benefit of NBI in identifying advanced 
tumors, which are readily seen in conventional WLE. Nevertheless, NBI is able to better specify 
their exact extension and show infiltration of neighboring structures. Additionally, NBI might 
detect second primaries or field cancerization in these patients (138) and it presents a potential 
advantage in post-treatment surveillance (247-249). Compared to AFE, NBI endoscopy has the 
advantage of being able to obtain the same information using both a videoendoscope coupled with 
a HDTV camera and rigid telescopes (137).  
• Compared with CAT and MRI, US has the advantage of earlier detection of smaller tumors (T1 >3 
mm) as well as improvement in determining their exact size and extension at significantly lower 
costs. Smaller cancers (Tis, T1 <3 mm) and their precursor lesions can be better assessed through 
optical coherence tomography (OCT), whereas advanced tumors (T2–T4) still require additional 
imaging techniques such as CT or MRI (250). Moreover, it permits observation of vocal cord 
mobility in real time (154,160162). In this setting, it is a promising tool for studying the 
physiology of the vocal folds in phonation function. Further studies must be conducted to clarify 
the role of the vocal fold body in the vibration of vocal folds.  !
12. Research implications. 
• Future prospective randomized clinical trials are necessary for a detailed assessment of the 
contribution from the most promising diagnostic tools, NBI and US, to the in vivo diagnosis of 
malignancies.  
• In this setting, a noninvasive imaging technique that allows histologic diagnoses to be made in 
vivo, without taking a biopsy, will have potential significant benefits for the patient pathway. First, 
by focusing attention onto areas that have histologic features of malignancy this would reduce the 
risk of non diagnostic or unnecessary mucosal biopsies from healthy mucosa, which is 
particularly important for lesions on the vocal cords where preservation of the delicate superficial 
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lamina propria is crucial for generating a normal voice. Second, it will potentially offer greater 
certainty about the position of tumor margins and facilitate decision-making during surgical tumor 
resection. Third, it may ultimately allow definitive histologic or molecular diagnoses to be made 
in the outpatient’s clinic, removing the need for a general anesthesia and significantly shortening 
the patient’s journey toward definitive treatment. 
• Furthermore, primary research is required to validate other emerging techniques, such as Raman 
spectroscopy, and to develop their clinical applications in the larynx.  
• The availability of powerful low-cost digital cameras and image-processing methods should help 
to standardize the analysis routines that may be used for clinical analysis. Collaboration between 
the clinician and the scientist in developing the software for imaging and analysis will go far in 
improving the knowledge base between clinical care and objective results. 
• Finally, future automatic imaging analysis systems could perform the real quantification of images 
with diagnostic purpose. Essentially three-dimensional imaging of the superficial lamina propria 
is yet undeveloped. Toward that end, future evaluation about optical coherence tomography 
(OCT) as a new technique to evaluate the layered microstructure of the vocal fold could be 
implemented. OCT represents the optical analog of ultrasound and involves the detection of light 
backscattered off tissue boundaries (changes in refractive index). OCT has demonstrated to be 
potentially used intraoperatively for accurate staging of locally invasive laryngeal tumors, thanks 
to its spatial resolution of <10 µm (112). On the wake of promising OCT’s results, the future 
deliver of an “optical biopsy” of the mucosa will improve the reach of a intraoperative diagnosis. 
Thus, OCT could be added to standard SML, allowing, in some instances, to remove the need for 
taking a tissue biopsy, maybe by replacing frozen section, and to guide surgeons towards more 
significant and representative areas of the suspect lesion. Moreover, OCT might become helpful 
during trans oral laser surgery since it provides a guide in tumor resection margins in three 
dimensions.  
• Another important objective to be covered is the statistical analysis of the biomechanical 
parameters extracted from a large population database of voice samples, including different 
pathological cases as well as normal ones, taking into account side conditions such as sex, age, 
and habits. !
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